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It is a source of embarrassment to me that, after having argued at length that protein synthesis 
is regulated by mechanisms which operate in the cytoplasm of the cell, I am unable to provide 
any serious body of experimental evidence concerning the precise chemical nature of this 
regulation.
Sir Henry Harris
Nucleus and cytoplasm. Oxford: Clarendon Press (1974).
If it don't fit, don't force it
Just relax and let it go
Just 'cause that's how you want it
Doesn't mean it will be so
If it don't fit don't force it
Composed by Larry Farrow and Carolyn Johns, interpreted by Kellee Patterson (1978).
 

Acknowledgments
I wish to thank:
Helge for trusting me as his first PhD student, for giving me the chance to work on an 
exciting and challenging topic, and for his continuous help in moving things forward during the 
last four years, always in a positive and motivating manner.
All the present and past members of the lab, for a very friendly and professional 
working atmosphere.
My thesis committee, Anne Ephrussi, Joy Alcedo, and Frederick Meins for their 
scientific support.
The Boehringer Ingelheim Foundation and the Novartis Research Foundation for 
financial support.
Carianne, my family: Mam's, Pap's, Alex, Paup, and Mike, and my friends: Nicolas, 
Philippe, Tiana, Keo, Marie, Vanessa, Julien, Tina, Almuth, and Claudia for their essential 
contributions to my happiness, sometimes challenged by the ups and downs of life and scientific 
research.
 

Table of content
1. ....................................................................................................Summary	

 1
2. ...............................................................................................Introduction	

 3
2.1. ..........................................................................................Regulatory noncoding RNAs	

 3
2.2. ..........................................................................................................microRNA biology	

 7
2.2.1. ...............................................................................The discovery of microRNAs	

 7
2.2.2. ..........................Biogenesis and post-transcriptional regulation of microRNAs	

 11
2.2.3. Publication: “Regulating the regulators: mechanisms controlling the maturation 
..................................................................................................of microRNAs” 	

 13
2.2.4. ...............................................................................microRNA modes-of-action 	

 25
2.2.5. ...................................................................Biological functions of microRNAs	

 33
2.3. ...........................................................................................................Aim of this work	

 37
3. .............................................................................Results and discussion	

 39
3.1. Publication: “The let-7 microRNA interfaces extensively with the translation 
...................................................................machinery to regulate cell differentiation” 	

 39
3.2. Publication: “Repression of C. elegans microRNA targets at the initiation level of 
..........................................................................translation requires GW182 proteins” 	

 49
3.3. ..........................................................................................................Additional results	

 75
3.3.1. ........................................................................................................Introduction	

 75
3.3.2. .................................................................................................................Results	

 77
3.3.3. ................................................................................................................Figures	

 81
3.3.4. .........................................................................................Material and methods	

 87
3.3.5. ..........................................................................................................Discussion	

 89
4. ...............................................................................................Conclusion	

 95
5. ............................................................................................Bibliography	

 97
6. ....................................................................................Curriculum vitae	

 109
 

1. Summary
microRNAs (miRNAs) are a large family of small non-coding RNAs, which post-
transcriptionally repress numerous genes; a type of regulation which is important for countless 
physiological processes of multicellular organisms in health and disease.
miRNAs are genomically encoded and transcribed as long precursors, which undergo a 
refined and tightly regulated maturation process giving rise to ~22 nucleotide-long RNAs. These 
small RNAs function as part of an RNA-protein complex termed miRNA induced silencing 
complex (miRISC). miRNAs, and by extension miRISCs, typically bind partially 
complementary elements in the 3' untranslated region (UTR) of target messenger RNAs 
(mRNAs), which become consequently repressed. A large set of studies clearly indicates that 
miRISC-mediated repression is achieved in metazoans by a variable combination of target 
mRNA degradation and translational repression. However, the phase of translation that is 
inhibited is a controversial subject. Various models have been proposed, based mostly on the 
study of artificial target reporters, which support either an initiation or a post-initiation block 
model. Argonaute proteins are core component of the miRISC and directly bind miRNAs. The 
GW182 protein, another miRISC component, has recently emerged as an essential mediator of 
miRNA-mediated repression action. However, its precise molecular function is still unclear.
The work presented here aimed at understanding the in vivo mechanistic aspects of 
miRNA-mediated repression in more details, using the nematode Caenorhabditis elegans as a 
model organism and focusing on the well characterized let-7 miRNA. Initial results from a 
large-scale genetic screen revealed a strong genetic interaction between let-7 and various 
translation initiation factors, leading me to propose that C. elegans miRNAs inhibit the 
initiation of translation on their target mRNAs. Additional genetic experiments uncovered an 
unsuspected widespread genetic interaction between let-7  and the translation machinery and 
suggested that let-7 might function by inhibiting the eukaryotic translation initiation factor 3 
(eIF3) activity. Biochemical experiments demonstrated that a large set of C. elegans miRNA 
targets are translationally repressed at the initiation step, sometimes in combination with 
mRNA degradation, and that the C. elegans GW182 homologs AIN-1 and AIN-2 are essential 
for these mechanisms. Additional unpublished data revealed that translational repression is 
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specifically mediated by AIN-1, whereas depletion of both AIN-1 and AIN-2 is necessary to 
prevent miRNA target degradation.
Collectively, these results show that C. elegans miRNAs employ at least two mechanisms 
in vivo, i.e. target degradation and inhibition of translation initiation, which are likely to be 
independent pathways.
2
2. Introduction
2.1. Regulatory noncoding RNAs
Molecular biology has been traditionally centered on the view that RNA molecules 
merely represent message transporters between the DNA encoded genetic information and 
functionally active proteins. In higher eukaryotes, this view has been challenged based on 
several observations (reviewed in (Mattick 2003)). First, in higher organisms the number of 
protein-coding genes is not only lower than expected, but also fails to reflect biological 
complexity: humans contain only about 30% more protein-coding genes than the simple 
nematode Caenorhabditis elegans (approximately 25‘000 and 19‘000, respectively). At the 
same time, the ratio between noncoding and coding sequences of the genome increases from 1,3 
in C. elegans to 47 in humans (Frith et al. 2005). Second, although the human euchromatic 
genome is composed of only 1.2% percent of protein-coding genes (Consortium 2004), more 
than 90% of it is likely to be transcribed on one or both strands (Birney et al. 2007). Indeed, 
~98% of the transcriptional output of mammalian genomes is composed of noncoding 
transcripts (Mattick 2003). Third, an increasing number of noncoding RNAs has been shown to 
be functionally active, regulating processes as diverse and important as chromosome structural 
organization and messenger RNAs (mRNAs) translation (reviewed in (Amaral et al. 2008)). 
Fourth, these noncoding RNAs appear to be developmentally regulated (Dinger et al. 2008) and 
in some cases, associated with diseases (reviewed in (Szymański and Barciszewski 2008)). 
Finally, promoter regions of noncoding genes do not only contain binding sites for common 
transcription factors (Cawley et al. 2004) but are also generally more conserved than the ones of 
protein-coding genes (Carninci et al. 2005). These accumulating evidences point to a much 
broader role of RNA molecules than previously acknowledged in the function, and more 
importantly, the regulation of cellular processes. Although there is still some debate about how 
much noise this high level of noncoding transcription represents, it has been proposed to have 
allowed higher eukaryotes to integrate the network of information needed to develop highly 
complex biological processes (Mattick 2001). In parallel to the “RNA world”  hypothesis, which 
proposes that DNA-based organisms originated from a cellular and pre-cellular RNA-based life, 
the idea of a “modern RNA world”  has been proposed, postulating that RNA is a more optimal 
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material than protein for certain functions and is therefore also employed for recently evolved 
and sophisticated tasks (Eddy 2001).
Regulatory noncoding transcripts are generally referred to as long or small noncoding 
RNAs, i.e. longer and shorter than approximately 300 nucleotide (nt) long. Rather than an 
objective size threshold, this classification reflects the fact that the former are much less 
characterized than the latter, which have only their relative small size in common. The 
importance of long noncoding RNAs is just starting to be appreciated and few paradigms of 
regulation mediated by these are appearing (reviewed in (Wilusz et al. 2009)). In general, such 
RNAs can modulate the transcription of downstream genes, either in trans or in cis, influence 
the processing of transcripts by base-pairing mechanisms, modify the activity of protein-binding 
partners, or serve as precursors of small RNA molecules. One outstanding example, due to its 
physiological importance, is X-chromosome inactivation (XCI). XCI is initiated by the 
recruitment of the Polycomb complex by the RepA noncoding RNA expressed from the Xist 
gene, which in turn induces repressive chromatin modifications on the chromosome to be 
inactivated (Zhao et al. 2008). It is likely that more regulatory mechanisms relying on long 
noncoding RNAs are yet to be discovered.
Regarding small noncoding RNAs, much attention has been brought to the so-called 
small silencing RNAs. Since their discovery in the early 1990s, they were shown to play an 
important role in regulating gene expression. The best understood classes of small silencing 
RNAs are the small interfering RNAs (siRNAs), microRNAs (miRNAs), and the more recently 
identified Piwi-interacting RNAs (piRNAs) (reviewed in (Ghildiyal and Zamore 2009)). 
siRNAs, miRNAs, and piRNAs share some similarities: they range between 20 to 30 
nucleotides in size, they associate with members of the Argonaute (Ago) protein family, and 
typically induce repression of target genes via a base-pairing mechanism. Beside these 
commonalities, these RNAs follow different biogenesis pathways, interact with distinct sets of 
factors, and are implicated in different regulation mechanisms.
The effects of small silencing RNAs were first documented in plants. The use of antisense 
transgenes of chalcone synthase (CHS), which encodes for an enzyme involved in flower 
pigmentation, resulted in a decrease, rather than an increase, of pigmentation intensity, due to a 
strong downregulation of endogenous CHS mRNA levels (van der Krol et al. 1988; Napoli et al. 
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1990). The exact mechanism involved remained elusive until further studies conducted in 
plants, Drosophila melanogaster, and C. elegans revealed that gene silencing can be triggered 
by long double stranded RNAs (dsRNAs), which are processed by Dicer, a type III 
endoribonuclease, into siRNAs (Fire et al. 1998; Hamilton and Baulcombe 1999; Hammond et 
al. 2000; Zamore et al. 2000; Bernstein et al. 2001). In brief, siRNAs function as part of the 
Ago-containing RNA induced silencing complex (RISC), which is recruited to target transcripts 
by perfect antisense base-pairing. Ago proteins direct the endonucleolytic cleavage (slicing) of 
targets and the resulting RNA fragments are rapidly degraded (reviewed in (Carthew and 
Sontheimer 2009)). This process, i.e. the conversion of long dsRNAs into siRNAs followed by 
post-transcriptional gene silencing (PTGS), has been termed RNA interference (RNAi). The 
discovery of RNAi had a deep impact on our understanding of molecular biology, both as tool 
and as a natural phenomenon (Novina and Sharp 2004). Exogenous long dsRNAs, from viruses 
or transgenes were originally thought to be the unique source of siRNAs, and therefore RNAi 
was essentially seen as a defense mechanism against foreign nucleic acids. It was later 
discovered that siRNAs can also be produced from endogenous triggers in plants and animals 
and control the expression of endogenous genes and transposons (reviewed in (Vazquez 2006; 
Okamura and Lai 2008)). In addition to playing a role in PTGS, siRNAs are also involved in 
heterochromatin formation in plants, fission yeasts, flies and nematodes (reviewed in (Buhler 
and Moazed 2007)), highlighting the broad action range of this type of small RNAs.
piRNAs differ significantly from siRNAs and miRNAs: they are produced by a poorly 
understood, but Dicer-independent, mechanism from single stranded precursors (reviewed in 
(Klattenhoff and Theurkauf 2008)). They interact with the Piwi clade of Ago proteins, whereas 
siRNAs and miRNAs do so with the Argonaute clade (see below). Their expression is restricted 
to the germline, where they seem to silence retrotransposons and thereby protect germline DNA 
integrity (Klattenhoff and Theurkauf 2008).
miRNAs represent the third well defined class of small silencing RNAs. miRNA biology 
is relatively well understood, due to extensive research efforts over the last 10 years. Yet, some 
aspects still remain unclear, especially about their precise mode-of-action. In the following 
sections, after a brief introduction about miRNA discovery, I present our current understanding 
of miRNA biogenesis, mode-of-action, and biological functions.
5

2.2. microRNA biology
2.2.1. The discovery of microRNAs
C. elegans develops to adulthood through four larval stages (L1 to L4), each separated by 
a molt. During this development, cell division patterns are essentially invariant among 
individuals, both in time and space, and have been extensively mapped (Sulston and Horvitz 
1977; Kimble and Hirsh 1979). This makes it possible to study mutants in which these patterns 
are altered. The locus of the first known miRNA, lineage-4 (lin-4), was initially described in 
1981 for this reason (Chalfie et al. 1981). In lin-4 animals, certain cells reiterate L1 parental 
division pattern during the L2 and L3 stages. Additionally, and probably consequently, lin-4 
mutants exhibit a delayed developmental timing and fail to form the adult cuticle, termed alae. 
(Chalfie et al. 1981). During the following years, numerous genetic and biochemical studies 
from the Ambros and Ruvkun laboratories helped understanding the role of lin-4 (reviewed in 
(Neilson and Sharp 2008)). It appeared that lin-14 loss-of-function (LOF) animals have a 
phenotype opposite to lin-4. Cells which adopt a retarded phenotype in lin-4 animals show a 
precocious development in lin-14 LOF, that is they adopt a L2 fate at the L1 stage already. 
Conversely, lin-14 gain-of-function mutations induce a similar phenotype as lin-4 mutations. 
Further analyses showed that lin-4 is epistatic to lin-14. It also became clear that elements in 3' 
untranslated region (UTR) of lin-14 mRNA were necessary and sufficient to allow lin-4 to 
repress lin-14 expression from the L2 stage onward. Nevertheless it was not before 1993 that 
the molecular identity of lin-4 was elucidated: a ~22 nucleotide-long RNA with partial antisense 
complementarity to elements of the lin-14 3'UTR (Lee et al. 1993). The lin-4 - lin-14  interaction 
established the paradigm of miRNA action: a small RNA represses the expression of a target 
mRNA by binding imperfect complementary elements in its 3'UTR. However, before becoming 
a classical example, this regulation was considered only as a curiosity: one small non-conserved 
RNA regulating one mRNA in C. elegans.
This all changed 7 years later with the discovery of a second C. elegans miRNA: 
lethality-7 (let-7) (Reinhart et al. 2000). let-7, which, as its name implies, is required for worm 
viability, was identified by a genetic screen devised to find new heterochronic genes, i.e. genes 
which, like lin-4  and lin-14, regulate developmental timing. Reinhart and co-workers showed 
that let-7 expression starts at the L3 stage and represses lin-41 expression, which in turn allows 
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the lin-29 transcription factor to be expressed and worms to properly reach the adult stage. 
Because similarly to lin-4, let-7  was shown to be a heterochronic gene itself and to regulate 
other members of this pathway, these RNAs were termed small temporal RNAs (stRNAs). 
However, this denomination was replaced by "microRNA" when it became clear later that not 
all members of this family regulate developmental timing.
Realizing that let-7 was not restricted to C. elegans, but highly conserved among 
bilaterians, with 100% homology between C. elegans and H. sapiens (Pasquinelli et al. 2000), 
gave its momentum to the miRNA field. Three studies, simultaneously published in Science in 
2001, reported the identification of numerous small RNA similar to lin-4 and let-7 in D. 
melanogaster and C. elegans and suggested to name this class of RNA "microRNA" (Lagos-
Quintana et al. 2001; Lau et al. 2001; Lee and Ambros 2001). At the same time, few miRNAs 
were also identified in Arabidopsis thaliana (Reinhart et al. 2002). 
Since 2001, the number of known miRNA did not stop to grow. The current miRBase 
release (13.0) refers almost 10'000 miRNAs among which 187 in A. thaliana, 152 in D. 
melanogaster, 155 in C. elegans, and 706 in H. Sapiens (Griffiths-Jones et al. 2008). Beside 
plants and metazoans, miRNAs have also been detected in some viruses (reviewed in (Cullen 
2009)) and in the unicellular algae Chlamydomonas reinhardtii (Molnár et al. 2007; Zhao et al. 
2007), suggesting that this type of RNA is evolutionary ancient.
Altogether, miRNAs represent today a large family of molecules regulating many genes 
relevant to important cellular and physiological processes (see section 2.2.5.). They are defined 
by a few common features which set them apart from siRNAs or piRNAs. They do not derive 
from long dsRNA molecules like siRNAs, but from hairpin-folded single stranded precursors, 
which undergo a specific maturation process (see section 2.2.2. and 2.2.3.) and, unlike piRNAs, 
require Dicer for their biogenesis. Additionally, at least in animals, they normally do not induce 
target endonucleolytic cleavage like siRNAs, but rather mediate target repression via a 
combination of translation inhibition and mRNA destabilization (see section 2.2.4.). This 
difference is thought to result mainly from the nature of the binding between miRNAs and their 
targets. Animal miRNAs, except for a few counterexamples (Yekta et al. 2004; Davis et al. 
2005) and contrary to plants miRNAs, bind target RNAs with limited complementarity, mostly 
restricted to the 5' region of the microRNA, the so-called "seed" region (reviewed in (Bartel 
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2009)). Another striking feature of miRNAs is that, although artificial binding sites placed in 
mRNA 5'UTRs or open reading frames (ORFs) seem functional (Saxena et al. 2003; 
Kloosterman et al. 2004; Lytle et al. 2007), endogenous binding sites are almost exclusively 
located in the 3'UTR of target mRNAs. One notable exception is the human miR-10a, which 
binds to mRNA 5'UTRs. However these interactions do not silence, but rather seem to stimulate 
target expression (Orom et al. 2008).
Similarly to siRNAs and piRNAs, miRNAs function in a complex with Ago proteins 
(reviewed in (Hutvagner and Simard 2008)). Ago proteins are essential for the function of small 
silencing RNAs and define the core of RISCs. They contain two RNA-binding domains: PAZ 
(PIWI/Argonaute/Zwille) and Piwi, which interact with the 3' and 5' ends of small silencing 
RNAs. Agos are present in bacteria, archea and eukaryotes and have undergone a high degree of 
gene duplication, especially in plants and metazoans. There are 8 Ago genes in humans, 5 in D. 
melanogaster, 10 in A. thaliana and 27 in C. elegans. Based on phylogenetic analysis, these 
genes can be classified in three groups: the Argonaute-like proteins (similar to A. thaliana 
AGO1), the Piwi-like proteins (similar to D. melanogaster PIWI), and the C. elegans specific 
group 3 Argonautes (Hutvagner and Simard 2008). Some Agos are specialized for one type of 
small silencing RNA. For example, piRNAs interact exclusively with Piwi-like Agos. Similarly, 
two out of the 27 C. elegans Agos are specific for miRNAs: ALG-1 and ALG-2 (Grishok et al. 
2001).
9

2.2.2. Biogenesis and post-transcriptional regulation of 
microRNAs
miRNA biogenesis is a multistep process. The production of ~22 nt-long miRNAs starts 
with the transcription of a primary-miRNA (pri-miRNA) of hundreds, sometimes thousands of 
nucleotides. Pri-miRNAs are first cleaved in the nucleus by the Drosha-Pasha complex to 
produce ~70 nt-long precursor miRNAs (pre-miRNAs). Pre-miRNAs are then exported in the 
cytoplasm where their cleavage by Dicer produces mature miRNAs able to associate with the 
RISC complex, termed miRISC in this case, and direct target transcript repression (this pathway 
is presented in more details in the review included in section 2.2.3.). Initially, miRNA 
biogenesis was thought to be a rather passive process. It was assumed that pri-miRNAs are 
directly and automatically converted into active miRNAs. However, an ever-increasing number 
of evidence shows that miRNA maturation is tightly regulated. This aspect of miRNA biology is 
reviewed in detail below (Ding et al. 2009). Since the publication of this review, two facets of 
miRNA life-cycle regulation have seen significant developments. These are the regulation of 
let-7  processing by the pluripotency factor LIN28 and the discovery of an active miRNA 
turnover mechanism in C. elegans.
The Lin28 gene, in addition to being a let-7  target itself, encodes an RNA-binding protein 
which regulates the processing of let-7 family members, i.e. let-7 and other miRNAs with 
identical 5' sequence. It has been proposed that Lin28 directly competes with Drosha and Dicer 
for the binding of the pri-miRNA and pre-miRNA intermediates, respectively (Newman et al. 
2008; Rybak et al. 2008; Viswanathan et al. 2008). A subsequent study suggested that LIN28 
induces pre-let-7 3' uridylation, which blocks its processing and directs it for degradation (Heo 
et al. 2008). Two recent studies in human cell lines and mouse embryonic stem cells 
substantiated this model by identifying the terminal uridyl transferase 4 (TUT4) as the enzyme 
involved in this process (Hagan et al. 2009; Heo et al. 2009). Moreover, a similar mechanism 
has been found to occur in C. elegans via the poly(U) polymerase PUP-2 (Lehrbach et al. 2009). 
Uridylation of miRNA intermediates is therefore a conserved mechanism and a potentially 
important way of regulating miRNA maturation. Interestingly, the addition of a 3'-terminal 
adenine to the mature miR-122 by the poly(A) polymerase GLD2 was recently shown to 
stabilize this miRNA in human hepatocytes (Katoh et al. 2009). These studies indicate that 
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sequence modification of miRNAs or miRNA precursors might be a widely employed 
mechanism to selectively regulate their processing and stability.
It is conceivable that mature miRNA level, and thereby activity, might also be regulated 
by an active degradation mechanism. However, besides the identification in plants of SDN1, a 
"small RNA degrading nuclease" able to degrade miRNAs in vitro (Ramachandran and Chen 
2008), there was so far no evidence for such a mechanism. Recently, Chatterjee and Grosshans 
showed that C. elegans mature miRNA levels are modulated by the 5' to 3' exonuclease XRN-2 
(Chatterjee and Grosshans 2009). XRN-2 depletion was shown to elevate the levels of several 
miRNAs and to reinforce let-7 target repression in vivo. Additionally, in vitro experiments using 
larval lysates suggested that miRNAs are first released from Ago proteins before being degraded 
by XRN-2. Interestingly, this release step can be blocked by the addition of target RNA 
molecules to the lysates. This suggests that the presence of miRNA targets might indirectly 
regulate the level of their cognate miRNAs and implies that miRNA clearance might be 
triggered by the disappearance of their targets.
Considering the broad effects of miRNAs on many biological processes (see section 
2.2.5.), it is not surprising that their activity has to be precisely controlled. Recent data now 
show that this control can take place at every step of the miRNA life-cycle, from pri-miRNA 
transcription to mature miRNA clearance.
12
2.2.3. Publication: “Regulating the regulators: mechanisms 
controlling the maturation of microRNAs” 
13
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Regulating the regulators: mechanisms
controlling the maturation of
microRNAs
Xavier C. Ding1, Jan Weiler2 and Helge Großhans1
1 Friedrich Miescher Institute for Biomedical Research (FMI), Maulbeerstrasse 66, WRO-1066.1.38, CH-4002 Basel, Switzerland
2Novartis Pharma AG, NIBR Biologics Center, Forum 1 Novartis Campus, WSJ-088.4.02, CH-4056 Basel, Switzerland
MicroRNAs (miRNAs) are small noncoding RNAs that
control diverse cellular and developmental events
through repression of large sets of target mRNAs.
Regulated transcription of the genes encoding miRNAs
by RNA polymerase II promotes specific expression pat-
terns of individual miRNAs. However, recent studies
have established that substantial regulation of mature
miRNA accumulation also occurs after transcription.
Here, we review the mechanisms of such post-transcrip-
tional regulation, with a particular focus on examples
where molecular mechanisms or physiological prin-
ciples are beginning to emerge. Elucidating these mech-
anisms will increase our understanding of gene
regulation and provide new insights into causes of
miRNA misexpression in diseases such as cancer.
Introduction
MicroRNAs (miRNAs) are a large class of genomically
encoded 22 nucleotide (nt)-long RNAs that regulate target
mRNAs in plants and animals through an antisense mech-
anism [1,2]. The first miRNA, lin-4, was identified in a
genetic screen for mutations causing abnormal temporal
regulation of cell differentiation in the nematode Caenor-
habditis elegans [3], and it was initially considered to be
unique to this organism. However, in the 15 years since,
small RNA cloning and computational sequence analysis
have tremendously expanded the number of known miR-
NAs and of organisms in which they occur; currently, there
are 695 miRNAs known in humans, 488 in mouse, 152 in
the fly Drosophila melanogaster and 154 in C. elegans
(miRBase 12.0, http://microrna.sanger.ac.uk/sequences/;
[4]). miRNAs thus outnumber even large classes of regu-
latory proteins such as kinases, providing a first indication
of the pervasiveness of gene regulation by miRNAs.
Indeed, each miRNA has several, possibly dozens or even
hundreds of targets (e.g. Refs [1,5,6]), which it recognizes
by binding to partially complementary sequences in the 30
untranslated regions (30UTRs) of the target mRNA [2].
Binding of the target results in repression of the target
mRNA through mechanisms that have not been fully
elucidated but seem to involve translational repression,
deadenylation and degradation of the target mRNAs [2].
Consistent with their abundance, miRNAs are involved
in various developmental and cellular processes, regulat-
ing, for instance, stem cell fates, apoptosis andmetabolism,
and miRNA dysregulation has been implicated in various
diseases, particularly cancers [1,7]. Accordingly, much
effort has been put into developing robust profiling
methods for miRNA expression patterns (Box 1) as exper-
imental tools for the biologist and potential diagnostic tools
for the clinician.
Although mature miRNAs are only !22 nt long, their
biogenesis is a complex affair; transcription of a primary
miRNA (pri-miRNA) of several hundred or thousands of
nucleotides in length is followed by two processing steps
mediated by the two nucleases Drosha and Dicer, respect-
ively, and then loading of the mature miRNA into a func-
tional protein complex containing an argonaute (AGO)
protein at its core (Figure 1; [7,8]). We are now beginning
to learn that the miRNA maturation events are highly
regulated, subjecting these small post-transcriptional reg-
ulators of gene expression themselves to extensive post-
transcriptional control. We will discuss here recent work
that has begun to elucidate some of the regulatory mech-
anisms, which can be specific for individual or a few
miRNAs or can affect miRNA expression more globally.
We will point out examples where physiological con-
sequences of such regulation are beginning to emerge.
Given the numerous examples where aberrant miRNA
expression contributes to pathologies, we predict that
these regulatory principles will provide important
insights into molecular mechanisms of disease and might
ultimately yield novel targets for therapeutic interven-
tion.
miRNA biogenesis: the main players
Transcription of the pri-miRNA is the first step along a
complex pathway that generates an active RNA-induced
silencing complex (RISC) loaded with a mature miRNA –
the so-called miRISC (Figure 1). Although a few miRNAs
seem to be transcribed by RNA polymerase III [9], the bulk
of pri-miRNAs is transcribed by RNA polymerase II, the
same enzyme that produces protein-coding mRNAs and is
accordingly subject to similar intricate means of transcrip-
tional regulation [7,10]. Indeed, a large fraction of
vertebrate miRNAs is encoded in the introns of protein-
coding host genes, with whom they are thus co-transcribed.
However, the promoters of ‘intergenic’ pri-miRNAs – that
is, those that are encoded outside protein-coding host genes
– are also subject to input from numerous transcriptional
Review
Corresponding author: Großhans, H. (helge.grosshans@fmi.ch).
0167-7799/$ – see front matter ! 2008 Elsevier Ltd. All rights reserved. doi:10.1016/j.tibtech.2008.09.006 Available online 13 November 2008 27
16
regulators [7]. Aberrant miRNA expression, which is fre-
quently associated with cancer [1], could thus be a con-
sequence of deregulated pri-miRNA transcription. Indeed,
many genes encoding miRNAs are located at fragile chro-
mosomal sites or chromosomal regions exhibiting altered
copy numbers or genetic rearrangements in cancer [11].
The identification of common putative regulatory motifs
upstream of human or C. elegans miRNAs [12] further
suggests that certain transcription factors, which might be
mutated or otherwise misexpressed in cancer, could act as
master regulators of miRNA transcription. One example is
MYC, which transcriptionally represses a large number of
mouse and human miRNA genes [13] and induces others
[14]. Epigeneticmechanismsmight also contribute to silen-
cing of certain miRNAs through histone deacetylation and
DNA methylation [10].
After transcription, the nuclear pri-miRNA is cleaved
endonucleolytically (‘cropped’; Figure 1) by the ‘micropro-
cessor’ complex consisting of the RNase Drosha and its
cofactor, the double-stranded RNA (dsRNA)-binding
protein DGCR8 (‘DiGeorge syndrome critical region gene
8’; named Pasha in flies and worms). Cropping seems to be
tightly coupled to transcription [15,16] and, for intronic
miRNAs, occurs before host intron splicing [16,17]. Crop-
ping releases the precursor miRNA (pre-miRNA), which is
60–70 nt in length and characterized by its stem–loop
structure [7,8]. The pre-miRNA is exported by the nuclear
export receptor exportin-5 (Ran-binding protein 21) into
the cytoplasm, where Dicer excises a !22 nt duplex RNA,
from which one strand will subsequently be selected as the
mature miRNA and incorporated into RISC.
Although Dicer alone is sufficient to cleave pre-miRNAs
in vitro, it associates with various proteins in the cell,
including TRBP2 (transactivation response element
RNA-binding protein 2), PACT (PRKRA; interferon-indu-
cible dsRNA-dependent protein kinase activator A) and
AGO proteins (also known as EIF2C proteins) to perform
pre-miRNA cleavage, mature strand selection and loading
onto an AGO protein to form an active RISC [18]. At the
core of RISC is a member of the AGO family, which binds
the mature miRNA. In humans, there are four AGO
proteins, AGO1–AGO4, among which only AGO2 has the
‘slicer’ activity required to cleave endonucleolytically tar-
get mRNAs that are perfectly complementary to miRNAs
[19]. However, perfect complementarity between miRNAs
and their targets is rare in animals, and all four AGO
proteins can mediate repression of partially complemen-
tary target mRNAs through slicer-independent mechan-
isms that are not well understood but seem to involve
translational repression, deadenylation and degradation
of the target mRNAs [2].
Conceivably, transcription of a pri-miRNA could inevi-
tably result in the expression of an active, mature miRNA,
and early miRNA profiling experiments used pri-miRNA
levels as a proxy for mature miRNA accumulation [20,21].
However, given the complexity of miRNA biogenesis, ma-
turemiRNA accumulation and activity could also be highly
regulated. Indeed, discrepancies between the levels of the
different processing intermediates and mature miRNAs
[22,23] soon hinted at a regulated maturation process.
Recent studies have begun to uncover various factors
and mechanisms at work, suggesting that such regulation
is widespread and physiologically relevant.
Regulation of pri-miRNA processing by Drosha
Although aberrant transcription can cause abnormal
miRNA expression patterns, transcriptional regulation is
not the only and possibly not even themost important layer
of regulation. Initial evidence for this was twofold: first, in
addition to deregulation of individual miRNAs, a global
decrease in miRNA levels was shown to occur in diverse
cancers [24]. Short of a master miRNA transcription factor
that would affect transcription of many or all miRNAs, a
post-transcriptional block at one or several steps of miRNA
maturation seemed to be amore viable explanation for this
observation. Second, although normal and tumor tissues
were clearly distinguishable by their different levels of
Box 1. MicroRNA expression analysis: opportunities and
challenges
To understand the function of miRNAs in biology and exploit their
utility as disease markers, robust and sensitive miRNA profiling
technologies are required. Recent years have indeed seen a move
from research-driven to application-oriented platforms comprising
oligonucleotide microarrays, PCR or high-throughput cloning and
sequencing approaches [78]. Nonetheless, considerable disagree-
ment frequently exists with respect to miRNA expression patterns
for a specific tissue or cell-type, which at least in part could be due to
technical differences among platforms [79].
As for mRNA expression profiling, variations at any stage in the
process, from sample collection and storage to RNA isolation,
detection and data analysis, can influence the quality and accuracy
of the final results. Additional challenges are imposed by the low
abundance of miRNAs (!0.01% of the total RNA mass) and their
small size, which leaves little flexibility for label attachment and
probe design. Accordingly, achieving comparable melting tempera-
tures for all miRNA–probe hybrids, which is essential to avoid
significant numbers of false negatives and false positives, requires
substantial effort [78]. Furthermore, although miRNA microarrays
might preferentially detect mature miRNAs [80], this specificity
might be insufficient when precursors accumulate to significant
levels. The stem–loop TaqMan reverse transcription (RT)–PCR
reagents [78] are one example of alternative tools with increased
specificity for mature miRNAs, but global expression profiling using
this system is cost-intensive and does not permit detection of the
precursor forms.
Apart from technical problems associated with measuring miRNA
expression, the subsequent analysis of miRNA expression data is
nontrivial, mainly due to the lack of standardized normalization and
scaling methods [81]. Consequently, efforts to standardize miRNA
profiling protocols and establish thoroughly characterized reference
sets are of paramount importance, and validation of putative
expression differences established by microarray-based approaches
by quantitative (q)RT–PCR or northern blotting remains advisable.
The total number of miRNAs keeps increasing, which makes it
difficult to compare miRNA expression datasets that have been
generated by different platforms based on different miRBase
releases [4]. Finally, recent reports using deep-sequencing technol-
ogy suggest that certain miRNAs can occur in more than one
variant, dependent on the cell- or tissue-type [82]. Sequences differ
primarily at the 30-end but also at the 50-end of the molecule.
Although the biological significance of these observations is
unclear, reliable, high-throughput discrimination is unlikely to be
feasible with available hybridization-based technology and might
require deep-sequencing instead. Regardless of the technical
strength or weakness of individual profiling technologies, in situ
hybridization approaches [83] are crucial for establishing the
specificity and cellular resolution of miRNA expression patterns in
vivo.
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mature miRNA expression, pri-miRNA expression pat-
terns indicated little difference, again pointing to differ-
ences in miRNA biogenesis activities, possibly at the level
of pri-miRNA cropping by Drosha [25]. Such an effect could
conceivably be a consequence of gene copy number vari-
ations or other mutagenic events that affect the expression
of Drosha or its cofactors, and altered Drosha expression
has indeed been observed in some tumors; for example, see
Refs [26,27]. However, the fact that differentiation of
embryonic stem cells also induced divergent expression
levels of mature miRNAs despite comparable pri-miRNA
levels provided strong evidence for a regulatory mechan-
ism [25].
Indeed, although the Drosha–DGCR8 ‘microprocessor’
complex is sufficient for processing of pri-miRNAs in vitro
[28,29], cropping seems to be exquisitely modulated
through accessory factors. A truncated, but functional,
recombinant version of DGCR8 binds to heme, and the
heme-bound, dimeric DGCR8 enhances Drosha activity
towards pri-miRNA in in vitro processing reactions [30].
Some of this stimulation can be recapitulated whenmutat-
ing the heme binding cysteine Cys352, which is conserved
across animals, suggesting that heme binding stimulates
Drosha–DGCR8 activity by masking a residue that nor-
mally interferes with cropping activity. It is currently
unclear whether stimulation of microprocessor activity
occurs also in the context of the full-length DGCR8 protein,
within eukaryotic cells, and whether it is physiologically
important.
In addition to its presence in the canonical Drosha–
DGCR8 microprocessor complex, human Drosha has also
been found in a larger complex that includes the DEAD box
RNA helicases DDX5 (also known as P68) and DDX17 (also
known as P72) but lacks DGCR8 [28]. Although Drosha in
Figure 1. Schematic view of miRNA biogenesis. miRNAs are initially transcribed by RNA polymerase II as long primary transcripts (pri-miRNA) of several hundred
nucleotides, either from intergenic regions or as part of protein coding genes. Pri-miRNAs are subsequently cleaved into shorter precursor miRNAs (pre-miRNA) of around
70 nucleotides by the microprocessor complex containing the RNase Drosha and its cofactor DGCR8 (‘cropping’). An alternative pathway is represented by the so-called
‘mirtrons’ which are directly spliced out from host genes as pre-miRNA and therefore do not depend on Drosha processing. Pre-miRNA are subsequently exported, in a
RanGTP (Ran-guanosine-triphosphatase bound to GTP)-dependent fashion, by exportin-5 (EXP5) to the cytoplasm, where the second maturation cleavage by the RNase
Dicer takes place (‘dicing’), producing 22-nt-long duplexes. By selectively loading one strand onto an argonaute (AGO) protein, the RNA-induced silencing complex (RISC) is
formed and can now bind to, and repress, target mRNAs containing sites of partially complementarity to the miRNA. Each of these successive maturation steps allows for
regulation in a general or miRNA-specific manner.
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the larger complex is substantially (approximately eight-
fold) less active [28], this might depend on the pri-miRNA
substrate. Consistent with this possibility, deletion of the
genes encoding mouse DDX5 or DDX17 induces downre-
gulation of a large, yet restricted, subset of miRNAs (94 out
266 surveyed) [31]. Among the unaffected miRNAs is miR-
19a, which was also used as the substrate when comparing
Drosha activity in the small versus large Drosha complex
[28]. However, reduction of mature miRNA in cells lacking
DDX17 and additionally depleted for DDX5 was not only
limited to a subset of miRNAs but also substantially less
complete than that seen upon Drosha depletion by RNA
interference (RNAi), suggesting that the helicases might
stimulate Drosha activity rather than being absolutely
required for it.
Further support for the idea that different Drosha
complexes might have different substrate preferences
comes from the finding that only a subset of pri-miRNAs
accumulates in DGCR8-hemizygous mice [32]. However,
even among those miRNAs whose primary transcripts
accumulated, only a single mature miRNA showed
appreciable, but moderate, depletion, making the
interpretation of these findings difficult. Indeed, distinct
large (DDX5-, DDX17-containing) and small (DGCR8-con-
taining) Drosha complexes have so far only been observed
in human embryonic kidney 293 (HEK293) cells but not in
mouse [31] or Drosophila cells [33]. Functional specializ-
ation of distinct Drosha complexes thus remains speculat-
ive, and confirmation will require testing of the large
human Drosha complex on a wider array of substrates,
including pri-mRNAs such as miR-21 whose efficient pro-
cessing depends on DDX5 and DDX17 [31,34].
Understanding how DDX5 and DDX17 activate Drosha
might also reveal why such stimulation is only seen for some
miRNAs. Human DDX5 can unwind a synthetic hairpin
structure resembling pre-let-7a in vitro, and this might be
important for incorporation of the maturemiRNA intomiR-
ISC after cleavage by Dicer [35]. Although such an unwind-
ing function could conceivably also act on the pri-miRNA, it
would seem an unlikely stimulus for the dsRNA-processing
enzyme Drosha. Instead, remodeling of a hypothetical ‘pri-
miRNP’ to displace Drosha-repressive proteins might be a
more likely, but currently speculative, mode of action.
Another class of proteins that modulate pri-miRNA
cropping are SMAD (small and mothers against decapen-
taplegic homolog) proteins [34], signal transducers best
known for their function in transcriptional activation of
various target genes in response to transforming growth
factor b (TGF-b) signaling [36]. TGF-bs and othermembers
of the TGF-b superfamily, such as bone morphogenetic
proteins (BMPs), can bind and activate transmembrane
receptor kinases, which in turn phosphorylate receptor
SMADs (R-SMADs), that is, SMAD1, SMAD2, SMAD3,
SMAD5 and SMAD8. Phosphorylated R-SMADs associate
with their shared ‘Co-SMAD’, SMAD4, to form heterodi-
mers that accumulate in the nucleus and induce transcrip-
tion of target genes. This signaling pathway functions in
many developmental processes, for instance in muscle cell
differentiation. Unexpectedly, recent work has identified a
role of SMAD proteins in miRNAmaturation that seems to
be independent of their transcriptional function: treatment
of human pulmonary artery smooth muscle cells with
BMP4 or TGF-b1 stimulates SMAD binding to the pri-
miRNA and increases Drosha activity in the extract [34].
This function is specific for miR-21 and miR-199a and
requires DDX5, which can bind to R-SMADs. The mech-
anism of Drosha activation has not yet been identified, but
increased co-immunoprecipitation of activated SMAD1
and SMAD5 with both Drosha and DDX5 suggests that
SMAD proteins might help to recruit DDX5 to the micro-
processor, or vice versa. However, SMAD proteins are
unlikely to function as simple switches because loss of
DDX5 reduces mature miR-21 levels independently of
ligand [31] and both Drosha and SMAD proteins can bind
to DDX5 in the absence of TGF-b, albeit less efficiently
[28,34,37]. At any rate, given that previous work has
identified a Drosha complex that processes pri-miRNAs
inefficiently and contained DDX5 and DDX17 but not
DGCR8 [28], it will be interesting to determine whether
SMAD proteins and TGF-b signaling affect the DGCR8-
binding status of the P68-Drosha.
Although the mechanistic details of Drosha activation
by SMAD proteins thus await clarification, Davis and
colleagues [34] make a strong case for its physiological
relevance in promoting smooth muscle cell differentiation.
This process depends on BMPs and TGF-b, and inhibition
of miR-21 can partially block this effect, at least in part
through causing upregulation of the miR-21 target pro-
grammed cell death protein 4 (PDCD4).
A particularly well-studied example of regulated
miRNA maturation involves repression of let-7 miRNA
biogenesis by LIN28 and its paralog LIN28B. miRNAs of
the let-7 family are important regulators of stem cell self-
renewal and differentiation that are absent from embryo-
nic and other stem cells but accumulate during differen-
tiation [38]. By contrast, LIN28 promotes pluripotency and
LIN28 and LIN28B are abundantly expressed in embryo-
nic stem cells and hepatocellular carcinoma cells, respect-
ively. This reciprocal expression is the result of an intricate
feedback loop where LIN28 or LIN28B repress let-7matu-
ration, whereas mature let-7 represses LIN28 and LIN28B
accumulation [38] (Figure 2).
Unexpectedly, the ability of LIN28 and LIN28B to block
accumulation of mature let-7 involves repression of both
Dicer [39] and Drosha activities [40–42], and LIN28 and
LIN28B each contain two types of RNA-binding domains, a
cold-shock domain (CSD) and two retroviral-type zinc-fin-
ger domains, through which they can bind pre-let-7 (and,
by inference, pri-let-7) [39–42]. Although it is not yet
established how LIN28-binding impairs let-7 maturation
in the cell, an attractive model suggests that LIN28 com-
peteswith Drosha andDicer for let-7 precursor binding and
prevents their access through steric hindrance. This notion
is consistent with the observations that LIN28 or LIN28B
are abundantly expressed in stem cells and exhibit in vitro
binding affinities to pre-let-7 in the high submicromolar
range [40,42], and in vitro binding experiments have
indeed confirmed that LIN28 can compete with Dicer for
pre-let-7 binding [39]. However, recent data also suggest
that LIN28B might prevent pre-miRNA processing by
inducing its degradation through 30 terminal oligouridyla-
tion (see ‘Note added in proof’ below).
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Specificity for LIN28 binding to let-7 miRNAs is pro-
vided by the pre-miRNA loop sequence, which contains
certain nucleotides that are invariant among pre-let-7
miRNAs, although there is some disagreement on the
precise identity of the nucleotides involved [41,42]. Inter-
estingly, the substrate specificity of LIN28 in inhibiting
dicing seems wider than for cropping, as dicing of pre-miR-
128, not a let-7 family member and without obviously
conserved regions in its loop sequence, is also affected
[39]. Nonetheless, LIN28 does not cause a general block
of Dicer activity because additional miRNAs, such as miR-
125, are insensitive to increased LIN28 levels.
As discussed elsewhere [38], let-7 accumulation is not
only regulated by LIN28 and LIN28B but also itself
regulates the expression of LIN28 and LIN28B through
let-7 binding sites in their 30UTRs. Moreover, the mature
let-7 RNA can compete with pre-let-7 for LIN28 binding in
vitro and might thus further regulate LIN28 protein
activity in vivo [39]. These findings suggest that an exqui-
site regulatory loop exists to promote a fast and stable
switch from situations of low to high let-7 levels, consistent
with the reciprocal expression patterns of let-7 and LIN28
and their opposing roles in regulating stem cell self-
renewal and differentiation [38].
The heterogeneous nuclear ribonucleoprotein A1
(hnRNP A1) exhibits an even narrower substrate speci-
ficity than that of LIN28. This single-strand RNA-binding
protein seems to stimulate exclusively maturation of miR-
18a, although miR-18a is contained in pri-miR-17!92,
which harbors five additional miRNAs [43]. Moreover,
hnRNP A1 seems to be dispensable for cropping of miR-
18b, which is encoded in a distinct pri-miRNA cluster,
although the pre-miRNA sequences of miR-18a and miR-
18b are highly similar. Experiments on chimeric pri-miR-
NAs indicate that the specificity for miR-18a involves
sequences outside the pre-miRNA cropping product, but
how these sequences function and how hnRNP A1 stimu-
lates pri-miR-18a cropping remains to be determined.
These results demonstrate that regulation of pri-miRNA
processing can extend down to the level of individual
miRNAs transcribed as part of a larger cluster. Because
miR-17!92 is an oncogene [1], it will be interesting to
determine in future experiments whether hnRNP A1
can modulate the tumorigenic activity of the cluster.
In the past two years, there have thus emerged several
examples of modulated cropping as a means of regulating
miRNA accumulation, and we can expect more in the
future. For instance, processing of pri-miR-155 (B-cell
integration cluster [BIC] RNA) occurs efficiently in
HEK293 cells but much less efficiently in Burkitt lym-
phoma-derived Ramos cells [44], although this might
depend on the specific experimental settings [45]. More-
over, a new class of intronic miRNAs (called ‘mirtrons’) has
recently been discovered that does not require Drosha for
biogenesis because splicing releases the corresponding pre-
miRNA stem–loop structures (Figure 1) [46–48]. Their
expression, in which the need for Drosha is bypassed, could
thus be regulated in a very distinct manner from that of
canonical miRNAs.
Pre-miRNA processing
After cropping of the pri-miRNA by Drosha in the nucleus,
the resulting pre-miRNA is exported into the cytoplasm
(Figure 1), where Dicer mediates its conversion into the
mature miRNA. Dicing typically seems to function quite
efficiently, as indicated by low levels of pre-miRNAs
relative to mature miRNAs [49,50]. Nonetheless, early
experiments already identified individual pre-miRNAs
that weremore abundant than their correspondingmature
forms [51], although it was unknownwhether this reflected
regulation or simply inefficient processing of particular
substrates under all conditions.
The first evidence that ‘dicing’ of specific pre-miRNAs
can be regulatedwas obtained formousemiR-138 [52]. Pre-
miR-138 was easily detectable in many tissues, whereas
the mature miR-138 derived from this precursor accumu-
Figure 2. Regulation of miRNA processing by LIN28. LIN28 and its paralog LIN28B compete with Drosha for binding to pri-miRNAs of the let-7 family and thereby inhibit
Drosha-mediated processing. A similar competition between LIN28 or LIN28B and Dicer prevents the processing of certain pre-miRNAs in the cytoplasm. LIN28 and LIN28B
also promote 30 terminal uridylation of the pre-miRNAs, which thus become resistant to processing by Dicer and undergo degradation. The fact that the mature let-7 miRNA
targets LIN28 and LIN28B mRNAs to prevent their expression establishes a feedback mechanism.
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lated only in mouse brain andmouse fetal liver. Processing
reactions with recombinant Dicer ruled out that pre-miR-
138 per se was refractory to processing, advocating the
presence of a specific inhibitor of pre-miR-138 processing in
non-neuronal tissues and cells. This activity has now been
found enriched in the cytoplasm, where pre-miR-138 is also
preferentially localized, ruling out that dicing is prevented
by nuclear retention of pre-miR-138 (P. Leuschner and J.
Martinez, personal communication). The molecular iden-
tity of the repressor has yet to be established.
As discussed in the previous chapter, dicing of let-7
family pre-miRNAs is also regulated, and the inhibitor
has been identified as LIN28 (Ref. [39]) – the same protein
that also inhibits cropping of pri-let-7 (Figure 2). Indeed,
regulation of dicing might be quite common: in a large-
scale profiling effort, expression of precursor and mature
forms of 201 miRNAs correlated poorly across various
human tissues and cell lines [49]. For instance, mature
miR-128a accumulates almost exclusively in brain and
skeletal muscle but not in spleen or B cells. However, pre-
and pri-miR-128a levels (which were not distinguished in
this PCR-based experiment) were considerably higher in
spleen and B cells than in skeletal muscle, albeit lower
than in the brain. In situ hybridization in cancer cell lines
that did not accumulate mature miR-128a, miR-105 or
miR-31 detected exclusively nuclear and/or nucleolar
signals, with probes detecting both pri- and pre-miRNAs
[49]. In a cell line that accumulated mature miR-31, such
a probe revealed additionally some cytoplasmic, but no
nucleolar, signal. The authors suggest that the nuclear
and/or nucleolar signal reflects pre-miRNA retention,
preventing access by cytoplasmic Dicer. How the nuclear
export of this pre-miRNA is regulated is not known.
Moreover, because northern blot analysis demonstrated
that long transcripts, presumably pri-miRNAs, were
abundant in cells lacking the mature miRNA, these
species might contribute a significant nuclear hybridiz-
ation signal.
A more general regulation of Dicer activity than in the
examples discussed above is conceivable. For instance,
Dicer can be proteolytically activated [53], possibly by
relieving the autoinhibitory function exerted by its helicase
domain [53,54]. Although this activation seemed to be
more substantial for dsRNA substrates than for pre-miR-
NAs [54], such a mechanism might affect miRNA accumu-
lation in the brain [55]. If Dicer activity is limiting, or close
to limiting, for pre-miRNA processing, regulation of Dicer
expression might also permit modulation of pre-miRNA
processing, an intriguing possibility given that Dicer
expression or gene copy number is altered in diverse
cancers [56]. ‘Decoy substrates’ that compete with Dicer
substrates for access to this nuclease but that, unlike true
substrates, are not cleaved might further regulate Dicer
activity. For instance, overexpression of the RNA rncs-1
(RNA noncoding, starvation upregulated) in C. elegans
reduces Dicer-dependent endogenous small interfering
RNA (endo-siRNA) accumulation [57]. When added to
embryo extract, this 800-nt-long dsRNA with structured
ends reduces siRNA generation from a long dsRNA sub-
strate without itself being cleaved. However, because pro-
cessing of pre-lin-4 miRNA was not affected, it remains to
be established whether such mechanisms also operate to
regulate pre-miRNA dicing.
Finally, efficient pre-miRNA processing involves
additional proteins, such as AGO proteins, TRBP2 and
PACT [18,58–60], so regulation of these proteins might
further modulate Dicer activity. Interestingly, stability of
human AGO2 has recently been shown to be affected by
proline hydroxylation through the type I collagen prolyl-4-
hydroxylase (C-P4H(I)) [61]. However, although C-P4H(I)
depletion reduced RISC activity, as determined by
decreased cleavage of a perfectly complementary let-7
target reporter, it is not known whether AGO2 destabiliza-
tion coincided with a depletion of mature miRNAs. More
importantly, because repression of a partially complemen-
tary miR-21 target reporter remained unaffected by both
AGO2 and C-P4H(I) depletion, it remains to be established
that thismodification significantlymodulates repression of
authentic miRISC targets. Nonetheless, this new finding
and the studies discussed above illustrate that there is
great potential for regulation of miRNA maturation at the
level of ‘dicing’, and we are just beginning to understand
some of the mechanisms at work.
miRNA turnover
Surprisingly, several of the events affecting processing of
intermediates along the miRNA biogenesis pathway do
not alter accumulation of the respective processing sub-
strates. For instance, LIN28 blocks processing, and thus
consumption, of pri-let-7 in stem cells, yet pri-let-7 levels
are equal in cells with and without LIN28 [25]. Similarly,
increased pri-miR-21 processing upon stimulation by
TFG-b or BMP4 does not alter pri-miR-21 levels [34]
and nor does loss of DDX5 and DDX17 [31]. One possible
explanation is that, in each of these cases, sufficient
transcriptional stimulation might balance out increased
consumption and, conversely, decreased consumption
might be paralleled by decreased transcription. Alterna-
tively, turnover of unprocessed, ‘naked’ transcripts might
be very fast so that binding by the respective processing
factors is required to sufficiently stabilize the substrate.
The experimental investigation of pri-miRNA transcrip-
tion rates could help to distinguish between these – not
mutually exclusive – possibilities. Whether such putative
turnover of miRNA processing intermediates is a
regulated or constitutive process remains an open ques-
tion for the time being.
In addition to miRNA processing intermediates, degra-
dation of mature miRNAs might also affect the net
accumulation of mature miRNAs. Possible examples in-
clude stabilization of miR-122a by the DNA and RNA-
binding translin (TSN) protein [62] or general destabiliza-
tion of mature miRNA levels by the Trim-NHL (tripartite
motif, NCL-1, HT2A and LIN-41 domain) protein and Ago1
binding partner Mei-P26 (meiotic gene recovered in a P-
element screen) in Drosophila stem cells [63]. Moreover,
cell-cycle status affects the stability of miR-29b, which is
rapidly degraded in proliferating cells but stabilized in
mitotically arrested cells [64]. However, mechanisms have
not been established for any of these events, and there is
only limited evidence that these proteins do indeed affect
miRNA turnover as opposed to a late biogenesis step.
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Although there is thus little known about any mechan-
isms of either constitutive or regulated degradation of
mature miRNAs in animals, recent work in plants has
identified the small RNA degrading nuclease SDN1, a
homolog of the yeast 30-to-50 exonucleases Rex1p (RNA
exonuclease 1) to Rex4p, as a nuclease that can degrade
‘naked’ small RNAs such as miRNAs in vitro [65]. Com-
bined knockdown of three nucleases of the SDN1 family in
Arabidopsis causes a two- to threefold increase in the levels
of several mature miRNAs, suggesting that these miRNAs
are also substrates of this family of RNases in vivo. How-
ever, it is currently not knownwhether the activity of these
RNases is regulated and whether enzymes of this family
affect miRNA stability in animals.
Concluding remarks
Although regulation of miRNA transcription is clearly
important for setting miRNA expression patterns, the
work that we have discussed here demonstrates that
additional, post-transcriptional mechanisms further
define miRNA activity, at least for a subset of miRNAs
and tissues. Other mechanisms, such as RNA editing (Box
2 and Figure 3), can affect miRNA maturation and func-
tion, as will mechanisms that have not yet been discovered.
However, one conclusion that we can already draw is that
the levels ofmiRNApathway intermediates will frequently
not be good proxies for the expression patterns of mature
miRNAs, which therefore need to be examined directly
(Box 1).
In addition, if we want to understand the roles of
miRNAs in specific cells or organisms and harness the
regulatory power of miRNAs at a diagnostic or even a
therapeutic level (Box 3), we need to consider additional
factors that determine miRNA activity. These include
‘static’ factors such as single nucleotide polymorphisms
and mutations, either in the miRNA or its targets, that
might generate or abolish miRNA binding sites or affect
their effectiveness (e.g. [66,67]). More importantly,
‘dynamic’ factors modulate miRNA activity without alter-
ing mature miRNA concentrations, for instance in
Box 2. Regulation of microRNA maturation and activity by
RNA editing
Adenosine deaminases acting on RNA (ADARs) can convert
adenosine to inosine (A-to-I editing) in various double-stranded
RNA substrates, and several studies have demonstrated that both
pri-miRNAs and pre-miRNAs can be substrates of ADARs [84,85]
(Figure 3). For instance, selective editing of human pri-miR-142
blocks its processing by Drosha [86]. The unprocessed pri-miR-142
is rapidly degraded in vitro by Tudor staphylococcal nuclease
homolog (Tudor-SN). As discussed elsewhere [87], this suggests
that editing of specific pri-miRNA might be common but fails to be
detected owing to efficient degradation, an idea that is also
supported by a recent study identifying 47 pri-miRNAs that are
edited without usually giving rise to edited mature miRNAs [85].
Editing also prevents the dicing of both mouse and human miR-151
[88], which therefore accumulate as pre-miRNAs. How editing
blocks processing and to what extent this mechanism is used and
possibly regulated remains to be elucidated.
In addition to affecting miRNAmaturation, editing can also affect
the specificity of the edited miRNAs if the edited site is included in
the mature miRNA, because inosine base-pairs with cytosine
instead of uracil. A survey of 99 miRNAs in human tissues revealed
that six of these were edited in at least one tissue, and a substantial
number of these editing events were predicted to modify target
recognitions [89]. Experimental confirmation of this hypothesis
was provided for miR-376, which is edited by both ADAR1 and
ADAR2, at different positions of the precursor [90]. ADAR2-
mediated editing of a nucleotide corresponding to position +4 in
the mature miR-376-5p in particular creates a miRNA that, unlike its
unmodified counterpart, represses phosphoribosyl pyrophosphate
synthetase 1 (PRPS1) expression and its resulting enzymatic
activity in vivo.
Intriguingly, a different type of editing enzyme, the cytidine
deaminase APOBEC3G (ABC3G), was found to counteract the
activity of several miRNAs [91]. However, this function does not
depend on the deaminase activity of ABC3G, leaving it unclear how
miRNA inactivation is achieved.
Although a recent deep-sequencing effort provided little evidence
for widespread A-to-I editing of miRNAs [82], editing can play a
crucial part in modifying the activity of a subset of miRNAs and thus
needs to be considered when evaluating the potential relevance of
miRNA-mediated gene regulation in vivo.
Figure 3. Modulation of miRNA maturation and activity by RNA editing. Both pri- and pre-miRNA can be substrates of adenosine deaminases acting on RNA (ADARs),
which convert adenosine to inosine. Editing (green dots) of pri-miRNAs and pre-miRNAs can prevent efficient processing by Drosha or Dicer and/or direct the edited
molecules to Tudor staphylococcal nuclease homolog (Tudor-SN) for degradation. Alternatively, editing of pri- or pre-miRNAs can also lead to the accumulation of modified
mature miRNAs (red lines) that can potentially recognize a different set of targets compared to the unedited miRNAs.
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response to cellular growth phase or stress. Examples are
the use of alternative forms of 30UTRs, with different
complements of miRNA target sites, by mRNAs [68,69],
expression of 30UTR binding proteins that affect accessi-
bility of miRNAs even to those target sites that are present
in a given 30UTR [70,71], ‘decoy’ RNAs that sequester
miRNAs away from their target [72] or, most dramatically,
a switch from target repression to target activation by
miRISC itself [73]. Some of these mechanisms can even
function post-repression, that is, they can derepress
mRNAs that have been translationally silenced by specific
miRNAs [70], and such induced reversal of miRNA-
mediated gene silencing might be particularly important
for activation-dependent, localized translation at neuronal
synapses [74]. Additional mechanisms such as ‘target pro-
tection’ [75] – that is, blocking of an miRNA target site
through binding of an oligonucleotide that overlaps the site
– are only speculative at present but work already as
experimental tools, making it tempting to propose that
cells might employ similar strategies as well.
Unraveling these complex networks of dynamic regu-
latory interactions will remain a major challenge for some
time to come and will require the use of both defined cell-
based assays and physiological systems, such as whole-
animal models. At the same time, the exquisite post-tran-
scriptional regulation of individual miRNAs might provide
unexpected opportunities for targeted manipulation of
miRNA expression as a promising complement to anti-
sense or RNA-based therapeutic approaches (Box 3).
Indeed, a first step towards exploiting this opportunity
has just been reported: enoxacin, a low-molecular-mass
antibacterial agent, promotes accumulation of a small
subset of maturemiRNAs, apparently through stimulating
pre-miRNA processing by TRBP2–Dicer and subsequent
RISC loading [76].
Note added in proof
LIN28B has recently also been observed to block dicing of
pre-let-7 in hepatocellular carcinoma cell lines [77]. Direct
competition between Dicer and LIN28 or LIN28B seemed
to contribute relatively little to repression of processing;
instead, binding by LIN28 or LIN28B promoted 30 terminal
oligouridylation of pre-let-7 by an unidentified terminal
uridyl transferase. The oligouridylated pre-let-7was resist-
ant to Dicer processing in vitro and underwent degra-
dation, providing a novel mechanism for inhibition of let-
7 maturation.
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2.2.4. microRNA modes-of-action
The nature of the mechanism by which animal miRNAs repress their targets is certainly 
the most debated aspect of miRNA biology. A plethora of models, sometimes mutually 
exclusive, has been proposed over the last years and have been the subject of an intense 
discussion in various reviews (Jackson and Standart 2007; Nilsen 2007; Pillai et al. 2007; 
Standart and Jackson 2007; Eulalio et al. 2008a; Filipowicz et al. 2008; Richter 2008; Wu and 
Belasco 2008; Carthew and Sontheimer 2009; Chekulaeva and Filipowicz 2009). Moreover, 
some studies suggest that, under specific conditions, miRNAs act as translational activators 
rather than repressors (Vasudevan et al. 2007; Henke et al. 2008; Orom et al. 2008). Admittedly, 
miRNAs might function via different mechanisms depending on the organism, cell type, 
miRNA, miRNA target, or conditions investigated. However, even studies reporting very 
similar experiments sometimes reached opposite conclusions (e.g. (Petersen et al. 2006) and 
(Humphreys et al. 2005)). Therefore, one can hope that a deeper understanding of the 
mechanisms at play might help, at least partially, to unify the large body of apparently 
conflicting data, which exists today.
In plants, miRNAs, defined as such based on their biogenesis, were thought to act 
essentially like siRNAs, that is to base-pair perfectly or almost perfectly to target transcripts, 
and to induce endonucleolytic cleavage (Llave et al. 2002; Rhoades et al. 2002). This simple 
picture was recently challenged by Brodersen and colleagues, who uncovered mutations in 
Arabidopsis, which induce accumulation of miRNA targets at the protein level without changes 
at the mRNA level, and proposed that plant miRNAs function partially also as translational 
repressor (Brodersen et al. 2008). However, this study and previous ones, which documented 
similar examples (Aukerman and Sakai 2003; Chen 2004; Gandikota et al. 2007), did not 
investigate directly the translational status of miRNA targets. Therefore, alternative 
mechanisms, such as nascent polypeptide degradation, cannot be excluded yet.
 Coming back to animal miRNAs, initial studies aimed at understanding their mode-of-
action were performed in C. elegans, focusing on the first identified miRNA, lin-4 and two 
validated targets: lin-14  and lin-28 (Olsen and Ambros 1999; Seggerson et al. 2002). This 
studies established that, if LIN-14 and LIN-28 protein levels are downregulated by lin-4, lin-14 
and lin-28  mRNAs are not significantly degraded and their polyadenylation status and 
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polyribosome association not substantially modified. Based on these observations, it was 
initially assumed that miRNAs function solely by inhibiting target translation at a step 
downstream on initiation without affecting the amount or structure of target mRNAs 
themselves.
Surprisingly, subsequent studies showed that miRNA targets often undergo a significant 
amount of degradation, most likely triggered by deadenylation. These include studies conducted 
in animal models (Bagga et al. 2005; Krutzfeldt et al. 2005; Giraldez et al. 2006; Mishima et al. 
2006), cell lines (Lim et al. 2005; Behm-Ansmant et al. 2006; Rehwinkel et al. 2006; Schmitter 
et al. 2006; Wu et al. 2006; Eulalio et al. 2007b; Eulalio et al. 2009b) or cell-free system 
(Wakiyama et al. 2007). Based on these results, it is today generally accepted that miRNAs can, 
to a certain extent, induce target degradation. miRISC components, such as Ago proteins and by 
extension miRNAs, together with miRNA targets were shown to colocalize with processing-
bodies (P-bodies), which are cellular foci enriched for the RNA degradation machinery 
(reviewed in (Parker and Sheth 2007)). Although P-bodies integrity is not required for miRNA 
mediated repression (Eulalio et al. 2007a), it was shown in Drosophila cells that the P-body 
components CAF1:CCR4:NOT1 (deadenylase complex), DCP1:DCP2 (decapping complex), 
and Xrn1 (exonuclease) mediate miRNA targets degradation (Behm-Ansmant et al. 2006; 
Eulalio et al. 2007b; Eulalio et al. 2009b).
 It is also generally acknowledged that miRNA can repress the translation of their targets 
in parallel with, or prior to, mRNA degradation. However no agreement could be reached so far 
about the step of translation that is inhibited (Chekulaeva and Filipowicz 2009). Early 
experiments support a post-initiation mechanism (Olsen and Ambros 1999; Seggerson et al. 
2002). This is essentially based on the observation that target mRNA distributions in sucrose 
density polysome gradients is unchanged whether or not the cognate miRNA is expressed, 
indicating that the repressed and non-repressed mRNAs are in average loaded with the same 
number of ribosomes. It was also shown that some miRNAs and miRISC components co-
sediment with polysomes in human neuronal cells, suggesting that repressed targets are still 
loaded with ribosomes (Nelson et al. 2004). A following study by Pillai and colleagues fired up 
the controversy (Pillai et al. 2005). The authors showed that in HeLa cells let-7 binding to 
reporters mRNA shifts them to lighter fractions of density polysome gradient, indicating that 
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less ribosomes are present on the repressed mRNAs, a hallmark of reduced translation initiation 
rates. Moreover, this study and another one agreed on the observation that reporters driven by 
internal ribosome entry sites (IRESs), i.e. reporters, which do not rely on a cap structure for 
their translation, are refractory to miRNA-mediated repression, suggesting that miRNAs prevent 
interaction between the mRNA cap and translation initiation factors (Humphreys et al. 2005; 
Pillai et al. 2005). However, the same two studies disagreed about whether a poly(A) tail is 
required for repression.
Adding to the confusion, a set of subsequent studies using human cell lines argued in 
favor of a post-initiation phenomenon, although suggesting different models (Maroney et al. 
2006; Nottrott et al. 2006; Petersen et al. 2006; Lytle et al. 2007). In these studies, arguments for 
a post-initiation mechanism are essentially based on observations that repressed mRNAs 
together with miRNAs sediment in deep (polysomal) fractions of polysome gradients and that 
reporters driven by certain types of IRES can still be repressed by miRNAs. Data from Maroney 
et al. suggest that repressed targets are actively translated and implicitly point toward a 
mechanism affecting the nascent polypeptide (Maroney et al. 2006). Such a model is also 
explicitly supported by Nottrott and colleagues, however direct experimental evidences are 
lacking (Nottrott et al. 2006). Peterson and co-workers proposed that translational repression is 
achieved by premature ribosome drop-off (Petersen et al. 2006). However, they do not see 
repressed targets shifting to lighter polysome fractions, something that, based on this model, 
would be expected as pointed out by Chekulaeva and Filipowicz (Chekulaeva and Filipowicz 
2009). Simultaneously, other studies substantiated the initiation model, using globally the same 
experimental strategies as the studies mentioned above but finding opposite results 
(Bhattacharyya et al. 2006; Huang et al. 2007). Importantly, Bhattacharyya and colleagues 
reported the first observation of an endogenous target, CAT-1, being repressed at the initiation 
level in human cells (Bhattacharyya et al. 2006).
Several laboratories recapitulated, at least to some extent, miRNA repression in cell-free 
systems (Wang et al. 2006; Mathonnet et al. 2007; Thermann and Hentze 2007; Wakiyama et al. 
2007). All these studies point to an initiation mechanism, based on the fact that reporters 
containing either a non-functional cap or an IRES cannot be repressed by miRNAs. The 
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initiation model was also further supported by two additional studies, while each implying a 
different mode-of-action (Chendrimada et al. 2007; Kiriakidou et al. 2007). 
By immunoprecipitation, Chendrimada et al. identified an interaction between miRISC 
and the eukaryotic translation initiation factor 6 (eIF6), a factor involved in preventing the 
premature association between the 60S and 40S ribosomal subunits. Depletion of eIF6 
prevented miRNA-mediated repression of reporter mRNAs in human cells and of the lin-4 
targets lin-14 and lin-28 in C. elegans, suggesting that miRNAs inhibit translation initiation by 
preventing the 60S ribosomal subunit joining (Chendrimada et al. 2007). This model was 
supported by experiments in reticulocyte lysate which showed that miRNA targets are enriched 
for 40S, but not 60S, ribosome components (Wang et al. 2008). However, as noted earlier 
(Filipowicz et al. 2008), the fact that eIF6 is involved in ribosome biogenesis renders these data 
difficult to interpret, as translation could be generally affected by eIF6 depletion. Chendrimada 
et al. argue that eIF6 depletion does not affect global translation, as determined by polysome 
profiling, however the quality of these experiments is questionable: polysomes are almost 
completely absent in every conditions tested, making it difficult to assess any change in 
polysome magnitude. Finally, if eIF6 really plays a role in miRNA-mediated repression, it does 
not seem to be conserved in D. melanogaster, where no effect on miRNA target reporters could 
be observed upon eIF6 depletion (Eulalio et al. 2008b).
Kiriakidou and colleagues uncovered two residues highly conserved among Ago proteins, 
which were proposed to allow Ago to bind the mRNA cap structure. It was therefore suggested 
that Ago proteins directly compete with eIF4E, the cap-binding translation initiation factor, to 
inhibit translation initiation on miRNA targets (Kiriakidou et al. 2007). However, a recent 
bioinformatic study suggests that the conserved residues cannot fold in a structure able to bind 
the cap (Kinch and Grishin 2009). Alternatively, Eulalio et al. showed that these residues are 
important for the interaction between Ago1 and GW182, a miRISC component, in Drosophila 
cells. This result might explain why these residues are conserved and suggests that Ago-GW182 
interaction is important for miRNA function (Eulalio et al. 2008b).
GW182 (a 182 kiloDaltons protein enriched in glycine and tryptophan repeats) was 
identified in 2002 using sera from a patient suffering from motor and sensory polyneuropathy 
and found to localize in discrete cytoplasmic foci named GW-bodies (Eystathioy et al. 2002). 
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Subsequent studies showed that GW-bodies correspond to P-bodies, indicating that GW182 
might be involved in the control of mRNA stability. In parallel, co-localization and co-
immunoprecipitation experiments in human cells showed that Ago proteins localize to P-bodies 
and interact with components of the mRNA degradation pathway and that miRNA targets are 
localized to P-bodies in a miRNA-dependent fashion (Liu et al. 2005b; Sen and Blau 2005). 
This suggested a link between GW182 and the miRNA pathway, which was confirmed by the 
observation that human and Drosophila GW182 physically interact with Ago proteins and that 
depletion of GW182 prevent efficient repression of miRNA target reporters (Liu et al. 2005a; 
Meister et al. 2005; Rehwinkel et al. 2005; Behm-Ansmant et al. 2006; Eulalio et al. 2008b). 
Three GW182 paralogs have been identified in vertebrates (TNRC6A/HW182, TNRC6B, 
TNRC6C) and one in insects (GW182 or Gwaky). C. elegans has also been found to encode two 
distant homologs of this protein family: ain-1 and ain-2 (alg-1 interacting protein) (Ding et al. 
2005; Ding and Han 2007; Zhang et al. 2007). Similarly to other GW182 proteins, AIN-1 and 
AIN-2 interact with ALG-1 and ALG-2, the C. elegans miRNA specific Ago proteins, and are 
essential for miRNA-mediated repression (Ding et al. 2005; Zhang et al. 2007). Recent efforts 
have been made to understand the architecture of GW182 proteins in flies and humans (Baillat 
and Shiekhattar 2009; Chekulaeva et al. 2009; Eulalio et al. 2009a; Eulalio et al. 2009c; 
Lazzaretti et al. 2009; Lian et al. 2009; Takimoto et al. 2009; Zipprich et al. 2009). These 
studies identified several domains required for Ago interaction and for miRNA target silencing 
(reviewed in (Eulalio et al. 2009d)), but did not address the mechanistic aspect of silencing 
itself. Therefore, although it is now manifest that GW182 proteins play a crucial role for 
miRNA-mediated silencing, it is unclear whether they are involved in an initiation or post-
initiation inhibition mechanism. It is also surprising that AIN-1 and AIN-2 function, at least 
superficially, similarly to human and flies GW182 proteins, since they are only distantly related 
to these and lack for example the silencing domains identified in the aforementioned studies 
(Eulalio et al. 2009d). This suggests that either C. elegans AIN-1 and AIN-2 might function in a 
different way than other GW182 proteins or that a feature common to all of them as not yet 
been identified.
In summary, among the very large body of literature related to miRNA mode-of-action 
common themes, as well as discrepancies are apparent. Essentially, miRNA targets can be either 
repressed translationally or degraded or undergo a combination of both, however it is not known 
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if degradation requires prior translational repression. Moreover, there is no consensus about how 
translation of miRNA targets is impaired and, although GW182 proteins are recognized to be 
central to this and the degradation processes, there is little to no information about their precise 
molecular functions. An interesting postulate is that core miRISCs function as platforms, which 
could recruit different sets of effector proteins in a time-, tissue-, or environment-dependent 
manner, allowing miRNAs to function differently in distinct contexts (discussed in (Hammell 
2008)). Such a scenario could explain that different experimental settings exhibit different type 
of miRNA-mediated repression, or even activation, mechanisms. In nematodes, food 
deprivation was shown for example to prevent lin-4 dependent lin-14 mRNA degradation, but 
not protein downregulation (Holtz and Pasquinelli 2009). Additionally, modulation activities 
could also be brought about by factors recruited to the 3'UTR of specific targets, such as, for 
instance, the RNA-binding protein Dnd1, which can mask certain miR-430 binding sites in 
zebrafish germ cells (Mishima et al. 2006; Kedde et al. 2007), or HuR, which can relieve CAT-1 
repression by miR-122 in liver cells under stress conditions (Bhattacharyya et al. 2006). 
Consequently, a better understanding of potential miRISC modulators might help to reconcile 
apparently conflicting data.
Finally, it has to be noted that most of the studies discussed here have been conducted 
using artificial reporter systems and also sometimes artificial miRNAs, leaving it unclear how 
faithfully these systems recapitulate the endogenous miRNA-mediated regulation process. In 
my opinion, observations made with non natural molecules should be inferred only very 
cautiously to the endogenous situation. Cellular processes are robust machineries which can 
accommodate varying situations (Stelling et al. 2004). It is not granted that such machineries 
will automatically function canonically when confronted with artificial substrates. Therefore, 
experiments employing non-endogenous substrates can only inform us about the functional 
possibilities of a cellular machinery but not directly about its endogenous mode-of-action. For 
example, the fact that an artificial reporter mRNA containing a histone stem loop instead of a 
poly(A) tail can be repressed by miRNAs (Wu et al. 2006) cannot not be directly used to 
demonstrate that poly(A) tails of endogenous targets do not play a role in miRNA-mediated 
repression. Unfortunately, this distinction is very often not made when discussing such results. 
This concern is also further underlined by the observations that the mode of reporter 
transfection or the type of viral promoter used to express reporters have been shown to influence 
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the apparent mode of miRNA-mediated repression (Lytle et al. 2007; Kong et al. 2008) and calls 
for studies focusing on the physiologically relevant aspects of miRNA-mediated repression.
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2.2.5. Biological functions of microRNAs
Regardless of how exactly miRNAs silence their target genes, this type of regulation has 
been shown to be relevant to an overwhelming large number of cellular and physiological 
processes in health and disease. These include developmental timing, stem cell maintenance, 
cellular proliferation and differentiation, apoptosis, viral infection, immune response, 
hematopoiesis, and angiogenesis, to name just a few (reviewed in (Bushati and Cohen 2007)). 
Importantly certain microRNAs have also been shown to function as tumor-suppressor or 
oncogene genes (reviewed in (Esquela-Kerscher and Slack 2006)). It is maybe not so surprising 
that the breadth of processes regulated by miRNAs is so large, considering that an average 
miRNA has been predicted to regulate more than hundred targets and that 20% to 30% of 
animal 3'UTRs contain at least one conserved miRNA predicted binding site (Krek et al. 2005; 
Lewis et al. 2005). These predictions are difficult to establish, due to the imperfect nature of 
miRNA - miRNA target binding in animals. Nevertheless, they have seen some experimental 
support from recent large-scale proteomics studies, which indicated that miRNAs typically 
repress hundreds of targets, albeit in average to a moderate extent (Baek et al. 2008; Selbach et 
al. 2008).
In general, miRNA interaction with their targets can be characterized according to how 
much a given target is repressed, how much the target repression physiologically matters, and 
how many targets a given miRNA represses to achieve its function. The consideration of these 
characteristics allows to classify miRNA activities as either "genetic switch" or "fine-
tuning" (Flynt and Lai 2008). Genetic switches generally concern cases one or a few targets. 
This is for example the C. elegans L1 to L2 developmental switch controlled by lin-4 repression 
of lin-14 (see section 2.2.1.). lin-4 expression allows worm development to proceed from the L1 
to the L2 stage by almost completely abolishing lin-14  expression. Another example of a clear 
developmental switch in nematodes comes from let-7. This miRNA, which regulates multiple 
targets, including various transcription factors (Grosshans et al. 2005), controls the L4 to adult 
transition by repressing the NHL protein LIN-41 (Reinhart et al. 2000). let-7 mutations, 
depending on their penetrance, lead to various phenotypic defects ranging from cuticular defects 
to death by vulva bursting (Reinhart et al. 2000). Interestingly, individual depletion of let-7 
targets is often sufficient to rescue let-7  mutant animals (Abrahante et al. 2003; Grosshans et al. 
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2005; Lall et al. 2006), suggesting that a complex network of genetic interactions might exist 
between the targets regulated by a given miRNA.
In instances of fine-tuning regulation, the role of miRNAs is to set a precise level of 
target activity, therefore, in this case and contrary to the lin-4 - lin-14 paradigm, targets are often 
co-expressed together with their cognate miRNAs. Importantly, fine-tuning regulation is not 
synonymous with trivial regulation, as exemplified by the D. melanogaster miR-8 regulation of 
atrophin (Karres et al. 2007). miR-8 mutant phenotypes - elevated apoptosis in the brain and 
behavioral defects - are caused by upregulated levels of Atrophin and can be rescued by deleting 
one copy of the atrophin  gene. Interestingly, knocking-down atrophin specifically in miR-8 
expressing cells below the level achieved by miR-8 repression also results in phenotypic defects. 
This shows that miR-8 functions by achieving a precise, physiologically optimal level of 
Atrophin. Another example comes from the study of B-cell differentiation. miR-150 regulates 
B-cell lineage development essentially by tuning precisely, among several predicted targets, the 
level of the c-Myb transcription factor (Xiao et al. 2007; Zhou et al. 2007). Here as well, too 
low and to high c-Myb levels are equally detrimental.
Some miRNA functions have also been shown to depend on the regulation of a large set 
of targets. An impressive example comes from the ectopic expression of tissue specific miRNAs 
in HeLa cells (Lim et al. 2005). Cells transfected with the brain specific miR-124 or the muscle 
specific miR-1 specifically shift their expression profile toward that of brain or muscle cells, 
respectively, as determined by level modulation of about hundred transcript in each cases. This 
and additional studies (Farh et al. 2005; Sood et al. 2006) show that miRNAs can enforce 
cellular identities by modulating a large number of targets, which are often co-expressed with 
tissue specific miRNAs, but kept to a low level. In an other study, it appears that certain 
Drosophila miRNAs and their cognate targets are reciprocally expressed in adjacent but not 
overlapping tissues (Stark et al. 2005). This suggests that miRNAs, by targeting genes that are 
already transcriptionally inactive, might also function as a backup system repressing 
transcriptional leaks. Such a model might explain why a large-scale study of individual miRNA 
mutants in C. elegans reported most of them to be superficially wild-type (Miska et al. 2007). 
Alternatively, this could indicate that a large degree of redundancy between certain miRNAs 
exist. Indeed, a large number of C. elegans and D. melanogaster miRNAs have homologues 
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predicted to regulate identical sets of targets (Ibanez-Ventoso et al. 2008). This could also 
suggest that, besides a few cases of life-or-death regulation, most miRNAs regulate subtle or 
environment-dependent phenotypes.
Altogether, miRNA-mediated repression, by being able to quickly block the expression of 
mRNAs, which might have otherwise long half-lives, seems particularly well adapted to 
situations requiring a rapid and clear change in gene expression. miRNAs are also well suited 
for local regulation of translation, like in neurons for instance (Ashraf et al. 2006). Additionally 
the fact that, in certain cases, miRNA-mediated repression is reversible (Bhattacharyya et al. 
2006), suggests that miRNAs can be particularly useful not only for a fast repression but also 
reactivation of their targets. Moreover, miRNAs probably represent a rather evolutionary plastic 
mode of gene regulation as the modification of only a few nucleotides in a transcript is sufficient 
to introduce or delete miRNA binding sites. This idea is supported by the observation that, 
although animal miRNAs are in general well conserved, only a few miRNA - miRNA target 
interactions are evolutionary preserved (Chen and Rajewsky 2006). These cumulative 
advantages of miRNAs might explain why they seem to play a role in virtually every biological 
process investigated so far.
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2.3. Aim of this work
Considering the existing controversy about the mode-of-action of miRNAs (see section 
2.2.4.) and the relative lack of in vivo studies on this topic, the aim of this work was to 
understand in more details the mechanistic aspects of miRNA-mediated repression in 
physiologically relevant context. This study was performed using C. elegans and focusing 
mostly on let-7, as a model miRNA (reviewed in (Bussing et al. 2008)). The premises of this 
work were laid by the results of a large-scale RNAi screen performed by H. Grosshans and 
aimed at identifying new interaction partners of let-7 in a unbiased manner (Ding et al. 2008). 
This initial experiment identified a potent genetic interaction between certain translation 
initiation factors, including subunits of eIF3, and let-7, which led me to propose the following 
thesis:
C. elegans miRNAs function in vivo, and at least partially, by inhibiting the initiation of 
translation on target mRNAs.
I explored this thesis by pursuing in parallel genetic as well as biochemical research 
approaches, which have been the objects of two independent publications included below (see 
sections 3.1. and 3.2.) (Ding et al. 2008; Ding and Grosshans 2009). The genetic experiments 
aimed at delineating the extent of the genetic interaction between let-7 and the translation 
machinery in general, and translation initiation factors in particular. These experiments 
uncovered an unexpected widespread genetic interaction between let-7  and the C. elegans 
translation machinery, suggesting that let-7  activity and let-7  targets are especially sensitive to 
alteration of the translation process. Additionally, these genetic data suggest, but do not 
demonstrate, that let-7 activity may directly oppose that of eIF3 (Ding et al. 2008). The 
biochemical experiments aimed at directly assessing the translational status and mRNA level of 
endogenous target mRNAs in response to repression by miRNAs. The results demonstrated that 
miRNA-mediated repression is achieved in C. elegans by a combination of target mRNA 
degradation and inhibition of translation initiation and that the GW182 homologs AIN-1 and 
AIN-2 are essential mediators of these mechanisms (Ding and Grosshans 2009). Importantly, 
these observations bring early C. elegans studies, which argued for a post-initiation model 
(Olsen and Ambros 1999; Seggerson et al. 2002) into a new perspective. Additional experiments 
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aimed at deciphering the role of individual miRISC components in the repression mechanisms 
are also presented and discussed (see section 3.3.).
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3. Results and discussion
3.1. Publication: “The let-7 microRNA interfaces extensively with the 
translation machinery to regulate cell differentiation”
39
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MicroRNAs (miRNAs) are noncoding RNAs that regulate 
numerous target genes through a posttranscriptional mechanism 
and thus control major developmental pathways. The phylo-
genetically conserved let-7 miRNA regulates cell proliferation 
and differentiation, thus functioning as a key regulator of devel-
opmental timing in C. elegans and a tumor suppressor gene in 
humans. Using a reverse genetic screen, we have identified genetic 
interaction partners of C. elegans let-7, including known and novel 
potential target genes. Initial identification of several transla-
tion initiation factors as suppressors of a let-7 mutation led us to 
systematically examine genetic interaction between let-7 and the 
translational machinery, which we found to be widespread. In the 
presence of wild-type let-7, depletion of the translation initiation 
factor eIF3 resulted in precocious cell differentiation, suggesting 
that developmental timing is translationally regulated, possibly by 
let-7. As overexpression of eIF3 in humans promotes translation 
of mRNAs that are also targets of let-7-mediated repression, we 
suggest that eIF3 may directly or indirectly oppose let-7 activity. 
This might provide an explanation for the opposite functions of 
let-7 and eIF3 in regulating tumorigenesis.
Introduction
MicroRNAs (miRNAs) are small, untranslated RNAs involved 
in numerous developmental pathways (reviewed in ref. 1). They 
function through an antisense mechanism where binding of an 
miRNA to complementary sequences in its target mRNAs (‘cognate 
mRNAs’) causes cognate mRNA repression, but the mechanisms of 
target mRNA repression are less clear. Many different, and some-
times contradictory, miRNA modes of action have been proposed 
(reviewed in refs. 2 and 3). These include inhibition of target mRNA 
translation either at the initiation or elongation step, target mRNA 
degradation in a non-endonucleolytic fashion, which may or may 
not result from deadenylation, and co-translational protein degrada-
tion. MicroRNAs may thus act through multiple mechanisms. These 
mechanisms may either function redundantly or as alternate path-
ways that affect only individual subsets of miRNAs and/or cognate 
mRNAs.2,3
The C. elegans let-7 miRNA was originally identified as a compo-
nent of the heterochronic pathway,4 which controls the temporal 
fate of cells during postembryonic development (reviewed in ref. 
5). Postembryonic development proceeds through the four larval 
stages, L1 through L4, followed by the sexually mature, adult stage. 
During normal development, cells adopt fates that are characteristic 
of the developmental stage of the animal, e.g., certain cells divide 
while others may exit the cell cycle and differentiate. Mutations 
in heterochronic genes may cause cells to prematurely adopt fates 
that are normally observed at a later developmental stage, i.e., cause 
precocious phenotypes. Alternatively, the mutant cells may display 
retarded phenotypes, i.e., characteristics typical of cells in earlier 
developmental stages. Partial loss of let-7 activity causes retarded 
phenotypes, i.e., repetition of fourth larval stage (L4) cell fates, while 
more complete loss of activity causes animals to die by bursting 
through the vulva at the larval-to-adult transition.4 These phenotypes 
are due to overexpression of let-7 target genes and can be partially 
suppressed by knock-down of individual let-7 target genes.6-10
let-7 is conserved in higher eukaryotes, with a striking 100% 
sequence identity in the case of the mature let-7 of C. elegans and 
humans.11,12 This, and the observation that let-7 expression is 
temporally regulated in invertebrates as well as vertebrates,11 suggests 
that let-7 function may also be conserved. This view is supported by 
our recent finding that C. elegans let-7 regulates let-60/ras expression, 
while human let-7 regulates the let-60 orthologue RAS.7,13 Human 
let-7 also regulates the chromatin-binding factor HMGA2, and 
failure of let-7-mediated HMGA2 repression promotes oncogenic 
transformation.14-18 Consistent with overproliferation of cells with 
reduced let-7 expression, let-7 also represses the expression of the cell 
cycle regulator CDC25A (refs. 19 and 20). Reduced let-7 expression 
in lung cancer13,21 may contribute to tumorigenic transformation 
through upregulation of these oncogenes,22,23 and reduced let-7 
expression levels are prognostic for poor patient survival.21,24 let-7 has 
also been shown to function as a tumor suppressor in breast cancer, 
where it controls proliferation and differentiation of tumor initiating 
cells.25 The converging results from these different experimental 
systems have supported a model of let-7 functioning as an important 
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regulator of stem cell fates in both normal and tumor 
cells.26 To achieve this function, let-7 expression is 
highly regulated not only at the transcriptional level, 
but, as recent data suggest, also posttranscriptionally 
(reviewed in ref. 26).
To identify interaction partners of the let-7 miRNA, 
which might include novel let-7 targets, regulators 
of let-7 expression, mediators of let-7 activity, or 
heterochronic genes, we devised a high-throughput, 
functional genomics screen based on RNA interference 
(RNAi). Through this screen, we identified 41 known 
and novel interaction partners of let-7. As several genes 
directly or indirectly involved in translation were found 
among the novel let-7 suppressors, we systematically 
examined genetic interactions between let-7 and the 
core translational machinery and found them to be 
widespread. Consistent with translational control of 
the heterochronic pathway, we found that depletion 
of several of these genes, in particular subunits of the 
tumor promoting translation initation factor eIF3, 
caused abnormal timing of cell differentiation in the 
presence of wild-type let-7.
Results
A reverse genetics screen reveals translation factors 
as suppressors of let-7. The temperature sensitive 
let-7(n2853) allele contains a point mutation in the 
mature let-7 sequence that impairs target binding.4,27 
In addition, reduced accumulation of the mutant 
let-7 RNA28 further impairs target repression and as 
a result, mutant animals die by bursting through the 
vulva at the larval-to-adult transition when grown at 
or above 20°C (reviewed in ref. 4). RNAi-mediated 
knockdown of individual let-7 targets can partially 
suppress this lethality.6-10 To identify novel interaction partners of 
the let-7 miRNA, we carried out a feeding RNAi screen to uncover 
additional suppressors of the let-7(n2853) bursting phenotype. We 
performed this screen by RNAi on synchronized L1 stage larvae to 
avoid missing factors whose efficient depletion would cause sterility 
and/or embryonic lethality. Using a previously described feeding 
library of bacteria producing double-strand RNA,29 we individually 
tested the suppressing effect of RNAi on almost 90% of the genes 
on chromosome I, i.e., ca. 2,400 genes (Fig. 1). We found that 41 
genes could efficiently suppress the conditional lethality of the let-7 
mutation when knocked down through RNAi by feeding (Table 1). 
Some but not all of the suppressor genes contained let-7 comple-
mentary sites, as defined previously,7 in their 3' untranslated regions 
(UTR) suggesting that these genes may be targets of the let-7 RNA 
(Table 1).
Our screening procedure was validated by two observations. First, 
we blindly identified lin-41, the only known heterochronic gene in 
the chromosome I library, as a potent suppressor of let-7(n2853) 
when depleted. lin-41 is a known downstream target of the let-7 
miRNA whose depletion had previously been shown to suppress 
let-7(n2853) (refs. 4 and 10). No RNAi construct targeting lin-28, 
another heterochronic gene and known suppressor of let-7 encoded 
on chromosome I, was included in the RNAi library.29 A second gene, 
lss-4 was identified independently by us through a  computational 
approach and also subsequently validated as a let-7 target.7 Second, 
seven genes in the library are targeted by two independent RNAi 
constructs,29 and we identified both clones for four of these genes, 
rpl-24.2, Y65B4BR.5, imb-5/xpo-2 and spg-7. In the remaining three 
cases differences in the RNAi phenotypes elicited by each pair of 
constructs were already previously noted.29
The largest class of suppressors identified in our screen is 
comprised of genes with a predicted function in the metabolism 
of RNA or protein, which account for nearly half (20/41) of the 
suppressors (Fig. 2). Genes from this category showed a 50% increase 
over the frequency found by Fraser et al.,29 who queried the library 
for genes eliciting any phenotype when depleted in wild-type animals 
(Fig. 2). This observation may suggest that genes of this functional 
class are particularly important as targets and/or mediators of let-7 
function or are heterochronic genes. Given the tight posttranscrip-
tional regulation of let-7 expression,26 it will also be of considerable 
interest to test in future work whether any of these novel let-7 inter-
actors control let-7 maturation.
Our list of suppressors contained several translation initiation 
factors: two putative subunits of the eukaryotic translation initia-
tion factor (eIF) 3, eif-3.H and eif-3.E (C41D11.2 and B0511.10, 
respectively) and the delta subunit of eIF2B (F11A3.2). We also 
Figure 1. A high-throughput reverse genetics screen to identify suppressors of let-7(n2853) 
lethality. See main text and Materials and Methods for details.
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Table 1 Suppressors of let-7(n2853) lethality identified in a screen
ORFa Locusb Function/Homologiesb,c LCSd Suppressione
DNA synthesis
W02D9.1 pri-2 DNA primase - +++
Y54E10A.15 cdt-1 Hs CDT1, Dm dup - +++
RNA metabolism
B0511.6  DEAD box helicase, Dm pit - ++
C17E4.5 pabp-2 Poly(A)-binding protein, Hs PABN1 - ++
C36B1.3 rbp-3 RNA polymerase II subunit - ++
C53H9.2  Nucleolar GTPase, Sc Lsg1p 1 +
F14B4.3  RNA Polymerase I, second largest subunit 1 ++
T19A6.2 ngp-1 Nucleolar GTPase, Sc Nog2p - +++
W01B11.3 nol-5 snoRNP associated, Sc Nop5p 1 ++
W04A4.5  Hs Integrator isoform 1 (U1, U2 RNA processing) - +++
Y48G1A.4  snoRNP associated, Sc Nop14p nd ++
Y54E10BR.6 rbp-7 RNA polymerase II subunit - ++
Y71F9B.4 snr-7 Hs SNRPG (spliceosome subunit) - ++
Y106G6H.2 pab-1 Poly(A)-binding protein, Sc Pab1p - ++
Protein metabolism
B0511.10 eif-3.E Translational initiation factor eIF3 subunit - ++
C03D6.8 rpl-24.2 Ribosomal protein L24-family, Sc Rlp24p - ++
C12C8.3 lin-41 NHL domains 2 +++
C41D11.2 eif-3.H Translational initiation factor eIF3 subunit - ++
C47B2.5 eif-6 Translational initiation factor eIF6 - ++
Y47G6A.10 spg-7 AAA-ATPase, protease - ++
F11A3.2f  Translational initiation factor, eIF2B! - +++
Y65B4BR.5  Nascent polypeptide associated complex "-chain - ++
Energy/metabolism
T09B4.9  Mitochondrial inner membrane translocase, Hs TIM44 - ++
W09C5.8  Subunit IV of cytochrome c oxidase - +
Chromosome dynamics
C45G3.1 aspm-1 Dm Asp - +
T03F1.9 hcp-4 CENP-C homologue - ++
Cell structure
F56A3.3 npp-6 Nuclear pore protein - +++
T19B4.2 npp-7 Nuclear pore protein 2 +++
T21E12.4 dhc-1 Dynein heavy chain - ++
Y48G1A.5 imb-5 Sc Cse1p, Hs CAS/CSE1 1 ++
Y71F9AM.5 nxt-1 NTF2-family - +
Y105E8A.9 apg-1 #-adaptin AP-1 1 ++
H15N14.2 nsf-1 Vesicle fusion - +
Specific transcription
C01G8.9 lss-4 Dm osa/eld 3 +++
F57B10.1  CREB/ATF family transcription factor - ++
Signalling
K12C11.2 smo-1 Hs SUMO-1 - +
ZC581.1 nekl-2 NEK kinase family - ++
Unknown
F20G4.1 smgl-1 Hs Neuroblastoma amplified gene protein - ++
F56A3.4 spd-5 Coiled coils - ++
T23D8.3  Hs LTV1; in operon with eif-3C - ++
Y63D3A.5 tfg-1 Hs TFG1 (TrkA-fused gene) - ++
aSome ORFs were targeted by more than one dsRNA construct and/or construct names might differ from those of the target ORF indicated here. bGene loci names according to Wormbase, Release 188. Gene names were not 
considered when assigning functional classes in cases where no published information or sequence homologies were available to support the gene designation. cSc: Saccharomyces cerevisiae, Dm: Drosophila melanogaster, 
Hs: Homo sapiens. In most cases functions are predicted from homologies. dLCS: let-7 complementary site as identified in7. nd: 3' UTR was not included in dataset used for LCS prediction. e+, >30%, ++, >50%, 
+++, >80% survival. fSequencing revealed plasmid contained other than predicted insert, targeting the indicated ORF (chromosome V).
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secretes collagenous structures termed alae. let-7 is expressed in 
the seam cells34 and in its absence, seam cells fail to terminally 
differentiate at this time and instead divide again.4 By contrast, 
overexpression of let-7 causes the opposite, precocious phenotype 
and seam cells fuse after the L3-to-L4 molt.4 We examined the effect 
of RNAi against eif-3.B, eif-3.C, eif-3.E, eif-3.H and eif-6 in animals 
carrying a wild-type allele of let-7. We selected these factors because 
they were amongst the first suppressors we had identified. While 
seam cell fusion is not observed in mock-treated animals at early L4 
stage, significant numbers of eif-3(RNAi) and eif-6(RNAi) animals 
displayed precocious seam cell fusion, as did the lin-41(RNAi) 
positive control animals (Fig. 3). In the case of eif-3.B(RNAi) and eif-
3.C(RNAi) we again had to dilute the RNAi-inducing bacteria with 
inert bacteria to avoid developmental arrest of the affected animals. 
These findings directly demonstrate that knock-down of this subset 
of the suppressing translation factors causes heterochronic defects.
To obtain further evidence for a role of translation factors in the 
heterochronic pathway we analyzed the genetic interaction between 
eif-3.E or eif-3.H and lin-41. lin-41 codes for a protein that prevents 
premature execution of adult fates by repressing production of the 
transcription factor LIN-29 until the L4 stage.10 LIN-41 protein 
levels themselves are regulated through the interaction of let-7 
miRNA with the let-7 complementary sites in the 3' UTR of lin-41 
mRNA.4,10,27 lin-41 loss-of-function mutations lead to partially 
penetrant precocious phenotypes in the seam cells and we previously 
showed that the penetrance of this phenotype can be enhanced when 
a second let-7 interactor, the let-7 target daf-12, is also knocked 
down.7 Similarly, while only 53.1% of the lin-41(ma104) animals 
display precocious alae (±2.4% SEM), the penetrance of this pheno-
type was significantly (p < 0.05, student’s t-test) increased to 65.0% ± 
1.2% for lin-41(ma104); eif-3.E(RNAi) animals and 80.1% ± 0.4% 
for lin-41(ma104); eif-3.H(RNAi) animals.
Analysis of seam cell fusion and alae formation thus indicate 
that the translation factors investigated modulate the heterochronic 
identified eif-6 (C47B2.5) as a let-7 suppressor, an unexpected 
result given previous data showing that depletion of eIF6 abrogated 
miRNA target repression.30 However, recent data from Drosophila 
S2 cells suggest that eIF6 may not be widely required for miRNA 
activity.31,32
As our initial screen did not cover the whole genome, we tested 
additional translation factors for a genetic interaction with let-7. 
Many translation factors have identifiable homologues in C. elegans33 
and we performed a systematic RNAi screen of these factors for 
suppression of the let-7(n2853) phenotype (Table 2). In most cases, 
knock-down of translation factors induced a slow growth or develop-
mental arrest phenotype. We could frequently avoid developmental 
arrest by mixing bacteria that carried the dsRNA producing plasmid 
with those carrying a plasmid without insert. We found that addi-
tional translation factors could suppress the let-7 mutation, in fact, 
most of the translation factors tested, including initiation, elonga-
tion, as well as termination factors, showed partial suppression. 
Many, but not all suppressors caused slow growth (Table 2), ruling 
out for at least a subset of translation factors that delayed develop-
ment is the cause for let-7 suppression. Moreover, an approximately 
wild-type rate of development also suggests that at least this subset 
of suppressors affects general translation only weakly. As a corollary, 
let-7 function and/or the heterochronic pathway appear to be highly 
sensitive to altered translation levels.
Depletion of translation factors affects the heterochronic 
pathway. To ascertain that the suppression of the let-7 vulval bursting 
phenotype through impaired translation was specific, i.e., mediated 
through a modulation of the heterochronic pathway rather than an 
indirect consequence of, for instance, aberrant vulval development, 
we investigated whether depletion of individual translation factors 
caused heterochronic phenotypes in the seam cells. Seam cells are 
a subset of hypodermal cells that display a stem-cell-like division 
pattern during larval stages. At the larval to adult transition, seam cells 
exit the cell cycle and fuse to form a syncytium, which subsequently 
Figure 2. let-7 suppressors are enriched for factors involved in RNA and protein metabolism. Genes involved in RNA and protein metabolism are enriched 
among the suppressors of the let-7(n2853) mutation. Indicated are the distributions across functional classes of genes causing suppression of the let-7(n2853)-
associated lethality (left chart) or visible phenotypes in otherwise wild-type animals (right chart; assembled from data in ref. 29). Assignments to functional 
classes are from Wormbase Release WS188. Where gene assignments had changed from those used by Fraser et al., their data were adjusted accordingly. 
Note that both studies used an identical RNAi library.
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pathway. This shows that depletion of these factors does not simply 
superficially rescue the let-7(n2853) mutant phenotype but impacts 
on a pathway known to be regulated by let-7. These data would 
suggest that translation of one or several heterochronic genes, 
possibly let-7 target genes, is inefficient and therefore particularly 
susceptible to further decreases in translation activity. Interestingly, 
overexpression of eIF3 subunits has been linked to various cancers 
(reviewed in ref. 35), and our findings indicate that the opposing 
effects of eIF3 and let-7 on cell differentiation might be a contrib-
uting factor (see Discussion).
Discussion
We have identified several novel genetic interaction partners of 
the let-7 miRNA. Some of these contain predicted let-7 binding 
sites, and future work may establish them as bona fide let-7 targets. 
Here, we have focused on the observation that our screen identified 
several translation initiation factors whose depletion allowed survival 
of let-7(n2853) worms (Table 1). Systematic depletion of individual 
translation factors subsequently allowed us to identify suppressors 
at each step of translation:33 initiation, elongation and termination 
(Table 2). These suppressors include a subunit of eIF2, which is 
part of the eIF2/GTP/Met-tRNAi
Met ternary complex and all but 
one subunit of the eIF2B factor, which catalyzes guanine nucleotide 
exchange on eIF2 bound to GDP. Among the factors required to 
recruit the 40S ribosomal subunit to the ternary complex to form 
the 43S pre-initiation complex (PIC), we observed that eIF1A and all 
but one of the eIF3 subunits that permitted larval growth results are 
suppressors. The eIF4F complex, which comprises the cap-binding 
eIF4E, the scaffolding eIF4G, and the ATP-dependent RNA helicase 
eIF4A, recruits the 43S PIC to mRNA via an interaction between 
eIF3 and eIF4G. Among these factors, none of the eIF4E homo-
logues (ife-1 to ife-5) individually tested showed suppression, eIF4G 
and one homologue of eIF4A (F57B9.3) showed developmental 
arrest, whereas the eIF4A homologue encoded by the F57B9.6 ORF 
showed potent suppression. Additionally eIF5, eIF5A and eIF5B 
were also identified as suppressors. Finally, all translation elongation 
and termination factors tested showed either a developmental block 
or suppression of the bursting phenotype.
Based on this result, it seems that suppression of the let-7(n2853) 
bursting phenotype can be rescued by decreasing the activity of 
virtually any step of the translation initiation process as well as the 
elongation and termination steps. Indeed, some of the other suppres-
sors found in our screen are predicted, by homology, to be part of 
the ribosome (rpl-24.2) or function in its biogenesis (the putative 
snoRNP proteins W01B11.3 and Y48G1A.4 and the putative nucle-
olar GTPases homologous to yeast Lsg1p and Nog2p) and we also 
found two poly(A)-tail binding proteins, pab-1 and pabp-2. However, 
not all translation factors could suppress let-7 lethality. This may be 
due to redundancy (e.g., ife-1 to ife-5), inefficient depletion by RNAi 
or a genuine lack of interaction between these two genes.
Unexpectedly, we also observed that depleting eIF6 rescues 
let-7(n2853) animals and causes precocious heterochronic pheno-
types in the presence of wild-type let-7, although this factor was 
reported to be required for miRNA mediated repression.30 If eIF6 
were similarly required for let-7 function, we would have expected 
to see the opposite phenotypes, i.e., enhancement of weak let-7 
alleles and or retarded heterochronic phenotypes. Our data would 
Table 2  Genetic interactions between let-7 and the 
translation machinery
Translation factor locus ORF let-7(n2853) suppression
Initiation factors
eIF1  T27F7.3b -
eIF1Aa  H06H21.3 ++
eIF2!b iftb-1 K04G2.1 ++
eIF2"d  Y39G10AR.8 x
eIF2A  E04D5.1 (a, b) -
eIF2B#  ZK1098.4 -
eIF2B!  Y47H9C.7 ++
eIF2B" ppp-1 C15F1.4 ++
eIF2B$  F11A3.2 +++
eIF2B%d  D2085.3 +++
eIF3ac,d egl-45 C27D11.1 x
eIF3bc,d eif-3.B Y54E2A.11a +++
eIF3cc,d eif-3.C T23D8.4 +++
eIF3dd eif-3.D R08D7.3 ++
eIF3ed eif-3.E B0511.10 +++
eIF3fd eif-3.F D2013.7 +++
eIF3gd eif-3.G F22B5.2 x
eIF3h eif-3.H C41D11.2 ++
eIF3ib eif-3.I Y74C10AR.1 x
eIF3k eif-3.K T16G1.11 -
eIF3ma cif-1 K08F11.3 +++
eIF4Ab,d inf-1 F57B9.6 x
eIF4Aa,d  F57B9.3 +++
eIF4E-1+5 ife-1 F53A2.6 - 
 ife-5 Y57A10A.30 (a, b)
eIF4E-2 ife-2 R04A9.4 -
eIF4E-3 ife-3 B0348.6 (a, b, c) -
eIF4E-4 ife-4 C05D9.5 -
eIF4Gb,d ifg-1 M110.4 (a, b) x
eIF4H drr-2 T12D8.2 -
eIF5b  C37C3.2 (a, b, c) ++
eIF5Ad iff-2 F54C9.1 +++
eIF5B iffb-1 Y54F10BM.2 +++
eIF6 eif-6 C47B2.5 ++
Elongation factors
eEF1Ab,d,e eft-3 F31E3.5 ++ 
 eft-4 R03G5.1 (a, b, c, d)
eEF1Be  Y41E3.10 ++ 
  F54H12.6
eEF2b,d eft-2 F25H5.4 +++
eEF2c,d eft-1 ZK328.2 ++
Release factors
eRF1c,d  T05H4.6 (a, b) x
eRF3b,d  H19N07.1 ++
In some cases, RNAi titration was performed to overcome developmental block by mixing bacteria that 
carried the dsRNA producing plasmid with those carrying a plasmid without insert. a1:1 dilution; b1:5 
dilution; c1:10 dilution; dslow growth; e multiple RNAi targets. Suppression: -,<20%, +, >20%, ++, 
>40%, +++, >80%, x, developmental block, n & 60 worms for each. Control animals fed with bacteria 
carrying empty L4440 vector showed never more than 10% survival, whereas daf-12(RNAi), our positive 
control, showed never less than 90% survival.
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beyond C. elegans. Indeed, increased amounts of eIF3 specifically 
stimulate translation of mRNAs involved in cell proliferation, in 
particular MYC and cyclin D1 (reviewed in ref. 48)—mRNAs that 
are repressed by let-7.26 We might thus speculate that the opposing 
activities of eIF3 and let-7 on a subset of cellular mRNAs contribute 
to the oncogenic functions of eIF3.
Taken together, we find widespread suppression of let-7 loss-of-
function through decreased cellular translation activity, suggesting 
that let-7 targets or other heterochronic genes may be translationally 
regulated to allow proper timing of cell differentiation.
thus argue against an involvement of eIF6 in let-7 
function, consistent with earlier reports from D. 
melanogaster cells that eIF6 does not seem to be 
generally involved in promoting miRNA func-
tion.31,32
It is also surprising to see that eif-3.D, along 
with almost all other eIF3 subunits, is found as an 
efficient suppressor. This observation is in contrast 
with a recent report indicating that eif-3.D(RNAi) 
in an RNAi sensitized strain enhanced the weak 
let-7(mg279) loss-of-function allele, as deter-
mined by increased vulval bursting.36 However, 
we found that eif-3.D(RNAi) can induce vulval 
bursting even in wild-type animals where ca. 
20% of animals die by bursting despite having 
functional let-7. It is possible that this bursting 
phenotype may dominate over a weak let-7 allele, 
particularly when RNAi is performed in an RNAi 
sensitized strain, as done in the earlier report.36
We are particularly intrigued to see that deple-
tion of eIF3 subunits causes precocious seam 
cell differentiation in the presence of wild-type 
let-7. This is because several of the thirteen 
subunits of human eIF3 have altered expression 
levels in cancers including lung, breast, cervical, 
esophageal, prostate and testicular cancers, and 
this aberrant expression is likely to contribute 
to oncogenesis.35 For instance, INT6/eIF3e was 
originally identified as a common integration 
site of mouse mammary tumor virus,37 and 
expression of the truncated INT6/eIF3e gene 
product, but not of the wild-type eIF3e gene, is 
sufficient to transform a number of cell lines.38,39 
Conversely, INT6/eIF3e loss-of-heterozygosity 
and decreased expression appear to be associated 
with breast and non-small cell lung cancers,37 
suggesting that INT6/eIF3e activity is particularly 
dosage dependent. Recently, eIF3h overexpression 
was shown to increase tumorigenic phenotypes in 
various cell lines,40 and eIF3h was also found in 
a genome-wide association screen for loci confer-
ring increased risk for colorectal cancer.41 Finally, 
eIF3a, the largest eIF3 subunit, is overexpressed 
in human lung, breast, cervical and esophageal 
cancers,42-45 and reduction of eIF3a levels in two 
human lung and breast cancer cell lines, respec-
tively, is sufficient to suppress the malignant phenotypes in vitro.46 
eIF3a expression is also higher in fetal than in more differentiated 
tissues,47 and thus reciprocal to let-7 expression.26
As expression of eIF3 subunits in human cells appears to be highly 
coordinated48 such that forced overexpression of individual subunits 
leads to increased accumulation of other subunits and incorporation 
into functional eIF3 complexes, it appears likely that additional eIF3 
subunits are deregulated in tumors.
When viewed together with the fact that let-7 functions as a 
tumor suppressor gene,26 these findings suggest that the opposing 
roles of eIF3 and let-7 on cell differentiation might be conserved 
Figure 3. Reduced levels of eIF3-subunits cause precocious seam cell fusion. Synchronized N2; 
wIs79 L1-stage larvae were grown on bacteria producing the indicated dsRNA and examined for 
presence of precocious seam cell fusion upon reaching early-L4 stage. (A–D) Photomicrographs 
of animals grown on the indicated bacteria. Arrowheads point to AJM-1/GFP signal between 
seam cells observed in the absence of cell fusion. Arrows in lower panels indicate the distal 
tips of the gonads, visualized through Nomarski optics, which demonstrate the appropriate 
early L4 developmental stage. Anterior of each animal is left, ventral down. Note that GFP and 
Nomarski micrographs show different parts of the same animal. (E) Percentages of animals with 
precocious seam cell fusion were averaged from at least two independent experiments. To avoid 
developmental arrest in the case of eif-3.B and eif-3.C subunits, and gonadal migration defects 
in the case of the eif-3.E, animals were fed bacteria expressing the appropriate dsRNA, diluted 
appropriately (1:2 to 1:6) with bacteria producing mock dsRNA. n ! 82 for each. Error bars 
correspond to SEM.
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Materials and Methods
let-7(n2853) suppressor screen and RNAi. Wild-type (N2) and 
let-7(n2853) (MT7626) strains used in this work were provided 
by the Caenorhabditis Genetics Center (CGC), which is founded 
by the NIH National Center for Research Resources. The screen 
was performed using RNAi by feeding with a published RNAi 
library29 covering ca. 90% of the genes on C. elegans chromosome I. 
Additional RNAi clones were obtained from RNAi libraries,49,50 or 
were created in the laboratory as follows by PCR on genomic DNA 
using the primers listed below. PCR fragments were digested with 
XbaI and KpnI (pXD10, pXD11 and pXD12), NdeI/XhoI (pHG8) 
or BamHI/XhoI (pHG9) and ligated into L4440 (reviewed in ref. 
51). The resulting constructs were transformed in E. coli HT115 for 
feeding RNAi experiments.
The screen was performed as illustrated in Figure 1, with every 
step done in duplicate. Supplements were used at the following 
concentrations: ampicillin: 100 µg/ml, tetracycline: 12.5 µg/ml, 
IPTG: 1 mM. Retesting and testing of additional translation factors 
was done at 20°C and 25°C on 6-cm diameter plates as described.7 
In some experiments, carbenicillin was used instead of ampicillin. 
Suppressor identity was confirmed through plasmid DNA recovery 
followed by sequencing. In some cases we were unable to stage 
worms reliably because RNAi caused gonad migration defects in the 
absence of oocytes. These candidates were discarded.
Enhancement of lin-41(ma104) precocious phenotypes was 
scored in at least two independent experiments with !19 animals per 
strain and a total of !100 animals scored per strain.
Oligonucleotide sequences.
Synthetic sequences are in lowercase, restriction sites underlined.
Precocious seam cells fusion. Precocious seam cell fusion was 
analyzed using strain wIs79[ajm-1::gfp; scm::gfp] (ref. 9). Microscopy 
images were acquired using a Zeiss Axioplan microscope equipped 
with a Zeisscam CCD camera and Axiovision software. Images were 
cropped and levels adjusted using Adobe Photoshop software.
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Name 5' to 3' sequence Plasmid
eIF1_F1 gctctagagcTGAAGTTGCTCACCATCTCG pXD10
eIF1_R1 ggggtaccccACTTCCTCGCCACTTCTTCA (L4440-eIF1)
cif-1_F1 gctctagagcGATGATGTCAAGCAGCTCCA pXD11
cif-1_R1 ggggtaccccCATTGTTCCGTTCCGAATCT (L4440-cif-1)
eIF5B_F1 gctctagagcGAAGAGGATTCGGATGGTGA pXD12
eIF5B_R1 ggggtaccccACCTCCTTCCTCTTGGCAAT (L4440-eIF5B)
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Repression of C. elegans microRNA targets at the
initiation level of translation requires GW182
proteins
Xavier C Ding and Helge Großhans*
Friedrich Miescher Institute for Biomedical Research (FMI), Basel,
Switzerland
MicroRNAs (miRNAs) repress target genes through a
poorly defined antisense mechanism. Cell-free and cell-
based assays have supported the idea that miRNAs repress
their target mRNAs by blocking initiation of translation,
whereas studies in animal models argued against this
possibility. We examined endogenous targets of the let-7
miRNA, an important regulator of stem cell fates. We
report that let-7 represses translation initiation in
Caenorhabditis elegans, demonstrating this mode of action
for the first time in an organism. Unexpectedly, although
the lin-4 miRNA was previously reported to repress its
targets at a step downstream of translation initiation, we
also observe repression of translation initiation for this
miRNA. This repressive mechanism, which frequently but
not always coincides with transcript degradation, requires
the GW182 proteins AIN-1 and AIN-2, and acts on several
mRNAs targeted by different miRNAs. Our analysis of an
expanded set of endogenous miRNA targets therefore
indicates widespread repression of translation initiation
under physiological conditions and establishes C. elegans
as a genetic system for dissection of the underlying
mechanisms.
The EMBO Journal advance online publication, 8 January
2009; doi:10.1038/emboj.2008.275
Subject Categories: RNA; proteins
Keywords: AIN-1; let-7; lin-4; microRNA; translational
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Introduction
MicroRNAs (miRNAs) are small, untranslated RNAs involved
in numerous developmental pathways in plants and animals
(reviewed in Bushati and Cohen, 2007). They regulate a large
fraction of cellular mRNAs by binding to complementary
sequences in their target mRNAs (‘cognate mRNAs’), but
the mechanisms involved in subsequent repression of the
mRNA are less clear (reviewed in Eulalio et al, 2008a;
Filipowicz et al, 2008). In the best understood example,
prevalent in plants, miRNAs function as small interfering
(si)RNAs and induce mRNA cleavage through the RNA-
induced silencing complex (RISC) when binding to perfectly
complementary sites in their target mRNAs (Jones-Rhoades
et al, 2006). In animals, this appears to be the exception, as
most animal miRNAs are only partially complementary to
their targets (Bushati and Cohen, 2007), thus precluding
RISC-mediated cleavage. Early work on the Caenorhabditis
elegans lin-4 miRNA established, instead, the paradigm
that miRNAs functioned by translationally repressing their
targets at a step downstream of translation initiation, without
substantially affecting transcript levels (Olsen and Ambros,
1999; Seggerson et al, 2002). By contrast, recent studies
aimed at recapitulating miRNA function in cell-free systems
concluded that miRNAs inhibit target mRNA translation at
the initiation step (Wang et al, 2006; Mathonnet et al, 2007;
Thermann and Hentze, 2007; Wakiyama et al, 2007).
Inhibition of translation initiation, as evidenced by the hall-
mark shift of target mRNAs from heavy to light polysomal or
monosomal fractions of sucrose density gradients in response
to the miRNA, has also been observed in a number of cell-
based studies. However, such studies also identified addi-
tional and sometimes conflicting miRNA modes of action
(Eulalio et al, 2008a; Filipowicz et al, 2008). These mechan-
isms include inhibition of target mRNA translation after
initiation, target mRNA degradation in a non-endonucleolytic
manner, which may or may not result from deadenylation,
and co-translational protein degradation. Target mRNA
degradation has also been observed for some miRNA targets
in vivo, in C. elegans and zebrafish (Bagga et al, 2005;
Giraldez et al, 2006).
Only a single study has so far demonstrated regulation of
an endogenous mRNA, CAT1, by its cognate miR-122 miRNA
at the level of translation initiation (Bhattacharyya et al,
2006). The other studies that examined endogenous miRNA
targets instead provided evidence against repression of trans-
lation initiation (Olsen and Ambros, 1999; Seggerson et al,
2002; Kong et al, 2008), and this includes the only two studies
that have tested this mechanism in an animal model, under
physiological conditions (Olsen and Ambros, 1999;
Seggerson et al, 2002). It is currently unclear whether this
divergence of results denotes specific mechanisms operating
for individual miRNAs and/or targets. Alternatively, the
transfected miRNA target reporters that were used in the
bulk of studies showing repression of translation initiation by
miRNAs might be particularly conducive to this mode of
action, consistent with reports that transfection modalities
(Lytle et al, 2007) and choice of the promoters that drive
reporter gene expression (Kong et al, 2008) can affect the
apparent mode of target repression.
Consistent with the elusive nature of miRNA mechan-
ism(s), few molecular players have been identified. Mature
miRNAs occur in a complex with Argonaute (AGO) family
proteins, and it has been suggested that direct binding of AGO
to the mRNA cap may be responsible for miRNA target
repression (Kiriakidou et al, 2007), but this has beenReceived: 14 August 2008; accepted: 3 December 2008
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controversial (Eulalio et al, 2008b). The translation initiation
factor eIF6 has been identified as a component of a large
AGO2-containing complex in human cells and eIF6 depletion
was shown to impair miRNA target gene silencing in human
cells and C. elegans (Chendrimada et al, 2007). However,
it has been suggested that the involvement of eIF6 may be
indirect (Filipowicz et al, 2008), and studies of Drosophila
cells have indicated that eIF6 may not be generally required
for miRNA function (Eulalio et al, 2007, 2008b). Consistent
with the latter notion, depletion of C. elegans eIF6 appears to
enhance rather than diminish let-7 miRNA activity by genetic
criteria (Ding et al, 2008).
AGO proteins also bind to members of the GW182 protein
family in various organisms and this interaction contributes
to miRNA function (reviewed in Ding and Han, 2007).
Tethering of GW182 to an mRNA leads to degradation of
this mRNA, and, conversely, GW182 depletion impairs
miRNA activity (Liu et al, 2005; Behm-Ansmant et al, 2006;
Eulalio et al, 2008b). In C. elegans, combined loss of the two
GW182-like proteins AIN-1/-2 partially phenocopies loss of
the AGO proteins ALG-1/-2 and causes upregulation of
reporter genes under miRNA control (Ding et al, 2005;
Zhang et al, 2007). The level and extent to which AIN-1/-2
contribute to miRNA function have remained unknown,
although it has been suggested that they might localize
repressed miRNA targets to P-bodies to enable their degrada-
tion (Ding et al, 2005).
We have focused here on the C. elegans let-7 miRNA to
examine the mechanism of action of miRNAs in vivo. let-7
was originally identified as a component of the C. elegans
heterochronic pathway (Reinhart et al, 2000), which controls
the temporal fate of cells during postembryonic development.
Several let-7 target genes have been identified (Slack et al,
2000; Abrahante et al, 2003; Lin et al, 2003; Grosshans et al,
2005; Lall et al, 2006) and among these, lin-41 and daf-12
have been characterized most extensively and their let-7-
binding sites partially mapped (Reinhart et al, 2000; Slack
et al, 2000; Vella et al, 2004; Grosshans et al, 2005). This
availability of in vivo validated targets combined with the fact
that the sequence of let-7 is perfectly conserved in animals
(Pasquinelli et al, 2000; Lagos-Quintana et al, 2002), and that
it has been used to examine miRNA mechanisms of action in
diverse experimental systems (Bagga et al, 2005; Pillai et al,
2005; Nottrott et al, 2006; Mathonnet et al, 2007; Wakiyama
et al, 2007), makes let-7 particularly suitable for our analysis.
In addition, understanding the mode of action of this specific
miRNA is of particular interest because of its important
developmental and pathological functions as a potent regu-
lator of stem cell fates and a tumour suppressor (reviewed
in Bu¨ssing et al, 2008).
We report that let-7 causes repression of translation
initiation as well as degradation of its endogenous lin-41
and daf-12 target mRNAs. Other miRNAs silence their
targets by the same mechanisms, and this includes lin-4
miRNA, previously reported to repress translation at a level
after initiation (Olsen and Ambros, 1999; Seggerson et al,
2002). Translational repression requires the GW182
proteins AIN-1/-2, as does mRNA degradation. Our findings
indicate that downregulation of translation initiation is
widely used under physiological conditions in C. elegans
and establish the nematode as a system for genetic dissection
of this process.
Results
Translational blockade of endogenous let-7 target genes
We recently observed widespread genetic interaction between
let-7 and the translational machinery in C. elegans (Ding et al,
2008). These findings prompted us to examine whether let-7
regulates its targets translationally in vivo. To this end, we
fractionated whole animal lysates by sucrose density gradient
ultracentrifugation to analyse the polyribosome association
of endogenous let-7 targets in wild-type and let-7(n2853)
mutant C. elegans at the L3 developmental stage, when let-7
activity is low, and at the late L4 stage, when let-7 activity is
high (Reinhart et al, 2000) (Figure 1A; Supplementary Figure S1).
As the two let-7 targets daf-12 and lin-41 (Slack et al, 2000;
Grosshans et al, 2005) are expressed at very low levels in L4
stage larvae (Snow and Larsen, 2000; Bagga et al, 2005 and
this study, below), we used reverse transcription–quantita-
tive PCR (RT–qPCR) to quantify them. It is to be noted that all
experiments were performed using random hexamer oligo-
nucleotides to prime RT, to include even mRNA, the poly(A)
tail of which might be short due to the action of the miRNA
(Eulalio et al, 2008a; Filipowicz et al, 2008). Additional
control experiments, described below, further confirmed
that we are detecting full-length mRNAs rather than partially
stable degradation fragments.
We found that both lin-41 and daf-12 mRNAs were mod-
erately, but consistently depleted from the highly translated
polysomal fractions in wild-type relative to let-7 mutant
animals at the late L4 stage (Figure 1B and C;
Supplementary Figure S1), in agreement with decreased
translation initiation (Eulalio et al, 2008a). By contrast,
ama-1 and act-1 mRNAs, which are not targeted by let-7,
displayed similar translational profiles in both strains (Figure
1B and C; Supplementary Figure S1).
L3 stage animals express little or no let-7 (Reinhart et al,
2000); accordingly, we see no difference when comparing
polysomal association of daf-12 and lin-41 mRNAs between
let-7 mutant and wild-type animals at this stage (Figure 1B
and C; Supplementary Figure S1). Moreover, in wild-type
animals, polysome association of daf-12 and lin-41 is de-
creased at L4 compared with L3 stage, consistent with the
establishment of an inhibitory mechanism affecting transla-
tion initiation as let-7 expression starts. A more moderate
decrease of polysome association is also seen when perform-
ing this comparison for let-7 mutant animals, suggesting that
the n2853 allele may provide residual let-7 activity or that
alternative mechanisms, possibly the let-7 sister miRNAsmir-
48, mir-84 and mir-241 (Abbott et al, 2005; Li et al, 2005),
may contribute.
To exclude the possibility that the RNA that we analysed in
our sucrose gradients was not representative for the total pool
of cellular RNA, we performed the following control experi-
ments. We used TRIzol to extract total RNA directly from
ground worms, from the cleared lysate used for sucrose
gradient centrifugation and from the pellet left behind upon
lysate clearing. We found, first, that B90% of the RNA is in
the lysate supernatant and will thus be loaded on the sucrose
gradient. Second, composition of RNA in the supernatant and
pellet is comparable, neither let-7 target nor control mRNAs
are preferentially enriched in, or depleted from, the super-
natant relative to RNA retained in the pellet (Supplementary
Figure S2). Finally, although increasing sucrose concentration
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in total lysates decreased the yield of extracted RNA, RNA
composition was largely unaffected (Supplementary Figure
S2). To ensure comparable recovery from each fraction and
greatest possible reproducibility, we equalized sucrose con-
centration in all fractions to 30% (w/v) prior to RNA extrac-
tions in all our experiments. This set of control experiments
confirms that any results that we obtained in our analysis can
be considered representative of the total pool of cellular RNA.
To determine further whether the fast-sedimenting mRNA
was indeed associated with polyribosomes, we treated lysates
with EDTA and observed that all four mRNAs were shifted to
the top of gradients. Distributions became indistinguishable
for late L4 wild-type and let-7(n2853) animals (Figure 1;
Supplementary Figure S1). As EDTA also disrupts non-ribo-
somal ribonucleoprotein complexes, we further used puro-
mycin to disassemble specifically polysomes by inducing
premature termination of the elongating peptide chains.
Puromycin treatment of extracts collapsed polysomes and
shifted the mRNAs deeper into the gradient (Supplementary
Figure S3), possibly reflecting aggregation of the mRNA and
not further pursued by us. The resulting sedimentation
patterns were indistinguishable for wild-type and let-7 ani-
mals and occurred for let-7 target as well as control mRNAs.
The coincident loss of polysomes and shift of mRNAs de-
monstrates that our assay examines mRNAs associated with
translation-competent ribosomes.
We conclude from these data that let-7 depletes its targets
lin-41 and daf-12 from bona fide polysomes, consistent with
blocking translation initiation on these mRNAs.
Translational repression requires let-7 complementary
sites in the lin-41 30UTR
The lin-41 30 untranslated region (30UTR) is necessary and
sufficient to confer let-7-mediated regulation on an unrelated
reporter gene (Slack et al, 2000). To verify that let-7 impaired
lin-41 translation by binding to the lin-41 30UTR, we em-
ployed transgenic animals expressing a lacZ reporter gene
fused to the lin-41 30UTR or a mutant variant thereof lacking
the let-7-binding sites (Figure 2A). We expressed the trans-
gene from the col-10 promoter to accumulate it specifically in
the seam cells, where let-7 mediates lin-41 repression (Slack
et al, 2000; Johnson et al, 2003).
Consistent with inhibition of translation initiation, we
observed that only 40% of the reporter mRNAwas associated
with polysomes in wild-type animals, whereas this level
reached almost 70% in let-7 mutant animals. Deletion of
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the validated let-7-binding sites in the reporter 30UTR (Vella
et al, 2004) relieved translational repression to the same
extent in wild-type animals (Figure 2B and C).
Consequently, let-7 mutation or deletion of its binding sites
increased the average number of ribosomes per lacZ mRNA
by more than two-fold relative to the wild-type situation,
whereas the average number of ribosomes per act-1 mRNA
stayed constant (Figure 2D; see Materials and methods for
details on the calculation). This result shows that the inter-
action between let-7 and its binding sites in the lin-41 30UTR
mediates significant translational repression of the target
mRNAs. This is confirmed by our finding that loss of let-7
regulation causes aX5-fold derepression of the lacZ reporter
(Supplementary Figure S4), although mRNA levels change
less than two-fold (see below).
mRNA degradation does not correlate with translational
repression
Bagga et al (2005) observed dramatic reduction of target
mRNA levels in the presence of their cognate miRNAs in
C. elegans. By RT–qPCR, we determined mRNA levels of the
let-7 targets in total RNA that we prepared from aliquots of
the same whole animal lysates that were used for the poly-
some profile experiments (Figure 3A). At the L3 stage, lin-41
and daf-12 mRNA levels are similar in wild-type and let-
7(n2853) animals. However, at the late L4 stage, lin-41mRNA
is six-fold and daf-12 two-fold more abundant in let-7(n2853)
relative to wild-type animals. Similar ratios were obtained
when summing up the amounts of these mRNAs across all
fractions of the sucrose gradients, further confirming that
RNA extracted from the gradients is representative of total
cellular full-length mRNAs. It is to be noted that the levels of
lin-41 and daf-12 mRNAs are reduced by two-fold even in the
let-7 mutant animals between the L3 and L4 stages.
For lin-41, our results are in agreement with those seen by
Bagga et al (2005), and northern blot analysis of total RNA
using a probe against lin-41 identified a single band, the
intensity of which mirrored the signal obtained by RT–qPCR
in the same backgrounds (Figure 3B). Although lin-41 mRNA
levels in individual sucrose gradient fractions were below the
limit of detection by northern blot analysis, these results
essentially exclude the possibility that accumulation of
lin-41 mRNA degradation products could bias our RT–qPCR
results and confirm that we reliably quantify full-length
mRNAs.
For daf-12 mRNA, its low abundance prevents detection by
northern blotting even in unfractionated, total RNA without
prior selection of polyadenylated mRNA (Snow and Larsen,
2000). Therefore, to confirm that our RT–qPCR assay simi-
larly measures the levels of full-length daf-12 mRNA, we
tested a second set of primers, and obtained comparable
results as expected (Supplementary Figure S5A). Finally, we
examined the expression levels of both daf-12 and lin-41
using cDNA obtained through oligo-dT-primed RT. Again,
we obtained comparable results (Supplementary Figure S5B
and C), arguing against the detection of a stable degradation
product and suggesting that any residual poly(A) tail on these
mRNAs is sufficient to support priming through oligo-dT
oligonucleotides. In summary, we confirm by several
independent methods that our assays quantify full-length
mRNAs, and we find that the daf-12 and lin-41 mRNAs are
not only translationally repressed by let-7 but also subject to
degradation.
Translational repression of daf-12 is at least equal to that of
lin-41 but the decrease of daf-12 mRNA levels is more
modest, suggesting that translational repression and trans-
cript degradation may not be directly linked. Indeed,
although the lacZHlin-41 reporter mRNA is very efficiently
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repressed translationally, mRNA levels differed by less than
two-fold in wild-type relative to let-7(n2853) animals
(Figure 3C). Although these findings strongly argue against
a scenario where lower abundance of an mRNA diminishes
its access to the translational machinery, we wished to
exclude the possibility further that the translational effects
that we observed were due to altered mRNA levels. ugt-63
and vit-1 are differentially expressed in synchronized late L4
wild-type and let-7(n2853) animals but are not direct targets
of let-7 (B Hurschler and HG, unpublished data). Although
vit-1 was four-fold less abundant in let-7(n2853) than in wild-
type animals, and ugt-63 was two-fold more abundant, the
translational profiles of both genes were similar in wild-type
and let-7(n2853) (Supplementary Figure S6). Thus, altered
mRNA levels per se do not appear to influence the efficiency
of translation initiation.
Multiple miRNAs function by preventing translation
initiation
The finding that let-7 mediates repression of translation
initiation on its targets in C. elegans was unexpected, as
C. elegans lin-4 was previously reported to repress these mRNAs
at a step downstream of translation initiation (Olsen and
Ambros, 1999; Seggerson et al, 2002). To determine whether
repression of translation initiation is specific for let-7 or a
more general mechanism, we tested whether lin-4 repressed
translation initiation of lin-14 and lin-28, two experimentally
validated targets (Wightman et al, 1993; Moss et al, 1997).
lin-4 is first expressed in the mid-L1 stage and represses lin-14
by late L1/early L2 and lin-28 one stage later (Olsen and
Ambros, 1999; Seggerson et al, 2002). When we compared
extracts from late L2 stage wild-type and lin-4(e912) mutant
animals, we observed that both mRNAs were shifted into the
polysomal fraction in the mutant (Figure 4A and B). This shift
is particularly pronounced for lin-28, where the effect is
highly statistically significant (Figure 4A). By contrast, poly-
some association of the control mRNAs act-1 and ama-1 and
the let-7 target daf-12 is identical in lin-4(e912) and wild-type
animals (Figure 4A and B). We conclude that lin-4, similar to
let-7, can repress its target at the level of translation initiation.
lin-14 and lin-28 transcript levels are increased in lin-4
mutants compared with wild-type animals, whereas daf-12,
act-1 and ama-1mRNA levels remain unchanged (Figure 4C).
The observation that lin-4 induces a stronger translational
blockade of lin-28 than of lin-14 and conversely a more
pronounced degradation of lin-14 than of lin-28 further
suggests that translational repression and target mRNA
degradation are not directly linked mechanisms.
Translational repression and degradation of miRNA
targets require the GW182 proteins AIN-1 and AIN-2
Having established that miRNAs mediate both target mRNA
degradation and translational repression in vivo, we sought to
identify the factors mediating these mechanisms. Good can-
didates were the GW182 homologues AIN-1 and AIN-2 (Ding
et al, 2005; Zhang et al, 2007), as depletion of GW182 causes
upregulation of miRNA target genes in various systems (Ding
and Han, 2007). However, although mRNA degradation is
readily prevented upon GW182 depletion, derepression of
those miRNA targets that are not strongly regulated by
degradation is typically well below that seen with AGO
depletion (Behm-Ansmant et al, 2006; Eulalio et al, 2007),
consistent with the proposal that GW182 proteins might
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enhance miRNA activity by targeting repressed mRNAs to
P-bodies for degradation (Ding et al, 2005).
To determine whether depletion of the GW182 family
members AIN-1 and AIN-2 permitted uncoupling of transla-
tional repression and degradation of miRNA targets, we
performed polysome profile analyses on L4 stage wild-type
and ain-2(RNAi); ain-1(ku322) animals and analysed various
targets of multiple miRNAs: the let-7 targets daf-12 and lin-41,
the lin-4 targets lin-14 and lin-28, the lsy-6 targets cog-1
(Johnston and Hobert, 2003) and hbl-1, which is targeted
by mir-48, mir-84, mir-241, let-7 and lin-4 (Abrahante et al,
2003; Lin et al, 2003; Abbott et al, 2005). As predicted,
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depletion of AIN-1/-2 increased lin-41 and daf-12 transcript
levels (Figure 5A). However, to our surprise, translational
repression of both let-7 targets was also efficiently relieved
(Figure 5B and C). In fact, the relief of both modes of let-7
target repression was more extensive in ain-2; ain-1 than in
let-7(n2853) mutant animals, possibly suggesting that re-
maining let-7 activity or distinct miRNAs, perhaps of the let-
7 family, contribute to residual repression of lin-41 and daf-12
in let-7(n2853) animals. Consistent with this idea, mRNA
levels of the two let-7 targets daf-12 and lin-41 are upregu-
lated in miR-48 miR-241; miR-84 triple mutant animals
(Supplementary Figure S7).
Translational repression was also relieved for lin-14, lin-28,
cog-1 and hbl-1, although the results for lin-28 and hbl-1
narrowly missed statistical significance (lin-28, P¼ 0.053;
hbl-1, P¼ 0.056). We also analysed genes not known to be
miRNA targets (act-1, tbb-2, ama-1 and eft-2). We observed
no effect on total mRNA levels and no consistent trend of
translational upregulation in response to AIN-1/-2 depletion
(Figure 5). Low abundance of the investigated miRNA target
mRNAs in late L4 wild-type animals (see Figure 3B) pre-
vented us from performing northern blot analysis on poly-
some profile fractions. However, consistent results were
obtained by RT–qPCR with multiple lin-14 primer pairs
(Supplementary Figure S8) and by semiquantitative classical
RT–PCR (Supplementary Figure S9) confirming our observa-
tion that translational repression of miRNA target is relieved
in AIN-1/-2 depleted animals.
Taken together, these data reveal that translational control
is a mechanism that is widely used by miRNAs in vivo.
Equally significant, our results show that AIN-1/-2 have
a general and important function in the process. Notably,
although transcript levels of lin-14, lin-28 and hbl-1 increased
in ain-2; ain-1 mutant relative to wild-type animals, cog-1
mRNA levels remained unchanged (Figure 5C), demonstrat-
ing that translational repression can occur independently of
target mRNA degradation.
Discussion
We report here that endogenous daf-12 and lin-41 mRNAs are
translationally controlled by let-7 in vivo. Polysomal shifts
can even be seen in whole worm lysates, despite the fact that
let-7 regulates these targets only in a subset of those tissues
where they are expressed (Antebi et al, 2000; Slack et al,
2000; Johnson et al, 2003). Nonetheless, the degree of spatial
and temporal co-expression of the miRNA and its targets
limits the sensitivity of our assay, as demonstrated for pha-4,
a third experimentally validated let-7 target (Grosshans et al,
2005). let-7 regulates pha-4 in the intestine (Grosshans et al,
2005), but not in the pharynx, where pha-4 expression is
particularly strong, and where let-7 is not co-expressed
(Azzaria et al, 1996; Johnson et al, 2003). Under these
conditions, we can neither observe polysomal shifts
(Supplementary Figure S1) nor pha-4 mRNA accumulation
(data not shown) in let-7 mutant relative to wild-type ani-
mals. By contrast, the magnitude of repression of translation
initiation can be well appreciated for the col-10HlacZHlin-41
reporter mRNA, which is exclusively expressed in the seam
cells where let-7 is also active.
We subsequently expanded our studies to mRNAs targeted
by other miRNAs, including the lin-4 targets lin-14 and lin-28
and found that these, too, were repressed at the level of
translation initiation. These findings resonate well with re-
sults from cell-free and a subset of cell culture-based assays
(Eulalio et al, 2008a; Filipowicz et al, 2008), and extend these
studies by demonstrating such function under physiological
conditions. Equally important, most published evidence for
translation initiation has been obtained through the use of
transfected target reporter genes, the mode of repression
of which appears to be susceptible to transfection conditions
(Lytle et al, 2007) and promoter choice (Kong et al, 2008). To
our knowledge, only a single endogenous target gene was
demonstrated to be repressed by this mechanism
(Bhattacharyya et al, 2006), whereas this has been ruled
out for others (Olsen and Ambros, 1999; Seggerson et al,
2002; Kong et al, 2008). Our study now demonstrates that
repression of translation initiation is nonetheless widespread
for endogenous miRNA targets, and different miRNAs.
Our finding that lin-4 represses its targets, at least in
part, at the level of translation initiation contrasts with
earlier experiments that had revealed largely unchanged
polysomal distributions of C. elegans lin-14 and lin-28 before
(L1 stage) and after (L2 stage) the onset of expression of their
cognate miRNA, lin-4 (Olsen and Ambros, 1999; Seggerson
et al, 2002). The reason for this discrepancy is currently
unclear, but as lin-4 mutant animals were not compared
with wild-type animals in the earlier studies, it is possible
that the resulting translational profiles might also have
reflected developmental, lin-4-independent effects such as
potential repression of lin-28 by LIN-66 (Morita and
Han, 2006). We also note that at least one of the earlier
publications (Olsen and Ambros, 1999) displayed a—statisti-
cally nonsignificant—trend of lin-14 shifting to the (sub-)
monosomal fraction at the L2 stage, when lin-4 expression is
high.
Other miRNAs, in addition to lin-4, possibly its ‘sister’ mir-
237, or even let-7 (Reinhart et al, 2000; Slack et al, 2000;
Esquela-Kerscher et al, 2005; Grosshans et al, 2005; Morita
and Han, 2006), may also regulate lin-14 or lin-28, and
contribute to the polysomal shift observed in ain-2; ain-1
mutant animals. However, although this remains to be tested
for lin-28, we did not detect any change in lin-14 mRNA
levels or translation in response to the let-7(n2853) mutation
(data not shown). Irrespective of this possibility, our experi-
ments using lin-4 mutant animals clearly demonstrate that
this miRNA can mediate repression of translation initiation.
In most instances, we observed significant amounts of
cognate mRNA degradation alongside translational repres-
sion, but the extent of degradation varied by target.
Moreover, there was no clear correlation between the extent
of translational repression and target mRNA degradation, for
example, we observed more degradation for endogenous lin-
41 than for the reporter mRNA, although less translational
silencing is apparent for the endogenous transcript. Although
we cannot formally rule out the possibility that this specific
case reflects differences between endogenous targets and
targets expressed from transgenes or that transcriptional
effects mediated by the lin-41 promoter may contribute to
these differences, we favour the idea that translational
repression and target mRNA degradation may be independent
mechanisms and that seam cells favour translational repres-
sion. This is consistent with an earlier study showing that
different types of cultured cells evoke different responses to
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identical target mRNA reporters, with degradation dominat-
ing in some cell lines and translational blockade in others
(Schmitter et al, 2006). Indeed, the observation that cog-1 is
regulated translationally, but not at the level of mRNA
degradation, further supports our conclusion that mRNA
degradation and translational repression are two distinct
mechanisms in vivo that may, however, frequently act
together on the same miRNA targets.
It is to be noted that our results cannot rule out that the
two mechanisms might function sequentially in that transla-
tional repression precedes mRNA degradation (e.g. Selbach
et al, 2008). Indeed, we note that repression of translation
initiation by lin-4 appears more prominent for lin-28 than lin-
14. As lin-14 is repressed at an earlier developmental stage
than lin-28 (Olsen and Ambros, 1999; Seggerson et al, 2002),
it is tempting to speculate that increased lin-14 mRNA
degradation might deplete the monosomal pool of transla-
tionally repressed mRNA, effectively reducing the apparent
polysomal shift. Analysis of polysome profiles at increased
temporal resolution might help to address this possibility in
the future.
Early reports on GW182 suggested a more auxiliary func-
tion in miRNA activity, with a greater importance in repres-
sing targets susceptible to mRNA degradation (Ding et al,
2005; Liu et al, 2005; Behm-Ansmant et al, 2006; Eulalio et al,
2007). However, as AIN-1/-2 appear rather distantly related
to GW182 proteins (Behm-Ansmant et al, 2006), it was
unknown whether their functions can be inferred from
GW182 activity in other organisms. Moreover, recent work
on Drosophila GW182 has shown that degradation-indepen-
dent, possibly translational, repressive mechanisms may also
crucially involve GW182 (Eulalio et al, 2008b), possibly in an
miRNA- and/or target-specific manner. We find that depletion
of the GW182 proteins AIN-1/-2 severely impairs both cog-
nate mRNA degradation and translational control in vivo, for
a number of different miRNA targets and miRNAs, supporting
the notion that these proteins are widely used, essential
effectors of miRNA activities. This conclusion is also consis-
tent with the alg-1/2-like phenotypes observed in ain-2; ain-1
double mutant animals (Zhang et al, 2007). In view of the fact
that both mRNA degradation and translational repression
require AIN-1/-2, we speculate that GW182 proteins may
coordinate these two activities, possibly through interaction
with distinct mediators or effectors, the identities of which
remain to be elucidated.
Taken together, our study provides insights into miRNA
function in an animal model and establishes C. elegans let-7
as a model for the genetic dissection of miRNA-mediated
repression of translation initiation, complementing available
biochemical systems. The fact that translational repression in
vivo may be substantial at least for a subset of targets, and
possibly occur even without any degradation altogether,
suggests that the identification of targets of this important
miRNA will benefit greatly from recently established proteo-
mics approaches (Baek et al, 2008; Selbach et al, 2008).
Materials and methods
C. elegans strains and RNAi
Wild-type N2, MT7626: let-7(n2853), MH2385: ain-1(ku322) and
DR721: lin-4(e912) strains were provided by the CGC; CT5a:
N2;Is[goa-1Hgfp; col-10HlacZHlin-41] (Caudy et al, 2003) by R
Plasterk; VT1066: mir-48 mir-241(nDf51); mir-84(n4037) (Abbott
et al, 2005) by V Ambros. The HW211: let-7(n2853);Is[goa-1Hgfp;
col-10HlacZHlin-41] strain was obtained by crossing CT5a with
MT7626. The HW390: N2;xeIs11[rol-6(su1006); col-10HlacZHlin-
41DLCS 1-3] strain was generated by genomic integration of an
extrachromosomal array made of pFS1031 and rol-6(su1006) (Vella
et al, 2004), followed by several rounds of backcrossing to N2. As
ain-2(tm1863); ain-1(ku322) (Zhang et al, 2007) double mutant
animals grow very poorly, we exposed ain-1(ku322) animals to ain-
2(RNAi), starting with L1 larvae and using a published RNAi
feeding construct and protocol (Kamath et al, 2003; Grosshans et al,
2005). Enhancement of the alae defect phenotype from 21%
penetrant in the ain-1(ku322) single mutant to 100% in the double
mutant confirmed efficient ain-2 knockdown (nX17 each). To
circumvent reduced brood size associated with the lin-4(e912) allele
and obtain a sufficiently large synchronized population, lin-4(e912)
animals were expanded at 201C on lin-14(RNAi). Following
synchronization by hatching in M9 buffer, animals were shifted
back to standard non-RNAi food (OP50) and grown to the desired
stage for extract preparation. The reappearance of the lin-4(e912)
phenotypes (long, egg-laying defective) on these animals excluded
the possibility that lin-14(RNAi) had prolonged effects.
Polysome profile analysis
A detailed description can be found in the Supplementary data.
Briefly, lysates of synchronized worms were layered on linear
sucrose gradients (15–60% w/v) and centrifuged for 3 h at
39 000 r.p.m., 41C, using a SW-40 rotor and an Optima L-80 XP
Ultracentrifuge (Beckman Coulter). The gradients were fractionated
in 12 fractions of equal volume while absorbance at 254nm was
recorded. The entire gradient was fractionated so that any pelleted
material would be recovered with the last fraction. However, we
typically found very little RNA in this fraction, suggesting that
RNAs did not substantially occur in heavy particles or compart-
ments under our experimental conditions. After adjusting sucrose
concentration in each fraction to 30% (w/v), RNA was extracted
using TRIzol (Invitrogen) and RNA integrity confirmed on ethidium
bromide-stained agarose gels before proceeding to RT. RNA
recovery was quantitative under these conditions reaching up to
89% of input RNA. See Results section for a discussion of control
experiments confirming that RNA extracted from the lysate is
representative of the composition of total cellular RNA.
RT–qPCR
RNA RT was performed using the ImProm-IITM Reverse Transcrip-
tion System (Promega) with random hexamer primers, according to
the manufacturer’s recommendations using equal amounts of RNA
(400 or 800ng) for each sample to avoid saturating the RT reactions
in fractions with high concentrations of RNA. For polysome profile
fractions, relative transcript levels quantified by qPCR (below) were
subsequently corrected for the total amount of RNA extracted from
each fraction and expressed as a percentage of the total amount
recovered for the gradients. Identical results were obtained using
oligo-(dT)15 primers and equal volumes of RNA without applying
any correction, validating the method and establishing that qPCR
following RT by random hexamer is unlikely to detect stable
degradation fragments. This was also directly examined for lin-14
and daf-12 using distinct qPCR primer sets, which yielded
comparable results to the original primers.
qPCR reactions were performed in technical duplicate using the
ABsoluteTM QPCR SYBRs Green ROX Mix (Thermo Fisher
Scientific), according to the manufacturer’s recommendations, on
an ABI Prism 7000 Sequence Detection System coupled to ABI
Prism 7000 SDS 1.0 Software (Applied Biosystems). Relative
transcript levels were calculated using the 2!DC
0
t method (Livak
and Schmittgen, 2001). For all primer pairs (Supplementary data),
amplification efficiencies were determined to be equal or superior
to 1.8. Control reactions lacking either the reverse transcriptase or
template mRNA confirmed specificity of the amplification reaction.
Northern blot
RNA electrophoresis and transfer were performed as described
earlier (Bagga et al, 2005). UV crosslinked membranes were
hybridized using ULTRAhyb hybridization buffer (Ambion) accord-
ing to the manufacturer’s recommendations with randomly radi-
olabelled probes prepared from PCR-amplified DNA (see
Supplementary data for oligonucleotide sequences). Radioactive
Repression of endogenous microRNA targets
XC Ding and H Großhans
The EMBO Journal &2009 European Molecular Biology Organization8
59
signals were detected and quantified using a Storage Phosphor
Screen and a Typhoon 9400 with the Imagequant TL software (all
GE Healthcare).
Calculation of average number of ribosomes per mRNA
To calculate the average number of ribosomes per mRNA, each
gradient fraction was assigned an average number of ribosomes by
counting the peaks of the polysome profile at 254 nm. This number
was multiplied with relative amount of the mRNA detected in this
specific fraction. The sum of this product over all the fractions
yielded the average number of ribosomes per mRNA.
Statistical methods
All statistical significances were calculated using the paired one-
tailed Student’s t-test. Note that the statistical significance in this
stringent test not only depends on the average and standard
deviation of the data sets but also on the variation of the difference
between the paired values so that error bars will not fully reflect the
statistical significance obtained through this test.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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Supplementary information 
Supplementary Material and Methods 
Polysome profile analysis 
Synchronized worms were grown at 25 °C (N2 L3 and late L4, let-7(n2853) 
and ain-2(tm1863);ain-1(RNAi)) or at 20 °C (N2 L2 and lin-4(e912)) and on NGM 
(2%) plates seeded with E. coli OP50. L2 (~200’000), L3 (~50’000), or late L4 
(~30’000) worms, staged by vulval and gonad development, were harvested and 
washed three times with cold M9 supplemented with 1 mM cycloheximide and once 
with Lysis Buffer (see composition below) without RNasin and PTE/DOC. Worms 
were pelleted and frozen in liquid N2. Worms resuspended in 450!l of cold Lysis 
Buffer (20mM Tris pH 8.5, 140 mM KCl, 1.5 mM MgCl2, 0.5 % Nonidet P40, 2% 
PTE (polyoxyethylene-10-tridecylether), 1% DOC (sodiumdeoxycholate 
monohydrate), 1mM DTT, 1mM cycloheximide, 0.4 U/!l RNasin) were crushed to a 
fine powder using mortar and pestle precooled with liquid N2. As the powder thawed, 
lysates were collected and cleared by centrifugation (10 min. at 10’000 g, 4 °C). 
Lysate absorbances at 260 nm were measured and equivalent amounts of 
material were loaded on sucrose gradients and centrifuged for 3 hours at 39’000 rpm, 
4 °C, using a SW-40 rotor and an Optima™L-80 XP Ultracentrifuge (Beckman 
Coulter). Linear 15% to 60% (w/v) sucrose gradients were prepared from 15% (w/v) 
and 60% (w/v) sucrose solutions containing 20 mM Tris pH 8.5, 140 mM KCl, 1.5 
mM MgCl2, 1 mM DTT and 1 mM cycloheximide using a Gradient Master 
(Biocomp). 
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Gradient fractionation was performed using a Tris Pump (Teledyn ISCO), a 
Gradient Fractionator (BR-184-X, Brandel), and a fraction collector (FC-203B, 
Gilson). Absorbance profiles were recorded at 254 nm with an Econo UV monitor 
EM-1 (Biorad) coupled to a data acquisition device (DI-158U, DATAQ Instruments) 
using the WinDaq Serial Acquisition software (version 3.17). Gradients were 
fractionated in 12 fractions of equal volume. RNA from lysates and from each 
fraction was extracted with TRIzol (Invitrogen), according to the manufacturer’s 
recommendations. RNA aliquots were quality controlled on ethidium bromide stained 
agarose gels prior to RT-qPCR analysis. For EDTA treatment, cycloheximide was 
omitted in M9, lysis buffer and sucrose solution and 10 mM EDTA was added to the 
lysis buffer and sucrose solutions. Incubation of extracts with puromycin (5mM for 20 
min. at 37 °C) led to collapse of the polysomes, confirming their translational 
competence. Unexpectedly, all mRNAs, including those not known to be regulated by 
miRNAs, shifted towards dense sucrose gradients under these conditions, suggesting 
that the ribosome-free RNAs aggregated. 
!-galactosidase assay 
CT5a, HW211 and HW390 animals were grown on DH5! bacteria that lack "-
galactosidase activity. Two animals of the desired stage were transferred into 1.5 #l 
BGA buffer (50 mM potassium phosphate, pH 7.2, 1 mM MgCl2) and fixed and 
permeabilized by addition of 15 #l ice-cold acetone. Animals were resuspended in 8 
#l of CPRG staining solution (1.5 mM CPRG [chlorophenolred-ß-D-
galactopyranoside] in BGA buffer) and incubated for 1 h to 24 h at 37 °C. Aliquots of 
2 #l were measured on a Nanodrop spectrophotometer at $ = 575 nm and corrected 
for absorption at $ = 700 nm. Enzyme activities remained stable over the whole 
period as determined by constant changes in extinction per hour and worm measured 
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for different time points. No difference in !-galactosidase activity was seen for 
transgenic animals grown at either 20 °C or 25 °C; animals lacking lacZ transgenes 
did not exhibit any !-galactosidase activity. Correct stages were confirmed by 
subsequent DAPI staining of the animals used for the assay and microscopic analysis 
of the gonad.  
Classical PCR and quantification 
Classical RT-PCRs were performed on cDNA prepared as mentioned in the 
experimental procedures section of the main text. PCRs were performed using Taq 
DNA polymerase (Qiagen) according to the manufacturer’s recommendations. lin-14, 
lin-41, and tbb-2 mRNA level were determined using same set of primers as for RT-
qPCR reactions (qPCR lin-14 F2/R2, qPCR lin-41 F/R, qPCR tbb-1 F1/R1, 
respectively). PCR products were resolved on SyberSafe (Invitrogen) stained agarose 
gels. Quantification of the PCR products was performed by densitometry analysis of 
agarose gel pictures using the ImageJ software (http://rsbweb.nih.gov/ij/index.html). 
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Oligonucleotide sequences 
Oligonucleotides used in the present study. The qPCR CT5a F1 and R1 
primers were used to detect the lacZ::lin-41 reporter mRNAs. The forward primer is 
complementary to the lacZ sequence and the reverse primer to the lin-41 3’UTR. 
Name 5' to 3' sequence 
qPCR act-1 F1 GTTGCCCAGAGGCTATGTTC 
qPCR act-1 R1 CAAGAGCGGTGATTTCCTTC 
qPCR ama-1 F1 GGATCGAAGGGATCGAAGA 
qPCR ama-1 R1 TGGAAGAAGAATTCCGATGG 
qPCR daf-12 F2 GATCCTCCGATGAACGAAAA 
qPCR daf-12 R2 CTCTTCGGCTTCACCAGAAC 
qPCR daf-12 F3 TTATATCCCGGCCACTCTCA 
qPCR daf-12 R3 TGGAACACCAGGTAACGACA 
qPCR lin-41 F1 GGATTGTTCGACACCAACG 
qPCR lin-41 R1 ACCATGATGTCAAACTGCTGTC 
qPCR CT5a F1 CGGTCGCTACCATTACCAAC 
qPCR CT5a R1 CTGGAATGTGTGTGCTTTGC 
qPCR pha-4 F1 CATGCAAGGAGGAGGAATTT 
qPCR pha-4 R1 TCGTGAGTTCTTGGCCTTG 
qPCR vit-1 F1 GAGGTTCGCTTTGACGGATA 
qPCR vit-1 R1 GGCTTCACATTCCTCGTTCT 
qPCR ugt-63 F1 AAAGACCCCCTGGATTGAAG 
qPCR ugt-63 R1 TCTCTTTGATGAGCCAAGCA 
qPCR tbb-2 F1 CAAATTCTGGGAGGTCATCTC 
qPCR tbb-2 R1 CATACTTTCCGTTGTTGGCT 
qPCR eft-2 F1 TGTGTTTCCGGAGTGTGTGT 
qPCR eft-2 R1 CCATCGTCGTCTCCGTAAGT 
qPCR hbl-1 F1 ACTGCACATATGCCACCAAA 
qPCR hbl-1 R1 TGATGTAACCGGCTCAACTG 
qPCR cog-1 F1 TCCAGCACTCAATGCAACTC 
qPCR cog-1 R1 TTTTGTACGACGGTTTTGGA 
qPCR lin-14 F1 TGCAAATCTTCCAATCAAAGG 
qPCR lin-14 R1 TTCTGCCTGAGCCTCTTCTC 
qPCR lin-14 F2 GGATTCAATGCGACAGGATT 
qPCR lin-14 R2 CGATGCTGGTTTCAATGATG 
qPCR lin-28 F1 ATTCAAGAGCGATCGAATGG 
qPCR lin-28 R1 CACACTTTTGCATCGGTTTTT 
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 NB lin-41 F1 CAAGACTCCTTTCGGTGCTC 
NB lin-41 R1 CTGCACGGCTCATCAAAGTA 
NB act-1 F1 GTTGCCCAGAGGCTATGTTC 
NB act-1 R1 CAAGAGCGGTGATTTCCTTC 
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Figure S1: Polysome profile distribution of endogenous let-7 target mRNAs.
(A) Typical polysome profiles from synchronized late L4 wild-type and let-7(n2853) animals in the presence of cycloheximide or EDTA, 
respectively. The solid line represents the separation between the (sub)monosomal and polysomal fractions. Lower panels are ethidium bromide 
stained agarose gels of RNA extracted from polysome profile fractions. The 26S, 18S, 5.8S and 5S rRNAs are visible. As indicated by absor-
bance profiles at 254 nm and rRNA distributions across fractions, cycloheximide treatment preserves polysome integrity, whereas EDTA 
treatment induces ribosome dissociation into 40S and 60S ribosomal subunits. Note that the absorbance profiles are those also shown in Fig. 1 
(B) Distribution of the let-7 targets daf-12 and lin-41 and of the control genes ama-1 and act-1 across polysome profiles from synchronized 
wild-type and let-7(n2853) L3 animals treated with cycloheximide, late L4 animals treated with cycloheximide, and late L4 animals treated 
with EDTA. pha-4 distribution is shown for synchronized wild-type and let-7(n2853) late L4 animals only. The dotted line represents the 
separation between the (sub)monosomal and polysomal fractions. Panel B, except EDTA treatment, shows averages of at least three biological 
replicates. EDTA treatment was performed in duplicate, one representative experiment is shown. Error bars are SEM. daf-12 and act-1 data are 
as in Fig. 1 and included for comparison.
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Figure S2: Analysis of RNA recovery from C. elegans lysate and polysome profile sucrose fractions. 
(A) Synchronized L4 wild-type and  let-7(n2853) animals were either resuspended in TRIzol or in polysome profile lysis buffer and crushed in 
mortar and pestle precooled with liquid nitrogen. RNA from worms resuspended in TRIzol was purified according to manufacturer’s instruc-
tion. Lysate of worms resuspended in lysis buffer was cleared by centrifugation (see material and methods). RNA from the supernatant and the 
pellet was extracted using TRIzol. Approximately 90% of the RNA that can be recovered from direct TRIzol extraction is found in the superna-
tant for both wild-type and let-7(n2853) animals as determined by spectrophotometric analysis. Equal amounts of each RNA samples were 
reverse transcribed using random hexamer and relative abundance of the two let-7 tragets daf-12 and lin-41 and of the two control genes act-1 
and ama-1 was determined by qPCR. No enrichment of any mRNA can be detected in the supernatant or pellet samples as compared to total 
RNA. (B) Aliquots from one whole worm lysate (corresponding to SN in (A)) were either used for direct RNA extraction or mixed with sucrose 
solutions to obtain the indicated volume and concentration before RNA extraction. Although the amount of RNA recovered form lysates 
decreases when mixed with higer volume or higher concentration of sucrose solution, the relative abundance of let-7 targets (daf-12 and lin-41) 
and of act-1 is only modestly (less than two-fold) affected as determined by random hexamer-primed RT-qPCR. Nevertheless, the sucrose 
concentration of polysome profile fractions was adjusted to 30% (w/v) before RNA purification in order to avoid underestimating the amount of 
RNA present in the deep part of the gradients.
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Figure S3: Puromycin treatment of C. elegans extract induces polysome dissociation.
(A) Typical polysome profiles from synchronized late L4 wild-type and let-7(n2853) animals in the presence of cycloheximide or puromycin. 
The solid line represents the separation between the (sub)monosomal and polysomal fractions. As indicated by absorbance profiles at 254 nm 
cycloheximide treatment preserves polysome integrity, whereas puromycin treatment induces polysome dissociation. Note that the absorbance 
profiles with cycloheximide are those also shown in Fig. 1 and S1. (B) Distribution of the let-7 target daf-12 and of the control gene act-1 
across polysome profiles from synchronized wild-type and let-7(n2853) late L4 animals treated with cycloheximide or puromycin. The dotted 
line represents the separation between the (sub)monosomal and polysomal fractions. Puromycin treatment collapses the elongation competent 
polysomes and no difference can be observed for daf-12 distribution between wild-type and let-7(n2853) animals, indicating that the differential 
distribution observed in cycloheximide treated samples is due to differences in ribosome load on daf-12 mRNAs. Surprisingly, all mRNAs, 
including mRNAs not targeted by miRNA, shift to denser fractions of the gradients under these conditions, suggesting that the ribosome-free 
mRNAs aggregate. For cycloheximide treatment, the averages of four biological replicates is shown and error bar are SEM, data are as in Fig. 1 
and S1 and included for comparison.
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Figure S4: lin-41 3’UTR confers let-7 mediated regulation
Quantitative measurement of the !-galactosidase (!-gal) activity in the different col-10::lacZ::lin-41 reporter strains shows that protein 
production is increased for the transgene lacking the lin-41 LCSs or in let-7 mutant worms, resulting in a respective five- and fifteen-fold 
increase in young adult compared to the activity in WT worms expressing a construct containing a full length lin-41 3’UTR. The lower 
level of !-Gal activity seen with the "LCS construct may indicate that other regulatory sites are still present in this 3’UTR. Averages of 
three biological replicates are shown, error bars are SEM.
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Figure S5 RT-qPCR validation
(A) daf-12 total mRNA levels of synchronized late L4 wild-type and let-7(n2853) worms were determined by RT-qPCR using two distant pairs 
of primers: “qPCR daf-12 F2/R2” which amplify a fragment in the coding region and “qPCR daf-12 F3/R3” which amplify a fragment in the 
3’UTR. The similarity of the results obtained with both primer pairs indicates that full length mRNA only is quantified.
(B-C) Reverse transcription reactions were performed on aliquots of the same total RNA extracted from wild-type and let-7(n2853) late L4 
synchronized worms. The relative abundance, as determined by qPCR, of two let-7 targets (lin-41 and daf-12) and of two control genes (eft-2 
and prp-4) was found to be similar for reactions using random hexamer (B) and oligo dT primers (C). This indicates that mRNA levels deter-
mined using random hexamer represent full length mRNAs and that any effect miRNAs might have on polyA tail lengths of their targets does 
not prevent efficient oligo dT-primed reverse transcription.
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Figure S6: Changes in total mRNA levels do not influence translation initiation.
Although vit-1 and ugt-63 are differentially expressed in wild-type and let-7(n2853) animals, these genes are equally efficiently translated in 
both strains. (A) Analysis of vit-1 and ugt-63 total mRNA levels in synchronized late L4 wild-type and let-7(n2853) animals by RT-qPCR. (B) 
Distribution of vit-1 and ugt-63 mRNAs across polysome profiles from synchronized late L4 wild-type and let-7(n2853) animals. (C) 
Polysomal vit-1 and ugt-63 mRNA in late L4 wild-type and let-7(n2853) animals as percentage of the total. Averages of two biological 
replicates are shown for each panel.
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Fig. S7 Regulation of let-7 targets by let-7 sister miRNAs.
Analysis of the let-7 target daf-12 and lin-41 and of control genes act-1 and ama-1 total mRNA levels in synchronized late L4 wild-type, 
let-7(n2853) and miR-48 miR-241(nDf51); miR-84(n4037) animals by RT-qPCR. Both let-7 targets are also regulated by miR-48, miR-84, and 
miR-241 although to different extents, which may be due to different temporal and spatial co-expression pattern with daf-12 and lin-41 (n=3, 
error bars are SEM).
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qPCR lin-41 F1 TGCAAATCTTCCAATCAA AGG
qPCR lin-41 R1 TTCTGCCTGAGCCTCTTCTC
qPCR lin-41 F2 GGATTCAATGCGACAGGATT
qPCR lin-41 R2 CGATGCTGGTTTCAATGATG
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Figure S8 Comparison of two lin-14 primer pairs 
lin-14 total mRNA level and distribution across polysome profile of synchronized L4 wild-type and ain-2(RNAi);ain-
1(ku322) animals were tested by RT-qPCR using two different pairs of primers amplifying distant regions from the 
same cDNA preparation. The similarity between the results obtained with both primer pairs indicates that full length 
mRNAs and not stabilized degradation products are quantified. (A) Schematic representation of the region amplified 
by RT-qPCR. (B) Polysome profile distribution. (C) Total mRNA level. (D) Percentage of mRNA in the polysomal 
fractions.
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Fig. S9 Comparison between RT-qPCR and RT-PCR analyses.
(A) cDNA of total RNA and of RNA from polysome profile of synchronized L4 wild-type and ain-2(RNAi);ain-1(ku322) animals was used for 
semi-quantitative classical PCR. Aliquots of PCR reactions were analyzed on SybrSafe stained agarose gel. Distribution of both miRNA targets 
lin-14 and lin-41, but not the tbb-2 control mRNA,  is shifted toward the polysomal fractions in ain-2(RNAi);ain-1(ku322) animals as compared 
to wild-type. Note that for each mRNA, wild-type and ain-2(RNAi);ain-1(ku322) samples were loaded on the same gel and photographed under 
identical conditions but are represented as separate pannels for better comparison. T, total RNA, -RT, negative control reaction lacking the 
reverse transcriptase using RNA from fraction 5. (B) Quantification of pictures shown in panel A was performed by densitometry analysis and 
is reported as percentage of the total. Note that values are corrected for total amount of RNA recovered from each fractions. Results from 
RT-qPCR analysis are shown for comparison. (C) Polysomal fraction of lin-14, lin-41 and tbb-2 mRNAs in synchronized L4 wild-type and 
ain-2(RNAi);ain-1(ku322) animals as percentage of the total determined by RT-PCR and RT-qPCR (D) Total levels of lin-14, lin-41 and tbb-2 
mRNAs in synchronized L4 wild-type and ain-2(RNAi);ain-1(ku322) animals as fold increase in ain-2(RNAi);ain-1(ku322) animals compared 
to wild-type determined by RT-PCR and RT-qPCR. The overall results obtained by RT-PCR are similar to the ones obtained by RT-qPCR, 
confirming the validity of the latter method.
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3.3. Additional results
3.3.1. Introduction
The results presented above show that C. elegans miRNAs repress target mRNAs by at 
least two mechanisms: mRNA degradation and inhibition of translation initiation, and that 
mutation of the GW182 homologs AIN-1 and AIN-2 is sufficient to prevent these two 
mechanisms. Moreover, the fact that cog-1 repression by the lys-6 miRNA seems to occur only 
at the level of translation suggests that mRNA degradation and translational control are two 
independent mechanisms, which often, but not always, occur concomitantly (Ding and 
Grosshans 2009).
Several questions remain to be addressed in order to understand in more detail how 
miRNAs function and what the exact interplay is between target translational repression and 
degradation. What are the exact molecular roles of AIN-1 and AIN-2? Do these factors 
physically repress target mRNAs or do they recruit additional effector proteins? What dictates 
the mechanism by which a target mRNA is repressed? The results presented in this section 
summarize preliminary experiments aimed at answering these points.
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3.3.2. Results
AIN-1 specifically mediates miRNA target translational control
Because C. elegans miRNA targets are repressed by two different mechanisms, it is 
tempting to speculate that miRISC composition, which could differ in a tissue or time specific 
manner, might determine by which means a target is repressed. This idea is supported by the 
observation that, in Drosophila embryo lysates, Ago1- and Ago2-containing miRISCs employ 
different mechanisms to repress target reporters (Iwasaki et al. 2009). To test for a similar 
phenomenon in C. elegans, I analyzed the repression status of several miRNA targets in animals 
mutated for either alg-1 or alg-2, the two C. elegans miRNA-specific Ago proteins, by 
polysome profile fractionation and RT-qPCR. Additionally, I also investigated the effects of 
individual ain-1 or ain-2 mutations on target repression. The results obtained were compared to 
the wild-type and ain-2;ain-1 situations, in which full repression and, respectively, derepression 
occur.
In alg-1(gk214) or alg-1(RNAi) mutants, translational repression and mRNA degradation 
of daf-12, a let-7  target, and lin-14, a lin-4 target, are both prevented to a similar extent as in 
ain-2(RNAi);ain-1(ku322) animals. Conversely, in alg-2(ok304) animals, daf-12 and lin-14 
repression is not detectably impaired (data not shown). These results suggest that ALG-1 plays a 
major role in mediating miRNA function, whereas ALG-2 on its own does not seem to be 
essential. This observation is in line with the respective phenotypes associated with these 
mutants: alg-1(gk214) display strongly penetrant phenotypes (alae defects, retarded 
development timing, and vulva bursting), while alg-2(ok304) are superficially wild-type 
(Grishok et al. 2001), and suggests that the Argonaute composition of the miRISC does not 
directly determine the nature of the repression mechanism.
In ain-1(ku322) single mutant, polysome profile analysis revealed that translational 
repression of various let-7 and lin-4 targets is lost to a similar extent as in ain-2(RNAi);ain-1
(ku322) animals. On the other hand, translational repression of miRNA targets is as strong in 
ain-2(tm1863) as in wild-type animals (fig. 1A). Concerning target mRNA degradation, the total 
mRNA level of daf-12 and lin-14  in ain-1(ku322) is very close to the low level found in wild-
type, while lin-41 and lin-28 levels are upregulated but not as much as in ain-2;ain-1 double 
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mutants. Total mRNA levels of all these targets are unchanged in ain-2(tm1863) (fig. 1B) as 
well as in the likely null ain-2(tm2424) mutants (data not shown) when compared to wild-type. 
These results indicate that miRNA target translational repression is specifically mediated by 
AIN-1 and that AIN-2 on its own, similarly to ALG-2, does not seem to play an essential role in 
any repression mechanism. Importantly this also shows that, in ain-1 mutants and for at least a 
subset of targets like daf-12 and lin-14, mRNA degradation still occurs even when translational 
repression is lost. See figure 4A for a summary of these results.
Genetic interaction between AIN-1 and various RNA binding factors
In order to identify factors which, like AIN-1, might be involved in one specific mode of 
miRNA-mediated repression, I performed a small scale genetic screen on putative candidates.  I 
hypothesized that depletion of miRNA effector proteins should produce a detectable phenotype 
in the sensitized ain-1(ku322) background, similar to ain-2 depletion, which induces a 
phenotypic response in ain-1 mutants but not in wild-type animals. I expected to identify factors 
which might be specific to the target mRNA degradation mechanism, like AIN-1 is to 
translational repression. Various factors were screened for their phenotypic effects when 
depleted in ain-1(ku322)  and wild-type animals. The factors tested include RNA binding 
proteins known to interact physically with AIN-2 (pab-2, sqd-1, car-1, tsn-1, aco-1) (Zhang et 
al. 2007), and factors reported to interact with the miRISC (tsn-1, vig-1, cgh-1, nhl-2) (Caudy et 
al. 2003; Hammell et al. 2009). Qualitatively, depletion of only pab-2, cgh-1, and sqd-1 showed 
and aggravation of ain-1(ku322) phenotypes. This was confirmed by quantitative analysis of 
alae defects and vulva bursting of wild-type and ain-1 animals subjected to the respective RNAi 
(fig. 2). pab-2, cgh-1, and sqd-1 depletions substantially increase alae defects in ain-1(ku322) 
animals but not, or only moderately, in wild-type (fig. 2A). However depletion of none of this 
factor reaches the effect induced by ain-2(RNAi) in ain-1 mutants. Concerning the vulva 
bursting phenotype, it was only slightly increased by pab-2(RNAi) compared to the empty 
vector control, while in the case of cgh-1  and sqd-1  it equaled the effect of ain-2 depletion. 
None of these RNAi conditions induced any bursting phenotype in wild-type animals (fig. 2B). 
These results indicate that pab-2, cgh-1, and sqd-1 might be involved in the execution of 
miRNA mediated repression. However, because the effects of the depletion of these factors did 
not equal that of ain-2, it seems unlikely that they play an essential role in this pathway. A view 
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further supported by the observation that depletion of none of these factors in ain-1 animals 
resulted in an upregulation of the lin-4 target lin-28, as determined by western blot (data not 
shown).
A more direct way to discover potential mediators of miRNA action in general, and of 
target translational repression in particular, is to identify factors which physically interact with 
AIN-1. An antiserum, which specifically recognizes AIN-1 (fig. 3A and (Zhang et al. 2007)), 
was used for immunoprecipitation experiments. A specific ALG-1/2 antibody (fig. 3B) was used 
to validate AIN-1 co-immunoprecipitation. ALG-1 and ALG-2 are both strongly enriched in the 
wild-type immunoprecipitate, but absent from the ain-1(ku322) sample (fig. 3C). Of the 
genetically identified factors mentioned above, an antibody is available only for CGH-1, which 
was not found to co-precipitate with AIN-1 (fig. 3C). This experiment confirms that AIN-1 
strongly interacts with ALG-1 and ALG-2 and indicates that, even though CGH-1 might play a 
role in the miRNA pathway, it is not tightly associated with miRISCs.
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3.3.3. Figures
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Figure 1 miRNA target translational repression is lost in ain-1(ku322) animals
Analysis of the translational status by polysome profile fractionation (A) and of the total 
mRNA level by qPCR (B) of the let-7 targets daf-12 and lin-41, the lin-4 targets lin-14 
and lin-28, and of the control gene act-1  in wild-type, ain-1(ku322), and ain-2(tm1863) 
synchronized L4 animals. Results of ain-2(RNAi);ain-1(ku322) analysis (Ding and 
Grosshans 2009) are included for comparison.
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Figure 2 Genetic interaction between ain-1 and various RNA interacting factors
(A) Alae structure analysis in wild-type and ain-1(ku322) young adult animals in response to 
depletion of ain-2, pab-2, cgh-1, and sqd-1 by RNAi at 25 ºC. (B) Quantification of the vulva 
bursting phenotype in wild-type and ain-1(ku322) animals at the L4 to adult transition in response 
to depletion of ain-2, pab-2, cgh-1, and sqd-1 by RNAi (n!50 for each, as the ain-1(ku322) burst-
ing phenotype is silenced at 20 ºC and above, this experiment was done at 15 ºC).
85
W
T
a
in
-1
W
T
a
in
-1
input
(10%) (100%)
AIN-1 IP
ALG-1 / ALG-2
CGH-1
P
o
n
c
e
a
u
 r
e
d
 s
ta
in
in
g
ACT-1
AIN-1
W
T
ai
n-
1(
ku
32
2)
ACT-1
ALG-2
ALG-1
W
T
al
g-
1(
gk
21
4)
al
g-
2(
ok
30
4)
A
B
C
Figure 3  AIN-1 immunoprecipitation
(A) Western blot analysis of AIN-1 in wild-type and ain-1(ku322) animals. (B) Western 
blot analysis of ALG-1 and ALG-2 in wild-type, alg-1(gk214), and alg-2(ok304) animals. 
(C) Immunoprecipitation of AIN-1 in wild-type and ain-1(ku322) animals. AIN-1 physi-
cally interacts with ALG-1 and ALG-2 but not with CGH-1.
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Figure 4 miRISC components role in miRNA mediated repression
(A) Effects of miRISC core factor mutations on specific repression mechanisms.
(B) Model of AIN-1 and AIN-2 role. Translational repression of miRNA targets is mediated by AIN-1, 
either directly or undirectly. Both AIN-1 and AIN-2 can apparently mediate miRNA target degrada-
tion. For some miRNA targets (daf-12 and lin-14), mRNA degradation can still occur in the absence 
of translational repression  suggesting that these two mechanisms might be independent path-
ways. Genetic data suggests that SQD-1, PAB-2, and CGH-1 might play an accessory role in the 
miRNA pathway. ALG-1, but apparently not ALG-2, is essential for both mechanisms.
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3.3.4. Material and methods
C. elegans strains and RNAi
Wild-type N2, MH2385: ain-1(ku322), VC446: alg-1(gk214), and RB574: alg-2(ok304) 
were provided by the the Caenorhabditis Genetics Center, which is funded by the NIH National 
Center for Research Resources, ain-2(tm1863) and ain-2(tm2424) by S. Mitani (National 
Bioresource Project, Japan), and let-7(mg279) (Reinhart et al. 2000) by F. Slack. RNAi was 
performed on synchronized population starting with L1 larvae and using a published RNAi 
feeding construct and protocol (Kamath et al. 2003; Grosshans et al. 2005). 
Polysome profile analysis and RT-qPCR
Polysome profile and and total mRNA level analysis by RT-qPCR were performed using 
synchronized late L4 animals grown at 25 ºC as described in (Ding and Grosshans 2009).
Western blot and immunoprecipitation
Protein lysates were prepared by crushing worm pellet resuspended in one volume of 
lysis buffer (20mM HEPES, 10% Glycerol, 0.1% Triton X-100, 0.42 M NaCl, 1.5mM 
MgCl2, 1 mM DTT, 1mM PMSF, complemented with EDTA-free protease inhibitor cocktail 
tablet (Roche Applied Science)) in mortar pre-cooled with liquid nitrogen. Lysates were cleared 
by centrifugation at 4 ºC for 10 min. at 10‘000 RCF. 30µg of protein samples were loaded on 
NuPAGE 4%–12% Bis-Tris gels (Invitrogen) and transfered to Immun-Blot PVDF Membranes 
(Bio-Rad). AIN-1, ALG-1/2, CGH-1, and ACT-1 immunodetections were performed according 
standard protocols using AIN-1 antiserum (dilution 1/10’000, a gift from M. Han), anti-
ALG-1/2 antibody (1/1’000 dilution, a gift from C. Mello), anti-CGH-1 antibody (1/2’000 
dilution, a gift from K. Blackwell), and anti-Actin antibody (1/1‘000 dilution, MAB1501, 
Chemicon International).
Immunoprecipitation was done with the Immunoprecipitation Kit (Protein G) 
(11719386001, Roche Applied Science) according to the manufacturer’s recommendation. 700 
µg of protein from ain-1(ku322) or wild-type lysates were used for immunoprecipitation with 2 
µl of AIN-1 antiserum.
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3.3.5. Discussion
Analysis of alg-1 and alg-2 mutants shows that these two factors do not have the same 
apparent importance in the execution of miRNA mediated repression. Both repression 
mechanisms are impaired in alg-1 mutants, but none are in alg-2 animals (fig. 4A). These two 
genes were thought to carry redundant functions because of their high homology (80% and 88% 
identical at the nucleotide and protein level, respectively (Grishok et al. 2001; Tops et al. 2006)) 
and the fact that they are synthetic lethal. However in vivo and in vitro data suggest that ALG-1 
and ALG-2 perform non overlapping functions. For example there is no overlap in genes 
causing synthetic lethality in alg-1 and alg-2 respectively (Tops et al. 2006). ALG-1 and ALG-2 
are ubiquitously expressed from early embryogenesis to adulthood and seem to associate with 
the same set of miRNAs, but to reside in complexes of different masses, as determined by size-
fractionation (Tops et al. 2006). One possible explanation for ALG-1 and ALG-2 functional 
differences could therefore be that a mediator of miRNA function associate with ALG-1-, but 
not ALG-2-containing miRISCs. Indeed ALG-1 is found in a single complex larger than 650 
kDa, whereas ALG-2 is present in two smaller complexes of about 250 and 500 kDa (Tops et al. 
2006). Nevertheless, the identity of this hypothetical factor has yet to be determined. Although 
both ALG-1 and ALG-2 bind mature miRNAs and are core components of the miRISC, it was 
proposed that ALG-2 might function essentially by promoting pre-miRNA processing and 
facilitating the loading of mature miRNA on ALG-1, which would in turn mediate target 
repression (Tops et al. 2006). This model fits the data presented here. Target repression is lost in 
alg-1 mutants, but, because pre-miRNA processing does not absolutely require ALG-2, miRNA 
mediated repression can still occur in alg-2 mutants. Nevertheless, the fact that alg-1(gk214) is 
a null mutant (fig. 3B) and synthetic lethal with alg-2 mutation indicates that these genes are 
likely to share additional partially overlapping functions.
Similarly to ALG-1 and ALG-2, AIN-1 and AIN-2 were postulated to have a redundant 
function (Zhang et al. 2007). This is based on partial homology between AIN-1 and AIN-2 and 
the observation that ain-1 mutants display only weakly penetrant phenotypes, and that ain-2 
mutants look superficially wild-type, but that ain-2;ain-1 double mutants show strong defects 
reminiscent of the phenotypes observed in worms deficient for miRNA function, such as 
delayed developmental timing, seam cells proliferation defects, and vulva bursting at the adult 
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transition (Zhang et al. 2007). For this reason, my initial experiments addressing the role of AIN 
proteins in the miRNA pathway were done using ain-2(RNAi);ain-1(ku322) double mutant 
worms (Ding and Grosshans 2009). Here I show that individual loss of AIN-1 or AIN-2 does 
not have the same effect on miRNA target repression, indicating that these factors are not 
completely redundant. ain-1  mutation prevents target translational repression but not, or only 
moderately, target mRNA degradation. On the other hand, both repression mechanisms are fully 
functional in ain-2 animals. These observations correlate well with the phenotype of the 
respective mutants: ain-2(tm1863) and ain-2(tm2424) are superficially wild-type and ain-1
(ku322) animals show mild defects in terms of alae structure, developmental timing, and 
bursting through the vulva (Fig. 2 and (Ding et al. 2005; Zhang et al. 2007)), which most likely 
result from loss of miRNA target translational repression. These phenotypes are more penetrant 
in ain-2;ain-1 double mutants, possibly because both miRNA target repression mechanisms are 
prevented in this background (Ding and Grosshans 2009). The observation that the two 
mechanisms by which miRNA repress target genes can be uncoupled suggests that they 
represent distinct pathways (fig. 4B). If this conclusion could be further experimentally 
validated, it would answer a long standing question: miRNA target degradation does not require 
prior translational repression to occur. This possibility is supported by recent findings showing 
that, upon nutrient deprivation, lin-14 mRNA degradation, but not protein downregulation, by 
lin-4 is prevented, showing, here as well, that miRNA-mediated repression is enforced by 
pathways which can be uncoupled (Holtz and Pasquinelli 2009). Moreover, experiments in yeast 
showed that mRNA degradation can be initiated on actively translated mRNAs (Hu et al. 2009), 
further supporting the idea that target mRNA do not necessarily need to be translationally silent 
to be degraded.
Although, similarly to ALG-1 and ALG-2, AIN-1 and AIN-2 are core components of the 
miRNA pathway, it seems that these factors function exclusively downstream of the mature 
miRNA production, as no accumulation of pre-miRNA or decrease of mature miRNA can be 
observed in ain-2;ain-1 double mutants (Zhang et al. 2007). The fact that target degradation is 
prevented only in ain-2;ain-1 double mutants shows that expression of AIN-1 or AIN-2 is 
sufficient to mediate this function, or recruit a mediator thereof. On the other hand, AIN-1 is 
required miRNA target translational repression. It is possible that AIN-1 serves as a platform to 
recruit an inhibitor of translation initiation, which would not be able to bind AIN-2. It is also 
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possible that AIN-1 directly inhibits miRNA target translation. One way to test this possibility 
would be to attempt to rescue ain-1(ku322) animals using transgenes coding for various 
portions of AIN-1. If a minimal ain-1 rescuing fragment can be identified, one could compare, 
by immunoprecipitation coupled to mass spectrometry, if the rescuing and non-rescuing 
fragments interact with the same set of factors. If this is the case, it would suggest that the 
concerned part of AIN-1 might be directly involved in translation repression, if not, this could 
reveal the identity of the factor mediating this activity.
There are several possible reasons to explain the functional differences between AIN-1 
and AIN-2. First, as discussed above, they might recruit different downstream effectors, which, 
considering the relative low homology between AIN-1 and AIN-2 (Zhang et al. 2007), would 
not be so surprising. Second, they might be expressed in a different subset of tissues. Although a 
gfp::ain-2 transgene was reported to be expressed ubiquitously (Zhang et al. 2007), the 
expression pattern of AIN-1 is not so clearly documented. L. Ding and colleagues, based on an 
ain-1::gfp translational reporter, reported that AIN-1 is expressed in “a variety of tissue types, 
including vulval precursor cells and multiple neurons”  (Ding et al. 2005). Therefore it is not 
clear whether AIN-1 is ubiquitously expressed or not. Third, AIN-1 and AIN-2, as determined 
by gfp reporter transgenes, do not have the same subcellular localization: AIN-2 is diffuse in the 
cytoplasm (Zhang et al. 2007), whereas AIN-1 localizes in DCP-2-containing punctuate 
structures corresponding to P-bodies (Ding et al. 2005). However, it is not known if this 
difference in localization is a cause or a consequence of AIN-1 and AIN-2 functional 
differences. Additional experiments might help to tell apart these possibilities. For example, if a 
transgene expressing AIN-2 under the ain-1 promoter can rescue ain-1 mutants, this would 
indicate that AIN-1/2 functional differences are likely due to different expression patterns. 
Finally, it is also possible that the modality by which a miRNA target is repressed depends on its 
3‘UTR architecture, such as for example the presence of binding sites for additional regulatory 
factors. Therefore, additional miRNA targets should be analyzed to confirm that the 
observations made so far are specifically due to miRISC factor mutations and not the identity of 
the targets investigated.
Genetic data indicate that pab-2, cgh-1, and sqd-1 might play a role in miRNA mediated 
repression. pab-2 encodes the closest C. elegans homolog of the human cytoplasmic poly(A)-
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binding protein (PABP) (Rhoads et al. 2006) and is likely to be involved in the general 
translation machinery. It is possible that the ain-1 phenotype enhancement upon pab-2  depletion 
results from general translation defects rather than a miRNA specific effect. The fact that pab-2 
RNAi did not enhance the weak vulva bursting phenotype of let-7(mg279) animals (data not 
shown), contrary to other factors involved in miRNA function (Parry et al. 2007), supports this 
idea. On the other hand, although pab-2(RNAi) failed to upregulate LIN-28 protein level in 
ain-1, it did so in wild-type animals (data not shown). This could be indicative of a partial 
overlap between AIN-1 and PAB-2 functions. Moreover, it was recently reported that, in mouse 
cell extract, GW182 interacts with PABP to promote miRNA target deadenylation (Fabian et al. 
2009). A similar interaction could occur between AIN-1/2 and PAB-2, but this has still to be 
demonstrated. 
CGH-1 is a conserved putative RNA helicase found in various RNA-protein granules, 
including P-bodies, and has been implicated in mRNA stability control and translational 
repression (reviewed in (Rajyaguru and Parker 2009)). This factor has recently been proposed to 
function together with the TRIM-NHL protein NHL-2 to modulate miRISC activity (Hammell 
et al. 2009). Enhancement of ain-1 phenotypes upon depletion of cgh-1 is in line with this idea, 
but the absence of effect upon nhl-2 depletion is not. However this might be due to incomplete 
nhl-2 depletion, as nhl-2(ok818);ain-1(ku322) animals have been reported to show enhanced 
alae defects compared to ain-1(ku322) (Hammell et al. 2009). Immunoprecipitation of CGH-1 
coprecipitates miRISC components such ALG-1, ALG-2, and AIN-1 (Hammell et al. 2009), 
however the AIN-1 immunoprecipitation experiment presented here failed to pull down CGH-1. 
This could be due to the fact that CGH-1 interaction with AIN-1 is mainly RNA dependent or 
that this interaction is weak by nature. In any cases, NHL-2 and CGH-1 seem to play only 
accessory roles in the miRNA pathway, as none is absolutely required for miRNA mediated 
repression.
The third factor identified, SQD-1, is homologous to the Drosophila RNA binding protein 
Squid. C. elegans SQD-1 is poorly defined, but Squid has been shown to directly mediate sub-
cellular localization of several mRNAs in Drosophila oocytes (Lall et al. 1999). It is therefore 
possible that SQD-1 might play a role in the relocalization of repressed miRNA targets, but 
92
additional experiments are needed to substantiate this idea. Again, as far as partial depletion by 
RNAi allows to tell, sqd-1 does not seem to be essential for miRNA function.
A comprehensive identification of factors physically interacting with AIN-1 and AIN-2 
would help to better understand their molecular functions. Immunoprecipitation of endogenous 
AIN-1 works efficiently, as determined by the co-immunoprecipitation of ALG-1 and ALG-2. 
Coupled to mass spectrometry analysis, this approach would allow to determine if AIN-1 binds 
additional proteins or if it interacts only with DCR-1, ALG-1, and ALG-2, as published earlier 
(Ding et al. 2005; Zhang et al. 2007). A similar approach could be applied to AIN-2, either by 
using a tagged ain-2 transgene or by raising an AIN-2 specific antibody. However, for this 
factor, a list of 39 interacting proteins has already been published (Zhang et al. 2007). 
Therefore, it may be more fruitful to extend the small-scale genetic screen presented here to all 
these factors, by using ain-1 or alg-1 sensitized backgrounds and looking for specific 
enhancement of phenotypic defects. This would allow to determine if any of these factors is 
directly relevant to miRNA functions.
In summary, the additional data presented here show that ain-1 and ain-2  are not 
functionally redundant and that translational repression of miRNA targets is likely to be 
mechanistically independent of the degradation mechanism. As discussed above, further 
experiments are needed to firmly confirm these conclusions and understand in more details the 
functional role of AIN-1 and AIN-2. This is an important research aim, as it may offer us a more 
comprehensive view of miRNA biology, possibly relevant for new therapeutic approaches to 
miRNA related diseases (reviewed in (Brown and Naldini 2009)).
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4. Conclusion
This study aimed at better understanding the in vivo  mechanisms of miRNA-mediated 
repression. The use of C. elegans as a model organism allowed to circumvent the potential 
artifacts associated with in vitro or ex vivo systems and to study directly the action of 
endogenous miRNAs acting on endogenous targets in a physiologically relevant context. I 
postulated that that C. elegans miRNAs function in vivo, and at least partially, by inhibiting the 
initiation of translation on target mRNAs. The results presented here make this thesis the most 
plausible explanation for the biological phenomena observed, which is as close to the truth as 
one can be. 
It is satisfying to achieve the validation of this thesis, as sanctioned by international peer-
reviewed publications. It represents for me the successful management of a project on the long 
term and the resolution of numerous technical and intellectual challenges. It answers a few 
questions, but most importantly open new ones, concerning for example the modalities of the 
mechanism uncovered. I can only hope that this work will challenge or inspire others to attempt 
to answer them, which will hopefully in turn bring new interrogations, as questioning is the 
essence of scientific reasoning.
95

5. Bibliography
Abrahante, J. E., A. L. Daul, M. Li, M. L. Volk, J. M. Tennessen, E. A. Miller and A. E. Rougvie (2003). 
"The Caenorhabditis elegans hunchback-like gene lin-57/hbl-1 controls developmental time and 
is regulated by microRNAs." Dev Cell 4(5): 625-37.
Amaral, P. P., M. E. Dinger, T. R. Mercer and J. S. Mattick (2008). "The eukaryotic genome as an RNA 
machine." Science 319(5871): 1787-9.
Ashraf, S. I., A. L. McLoon, S. M. Sclarsic and S. Kunes (2006). "Synaptic protein synthesis associated 
with memory is regulated by the RISC pathway in Drosophila." Cell 124(1): 191-205.
Aukerman, M. J. and H. Sakai (2003). "Regulation of flowering time and floral organ identity by a 
MicroRNA and its APETALA2-like target genes." Plant Cell 15(11): 2730-41.
Baek, D., J. Villen, C. Shin, F. D. Camargo, S. P. Gygi and D. P. Bartel (2008). "The impact of 
microRNAs on protein output." Nature 455(7209): 64-71.
Bagga, S., J. Bracht, S. Hunter, K. Massirer, J. Holtz, R. Eachus and A. E. Pasquinelli (2005). "Regulation 
by let-7 and lin-4 miRNAs results in target mRNA degradation." Cell 122(4): 553-63.
Baillat, D. and R. Shiekhattar (2009). "Functional dissection of the human TNRC6 (GW182-related) 
family of proteins." Mol Cell Biol 29(15): 4144-55.
Bartel, D. P. (2009). "MicroRNAs: target recognition and regulatory functions." Cell 136(2): 215-33.
Behm-Ansmant, I., J. Rehwinkel, T. Doerks, A. Stark, P. Bork and E. Izaurralde (2006). "mRNA 
degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 
decapping complexes." Genes Dev 20(14): 1885-98.
Bernstein, E., A. A. Caudy, S. M. Hammond and G. J. Hannon (2001). "Role for a bidentate ribonuclease 
in the initiation step of RNA interference." Nature 409(6818): 363-6.
Bhattacharyya, S. N., R. Habermacher, U. Martine, E. I. Closs and W. Filipowicz (2006). "Relief of 
microRNA-mediated translational repression in human cells subjected to stress." Cell 125(6): 
1111-24.
Birney, E., J. A. Stamatoyannopoulos, A. Dutta, R. Guigo, T. R. Gingeras, E. H. Margulies, Z. P. Weng, 
M. Snyder, E. T. Dermitzakis, J. A. Stamatoyannopoulos, R. E. Thurman, et al. (2007). 
"Identification and analysis of functional elements in 1% of the human genome by the ENCODE 
pilot project." Nature 447(7146): 799-816.
Brodersen, P., L. Sakvarelidze-Achard, M. Bruun-Rasmussen, P. Dunoyer, Y. Y. Yamamoto, L. Sieburth 
and O. Voinnet (2008). "Widespread translational inhibition by plant miRNAs and siRNAs." 
Science 320(5880): 1185-90.
97
Brown, B. D. and L. Naldini (2009). "Exploiting and antagonizing microRNA regulation for therapeutic 
and experimental applications." Nat Rev Genet 10(8): 578-85.
Buhler, M. and D. Moazed (2007). "Transcription and RNAi in heterochromatic gene silencing." Nat 
Struct Mol Biol 14(11): 1041-1048.
Bushati, N. and S. M. Cohen (2007). "microRNA functions." Annu Rev Cell Dev Biol 23: 175-205.
Bussing, I., F. J. Slack and H. Grosshans (2008). "let-7 microRNAs in development, stem cells and 
cancer." Trends Mol Med 14(9): 400-9.
Carninci, P., T. Kasukawa, S. Katayama, J. Gough, M. C. Frith, N. Maeda, R. Oyama, T. Ravasi, B. 
Lenhard, C. Wells, R. Kodzius, et al. (2005). "The transcriptional landscape of the mammalian 
genome." Science 309(5740): 1559-63.
Carthew, R. and E. Sontheimer (2009). "Origins and Mechanisms of miRNAs and siRNAs." Cell 136(4): 
642-55.
Caudy, A. A., R. F. Ketting, S. M. Hammond, A. M. Denli, A. M. Bathoorn, B. B. Tops, J. M. Silva, M. 
M. Myers, G. J. Hannon and R. H. Plasterk (2003). "A micrococcal nuclease homologue in 
RNAi effector complexes." Nature 425(6956): 411-4.
Cawley, S., S. Bekiranov, H. H. Ng, P. Kapranov, E. A. Sekinger, D. Kampa, A. Piccolboni, V. 
Sementchenko, J. Cheng, A. J. Williams, R. Wheeler, et al. (2004). "Unbiased mapping of 
transcription factor binding sites along human chromosomes 21 and 22 points to widespread 
regulation of noncoding RNAs." Cell 116(4): 499-509.
Chalfie, M., H. R. Horvitz and J. E. Sulston (1981). "Mutations that lead to reiterations in the cell lineages 
of C. elegans." Cell 24(1): 59-69.
Chatterjee, S. and H. Grosshans (2009). "Active turnover modulates mature microRNA activity in 
Caenorhabditis elegans." Nature 10.1038/nature08349.
Chekulaeva, M. and W. Filipowicz (2009). "Mechanisms of miRNA-mediated post-transcriptional 
regulation in animal cells." Curr Opin Cell Biol 21(3): 452-60.
Chekulaeva, M., W. Filipowicz and R. Parker (2009). "Multiple independent domains of dGW182 
function in miRNA-mediated repression in Drosophila." RNA 15(5): 794-803.
Chen, K. and N. Rajewsky (2006). "Deep conservation of microRNA-target relationships and 3'UTR 
motifs in vertebrates, flies, and nematodes." Cold Spring Harb Symp Quant Biol 71: 149-56.
Chen, X. (2004). "A microRNA as a translational repressor of APETALA2 in Arabidopsis flower 
development." Science 303(5666): 2022-5.
Chendrimada, T. P., K. J. Finn, X. Ji, D. Baillat, R. I. Gregory, S. A. Liebhaber, A. E. Pasquinelli and R. 
Shiekhattar (2007). "MicroRNA silencing through RISC recruitment of eIF6." Nature 447
(7146): 823-8.
98
Consortium, I. H. G. S. (2004). "Finishing the euchromatic sequence of the human genome." Nature 431
(7011): 931-45.
Cullen, B. R. (2009). "Viral and cellular messenger RNA targets of viral microRNAs." Nature 457(7228): 
421-5.
Davis, E., F. Caiment, X. Tordoir, J. Cavaillé, A. Ferguson-Smith, N. Cockett, M. Georges and C. Charlier 
(2005). "RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus." Curr Biol 
15(8): 743-9.
Ding, L. and M. Han (2007). "GW182 family proteins are crucial for microRNA-mediated gene 
silencing." Trends Cell Biol 17(8): 411-6.
Ding, L., A. Spencer, K. Morita and M. Han (2005). "The developmental timing regulator AIN-1 interacts 
with miRISCs and may target the argonaute protein ALG-1 to cytoplasmic P bodies in C. 
elegans." Mol Cell 19(4): 437-47.
Ding, X. C. and H. Grosshans (2009). "Repression of C. elegans microRNA targets at the initiation level 
of translation requires GW182 proteins." EMBO J 28(3): 213-22.
Ding, X. C., F. J. Slack and H. Grosshans (2008). "The let-7 microRNA interfaces extensively with the 
translation machinery to regulate cell differentiation." Cell Cycle 7(19): 3083-90.
Ding, X. C., J. Weiler and H. Grosshans (2009). "Regulating the regulators: mechanisms controlling the 
maturation of microRNAs." Trends Biotechnol 27(1): 27-36.
Dinger, M. E., P. P. Amaral, T. R. Mercer, K. C. Pang, S. J. Bruce, B. B. Gardiner, M. E. Askarian-Amiri, 
K. Ru, G. Solda, C. Simons, S. M. Sunkin, et al. (2008). "Long noncoding RNAs in mouse 
embryonic stem cell pluripotency and differentiation." Genome Res 18(9): 1433-45.
Eddy, S. R. (2001). "Non-coding RNA genes and the modern RNA world." Nat Rev Genet 2(12): 919-29.
Esquela-Kerscher, A. and F. J. Slack (2006). "Oncomirs - microRNAs with a role in cancer." Nat Rev 
Cancer 6(4): 259-69.
Eulalio, A., I. Behm-Ansmant, D. Schweizer and E. Izaurralde (2007a). "P-body formation is a 
consequence, not the cause, of RNA-mediated gene silencing." Mol Cell Biol 27(11): 3970-81.
Eulalio, A., S. Helms, C. Fritzsch, M. Fauser and E. Izaurralde (2009a). "A C-terminal silencing domain 
in GW182 is essential for miRNA function." RNA 15(6): 1067-77.
Eulalio, A., E. Huntzinger and E. Izaurralde (2008a). "Getting to the Root of miRNA-Mediated Gene 
Silencing." Cell 132(1): 9-14.
Eulalio, A., E. Huntzinger and E. Izaurralde (2008b). "GW182 interaction with Argonaute is essential for 
miRNA-mediated translational repression and mRNA decay." Nat Struct Mol Biol 15(4): 
346-53.
99
Eulalio, A., E. Huntzinger, T. Nishihara, J. Rehwinkel, M. Fauser and E. Izaurralde (2009b). 
"Deadenylation is a widespread effect of miRNA regulation." RNA 15(1): 21-32.
Eulalio, A., J. Rehwinkel, M. Stricker, E. Huntzinger, S. F. Yang, T. Doerks, S. Dorner, P. Bork, M. 
Boutros and E. Izaurralde (2007b). "Target-specific requirements for enhancers of decapping in 
miRNA-mediated gene silencing." Genes Dev 21(20): 2558-70.
Eulalio, A., F. Tritschler, R. Buttner, O. Weichenrieder, E. Izaurralde and V. Truffault (2009c). "The RRM 
domain in GW182 proteins contributes to miRNA-mediated gene silencing." Nucleic Acids Res 
37(9): 2974-83.
Eulalio, A., F. Tritschler and E. Izaurralde (2009d). "The GW182 protein family in animal cells: new 
insights into domains required for miRNA-mediated gene silencing." RNA 15(8): 1433-42.
Eystathioy, T., E. K. Chan, S. A. Tenenbaum, J. D. Keene, K. Griffith and M. J. Fritzler (2002). "A 
phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human 
mRNAs within novel cytoplasmic speckles." Mol Biol Cell 13(4): 1338-51.
Fabian, M. R., G. Mathonnet, T. Sundermeier, H. Mathys, J. T. Zipprich, Y. V. Svitkin, F. Rivas, M. Jinek, 
J. Wohlschlegel, J. A. Doudna, C. A. Chen, et al. (2009). "Mammalian miRNA RISC Recruits 
CAF1 and PABP to Affect PABP-Dependent Deadenylation." Mol Cell: 1-13.
Farh, K. K., A. Grimson, C. Jan, B. P. Lewis, W. K. Johnston, L. P. Lim, C. B. Burge and D. P. Bartel 
(2005). "The widespread impact of mammalian MicroRNAs on mRNA repression and 
evolution." Science 310(5755): 1817-21.
Filipowicz, W., S. N. Bhattacharyya and N. Sonenberg (2008). "Mechanisms of post-transcriptional 
regulation by microRNAs: are the answers in sight?" Nat Rev Genet 9(2): 102-14.
Fire, A., S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver and C. C. Mello (1998). "Potent and 
specific genetic interference by double-stranded RNA in Caenorhabditis elegans." Nature 391
(6669): 806-11.
Flynt, A. S. and E. C. Lai (2008). "Biological principles of microRNA-mediated regulation: shared 
themes amid diversity." Nat Rev Genet 9(11): 831-42.
Frith, M. C., M. Pheasant and J. S. Mattick (2005). "The amazing complexity of the human 
transcriptome." Eur J Hum Genet 13(8): 894-7.
Gandikota, M., R. P. Birkenbihl, S. Höhmann, G. H. Cardon, H. Saedler and P. Huijser (2007). "The 
miRNA156/157 recognition element in the 3' UTR of the Arabidopsis SBP box gene SPL3 
prevents early flowering by translational inhibition in seedlings." Plant J 49(4): 683-93.
Ghildiyal, M. and P. D. Zamore (2009). "Small silencing RNAs: an expanding universe." Nat Rev Genet 
10(2): 94-108.
100
Giraldez, A. J., Y. Mishima, J. Rihel, R. J. Grocock, S. Van Dongen, K. Inoue, A. J. Enright and A. F. 
Schier (2006). "Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs." 
Science 312(5770): 75-9.
Griffiths-Jones, S., H. K. Saini, S. van Dongen and A. J. Enright (2008). "miRBase: tools for microRNA 
genomics." Nucleic Acids Res 36(Database issue): D154-8.
Grishok, A., A. E. Pasquinelli, D. Conte, N. Li, S. Parrish, I. Ha, D. L. Baillie, A. Fire, G. B. Ruvkun and 
C. C. Mello (2001). "Genes and mechanisms related to RNA interference regulate expression of 
the small temporal RNAs that control C. elegans developmental timing." Cell 106(1): 23-34.
Grosshans, H., T. Johnson, K. L. Reinert, M. Gerstein and F. J. Slack (2005). "The temporal patterning 
microRNA let-7 regulates several transcription factors at the larval to adult transition in C. 
elegans." Dev Cell 8(3): 321-30.
Hagan, J. P., E. Piskounova and R. I. Gregory (2009). "Lin28 recruits the TUTase Zcchc11 to inhibit let-7 
maturation in mouse embryonic stem cells." Nat Struct Mol Biol 10.1038/nsmb.1676.
Hamilton, A. J. and D. C. Baulcombe (1999). "A species of small antisense RNA in posttranscriptional 
gene silencing in plants." Science 286(5441): 950-2.
Hammell, C. M. (2008). "The microRNA-argonaute complex: a platform for mRNA modulation." RNA 
Biol 5(3): 123-7.
Hammell, C. M., I. Lubin, P. R. Boag, T. K. Blackwell and V. R. Ambros (2009). "nhl-2 Modulates 
MicroRNA Activity in Caenorhabditis elegans." Cell 136(5): 926-38.
Hammond, S. M., E. Bernstein, D. Beach and G. J. Hannon (2000). "An RNA-directed nuclease mediates 
post-transcriptional gene silencing in Drosophila cells." Nature 404(6775): 293-6.
Henke, J. I., D. Goergen, J. Zheng, Y. Song, C. G. Schuttler, C. Fehr, C. Junemann and M. Niepmann 
(2008). "microRNA-122 stimulates translation of hepatitis C virus RNA." EMBO J 27(24): 
3300-10.
Heo, I., C. Joo, J. Cho, M. Ha, J. Han and V. N. Kim (2008). "Lin28 mediates the terminal uridylation of 
let-7 precursor MicroRNA." Mol Cell 32(2): 276-84.
Heo, I., C. Joo, Y. K. Kim, M. Ha, M. J. Yoon, J. Cho, K. H. Yeom, J. Han and V. N. Kim (2009). "TUT4 
in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation." 
Cell 138(4): 696-708.
Holtz, J. and A. E. Pasquinelli (2009). "Uncoupling of lin-14 mRNA and protein repression by nutrient 
deprivation in Caenorhabditis elegans." RNA 15(3): 400-5.
Hu, W., T. J. Sweet, S. Chamnongpol, K. E. Baker and J. Coller (2009). "Co-translational mRNA decay in 
Saccharomyces cerevisiae." Nature 461(7261): 225-9.
101
Huang, J., Z. Liang, B. Yang, H. Tian, J. Ma and H. Zhang (2007). "Derepression of microRNA-mediated 
protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-
like 3G (APOBEC3G) and its family members." J Biol Chem 282(46): 33632-40.
Humphreys, D. T., B. J. Westman, D. I. Martin and T. Preiss (2005). "MicroRNAs control translation 
initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function." Proc Natl 
Acad Sci USA 102(47): 16961-6.
Hutvagner, G. and M. J. Simard (2008). "Argonaute proteins: key players in RNA silencing." Nat Rev 
Mol Cell Biol 9(1): 22-32.
Ibanez-Ventoso, C., M. Vora and M. Driscoll (2008). "Sequence relationships among C. elegans, D. 
melanogaster and human microRNAs highlight the extensive conservation of microRNAs in 
biology." PLoS ONE 3(7): e2818.
Iwasaki, S., T. Kawamata and Y. Tomari (2009). "Drosophila argonaute1 and argonaute2 employ distinct 
mechanisms for translational repression." Mol Cell 34(1): 58-67.
Jackson, R. J. and N. Standart (2007). "How do microRNAs regulate gene expression?" Sci STKE 2007
(367): re1.
Kamath, R. S., A. G. Fraser, Y. Dong, G. Poulin, R. Durbin, M. Gotta, A. Kanapin, N. Le Bot, S. Moreno, 
M. Sohrmann, D. P. Welchman, et al. (2003). "Systematic functional analysis of the 
Caenorhabditis elegans genome using RNAi." Nature 421(6920): 231-7.
Karres, J. S., V. Hilgers, I. Carrera, J. Treisman and S. M. Cohen (2007). "The conserved microRNA 
miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila." Cell 131(1): 136-45.
Katoh, T., Y. Sakaguchi, K. Miyauchi, T. Suzuki, S. Kashiwabara, T. Baba and T. Suzuki (2009). 
"Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the 
cytoplasmic poly(A) polymerase GLD-2." Genes Dev 23(4): 433-8.
Kedde, M., M. J. Strasser, B. Boldajipour, J. A. Vrielink, K. Slanchev, C. le Sage, R. Nagel, P. M. 
Voorhoeve, J. van Duijse, U. A. Ørom, A. H. Lund, et al. (2007). "RNA-binding protein Dnd1 
inhibits microRNA access to target mRNA." Cell 131(7): 1273-86.
Kimble, J. and D. Hirsh (1979). "The postembryonic cell lineages of the hermaphrodite and male gonads 
in Caenorhabditis elegans." Dev Biol 70(2): 396-417.
Kinch, L. N. and N. V. Grishin (2009). "The human Ago2 MC region does not contain an eIF4E-like 
mRNA Cap Binding motif." Biology Direct 2009 4:2 4(1): 2.
Kiriakidou, M., G. S. Tan, S. Lamprinaki, M. De Planell-Saguer, P. T. Nelson and Z. Mourelatos (2007). 
"An mRNA m7G cap binding-like motif within human Ago2 represses translation." Cell 129(6): 
1141-51.
Klattenhoff, C. and W. Theurkauf (2008). "Biogenesis and germline functions of piRNAs." Development 
135(1): 3-9.
102
Kloosterman, W. P., E. Wienholds, R. F. Ketting and R. H. Plasterk (2004). "Substrate requirements for 
let-7 function in the developing zebrafish embryo." Nucleic Acids Res 32(21): 6284-91.
Kong, Y. W., I. G. Cannell, C. H. de Moor, K. Hill, P. G. Garside, T. L. Hamilton, H. A. Meijer, H. C. 
Dobbyn, M. Stoneley, K. A. Spriggs, A. E. Willis, et al. (2008). "The mechanism of micro-RNA-
mediated translation repression is determined by the promoter of the target gene." Proc Natl 
Acad Sci U S A 105(26): 8866-71.
Krek, A., D. Grun, M. N. Poy, R. Wolf, L. Rosenberg, E. J. Epstein, P. MacMenamin, I. da Piedade, K. C. 
Gunsalus, M. Stoffel and N. Rajewsky (2005). "Combinatorial microRNA target predictions." 
Nat Genet 37(5): 495-500.
Krutzfeldt, J., N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan and M. Stoffel (2005). 
"Silencing of microRNAs in vivo with 'antagomirs'." Nature 438(7068): 685-9.
Lagos-Quintana, M., R. Rauhut, W. Lendeckel and T. Tuschl (2001). "Identification of novel genes coding 
for small expressed RNAs." Science 294(5543): 853-8.
Lall, S., H. Francis-Lang, A. Flament, A. Norvell, T. Schüpbach and D. Ish-Horowicz (1999). "Squid 
hnRNP protein promotes apical cytoplasmic transport and localization of Drosophila pair-rule 
transcripts." Cell 98(2): 171-80.
Lall, S., D. Grun, A. Krek, K. Chen, Y. L. Wang, C. N. Dewey, P. Sood, T. Colombo, N. Bray, P. 
Macmenamin, H. L. Kao, et al. (2006). "A genome-wide map of conserved microRNA targets in 
C. elegans." Curr Biol 16(5): 460-71.
Lau, N. C., L. P. Lim, E. G. Weinstein and D. P. Bartel (2001). "An abundant class of tiny RNAs with 
probable regulatory roles in Caenorhabditis elegans." Science 294(5543): 858-62.
Lazzaretti, D., I. Tournier and E. Izaurralde (2009). "The C-terminal domains of human TNRC6A, 
TNRC6B, and TNRC6C silence bound transcripts independently of Argonaute proteins." RNA 
15(6): 1059-66.
Lee, R. C. and V. R. Ambros (2001). "An extensive class of small RNAs in Caenorhabditis elegans." 
Science 294(5543): 862-4.
Lee, R. C., R. L. Feinbaum and V. R. Ambros (1993). "The C. elegans heterochronic gene lin-4 encodes 
small RNAs with antisense complementarity to lin-14." Cell 75(5): 843-54.
Lehrbach, N. J., J. Armisen, H. L. Lightfoot, K. J. Murfitt, A. Bugaut, S. Balasubramanian and E. A. 
Miska (2009). "LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing 
in Caenorhabditis elegans." Nat Struct Mol Biol 10.1038/nsmb.1675.
Lewis, B. P., C. B. Burge and D. P. Bartel (2005). "Conserved seed pairing, often flanked by adenosines, 
indicates that thousands of human genes are microRNA targets." Cell 120(1): 15-20.
103
Lian, S. L., S. Li, G. X. Abadal, B. A. Pauley, M. J. Fritzler and E. K. Chan (2009). "The C-terminal half 
of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate 
silencing." RNA 15(5): 804-13.
Lim, L. P., N. C. Lau, P. Garrett-Engele, A. Grimson, J. M. Schelter, J. Castle, D. P. Bartel, P. S. Linsley 
and J. M. Johnson (2005). "Microarray analysis shows that some microRNAs downregulate 
large numbers of target mRNAs." Nature 433(7027): 769-73.
Liu, J., F. V. Rivas, J. A. Wohlschlegel, J. R. Yates, R. Parker and G. J. Hannon (2005a). "A role for the P-
body component GW182 in microRNA function." Nat Cell Biol 7(12): 1261-6.
Liu, J., M. A. Valencia-Sanchez, G. J. Hannon and R. Parker (2005b). "MicroRNA-dependent localization 
of targeted mRNAs to mammalian P-bodies." Nat Cell Biol 7(7): 719-23.
Llave, C., Z. Xie, K. D. Kasschau and J. C. Carrington (2002). "Cleavage of Scarecrow-like mRNA 
targets directed by a class of Arabidopsis miRNA." Science 297(5589): 2053-6.
Lytle, J. R., T. A. Yario and J. A. Steitz (2007). "Target mRNAs are repressed as efficiently by 
microRNA-binding sites in the 5' UTR as in the 3' UTR." Proc Natl Acad Sci USA 104(23): 
9667-72.
Maroney, P. A., Y. Yu, J. Fisher and T. W. Nilsen (2006). "Evidence that microRNAs are associated with 
translating messenger RNAs in human cells." Nat Struct Mol Biol 13(12): 1102-7.
Mathonnet, G., M. R. Fabian, Y. V. Svitkin, A. Parsyan, L. Huck, T. Murata, S. Biffo, W. C. Merrick, E. 
Darzynkiewicz, R. S. Pillai, W. Filipowicz, et al. (2007). "MicroRNA inhibition of translation 
initiation in vitro by targeting the cap-binding complex eIF4F." Science 317(5845): 1764-7.
Mattick, J. S. (2001). "Non-coding RNAs: the architects of eukaryotic complexity." EMBO Rep 2(11): 
986-91.
Mattick, J. S. (2003). "Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex 
organisms." Bioessays 25(10): 930-9.
Meister, G., M. Landthaler, L. Peters, P. Y. Chen, H. Urlaub, R. Lührmann and T. Tuschl (2005). 
"Identification of novel argonaute-associated proteins." Curr Biol 15(23): 2149-55.
Mishima, Y., A. J. Giraldez, Y. Takeda, T. Fujiwara, H. Sakamoto, A. F. Schier and K. Inoue (2006). 
"Differential regulation of germline mRNAs in soma and germ cells by zebrafish miR-430." 
Curr Biol 16(21): 2135-42.
Miska, E. A., E. Alvarez-Saavedra, A. L. Abbott, N. C. Lau, A. B. Hellman, S. M. McGonagle, D. P. 
Bartel, V. R. Ambros and H. R. Horvitz (2007). "Most Caenorhabditis elegans microRNAs Are 
Individually Not Essential for Development or Viability." PLoS Genet 3(12): e215.
Molnár, A., F. Schwach, D. J. Studholme, E. C. Thuenemann and D. C. Baulcombe (2007). "miRNAs 
control gene expression in the single-cell alga Chlamydomonas reinhardtii." Nature 447(7148): 
1126-9.
104
Napoli, C., C. Lemieux and R. Jorgensen (1990). "Introduction of a Chimeric Chalcone Synthase Gene 
into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans." Plant Cell 2
(4): 279-289.
Neilson, J. R. and P. A. Sharp (2008). "Small RNA regulators of gene expression." Cell 134(6): 899-902.
Nelson, P. T., A. G. Hatzigeorgiou and Z. Mourelatos (2004). "miRNP:mRNA association in 
polyribosomes in a human neuronal cell line." RNA 10(3): 387-94.
Newman, M. A., J. M. Thomson and S. M. Hammond (2008). "Lin-28 interaction with the Let-7 
precursor loop mediates regulated microRNA processing." RNA 14(8): 1539-49.
Nilsen, T. W. (2007). "Mechanisms of microRNA-mediated gene regulation in animal cells." Trends 
Genet 23(5): 243-9.
Nottrott, S., M. J. Simard and J. D. Richter (2006). "Human let-7a miRNA blocks protein production on 
actively translating polyribosomes." Nat Struct Mol Biol 13(12): 1108-14.
Novina, C. D. and P. A. Sharp (2004). "The RNAi revolution." Nature 430(6996): 161-4.
Okamura, K. and E. C. Lai (2008). "Endogenous small interfering RNAs in animals." Nat Rev Mol Cell 
Biol 9(9): 673-8.
Olsen, P. H. and V. R. Ambros (1999). "The lin-4 regulatory RNA controls developmental timing in 
Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation." 
Dev Biol 216(2): 671-80.
Orom, U. A., F. C. Nielsen and A. H. Lund (2008). "MicroRNA-10a Binds the 5'UTR of Ribosomal 
Protein mRNAs and Enhances Their Translation." Mol Cell 30(4): 460-71.
Parker, R. and U. Sheth (2007). "P bodies and the control of mRNA translation and degradation." Mol 
Cell 25(5): 635-46.
Parry, D. H., J. Xu and G. B. Ruvkun (2007). "A whole-genome RNAi Screen for C. elegans miRNA 
pathway genes." Curr Biol 17(23): 2013-22.
Pasquinelli, A. E., B. J. Reinhart, F. J. Slack, M. Q. Martindale, M. I. Kuroda, B. Maller, D. C. Hayward, 
E. E. Ball, B. Degnan, P. Müller, J. Spring, et al. (2000). "Conservation of the sequence and 
temporal expression of let-7 heterochronic regulatory RNA." Nature 408(6808): 86-9.
Petersen, C. P., M. E. Bordeleau, J. Pelletier and P. A. Sharp (2006). "Short RNAs repress translation after 
initiation in mammalian cells." Mol Cell 21(4): 533-42.
Pillai, R. S., S. N. Bhattacharyya, C. G. Artus, T. Zoller, N. Cougot, E. Basyuk, E. Bertrand and W. 
Filipowicz (2005). "Inhibition of translational initiation by Let-7 MicroRNA in human cells." 
Science 309(5740): 1573-6.
105
Pillai, R. S., S. N. Bhattacharyya and W. Filipowicz (2007). "Repression of protein synthesis by miRNAs: 
how many mechanisms?" Trends Cell Biol 17(3): 118-26.
Rajyaguru, P. and R. Parker (2009). "CGH-1 and the control of maternal mRNAs." Trends Cell Biol 19
(1): 24-8.
Ramachandran, V. and X. Chen (2008). "Degradation of microRNAs by a family of exoribonucleases in 
Arabidopsis." Science 321(5895): 1490-2.
Rehwinkel, J., I. Behm-Ansmant, D. Gatfield and E. Izaurralde (2005). "A crucial role for GW182 and the 
DCP1:DCP2 decapping complex in miRNA-mediated gene silencing." RNA 11(11): 1640-7.
Rehwinkel, J., P. Natalin, A. Stark, J. Brennecke, S. M. Cohen and E. Izaurralde (2006). "Genome-wide 
analysis of mRNAs regulated by Drosha and Argonaute proteins in Drosophila melanogaster." 
Mol Cell Biol 26(8): 2965-75.
Reinhart, B. J., F. J. Slack, M. Basson, A. E. Pasquinelli, J. C. Bettinger, A. E. Rougvie, H. R. Horvitz and 
G. B. Ruvkun (2000). "The 21-nucleotide let-7 RNA regulates developmental timing in 
Caenorhabditis elegans." Nature 403(6772): 901-6.
Reinhart, B. J., E. G. Weinstein, M. W. Rhoades, B. Bartel and D. P. Bartel (2002). "MicroRNAs in 
plants." Genes Dev 16(13): 1616-26.
Rhoades, M. W., B. J. Reinhart, L. P. Lim, C. B. Burge, B. Bartel and D. P. Bartel (2002). "Prediction of 
plant microRNA targets." Cell 110(4): 513-20.
Rhoads, R. E., T. D. Dinkova and N. L. Korneeva (2006). "Mechanism and regulation of translation in C. 
elegans." WormBook : the online review of C elegans biology: 1-18.
Richter, J. D. (2008). "Think you know how miRNAs work? Think again." Nat Struct Mol Biol 15(4): 
334-6.
Rybak, A., H. Fuchs, L. Smirnova, C. Brandt, E. E. Pohl, R. Nitsch and F. G. Wulczyn (2008). "A 
feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell 
commitment." Nat Cell Biol 10(8): 987-93.
Saxena, S., Z. O. Jónsson and A. Dutta (2003). "Small RNAs with imperfect match to endogenous 
mRNA repress translation. Implications for off-target activity of small inhibitory RNA in 
mammalian cells." J Biol Chem 278(45): 44312-9.
Schmitter, D., J. Filkowski, A. Sewer, R. S. Pillai, E. J. Oakeley, M. Zavolan, P. Svoboda and W. 
Filipowicz (2006). "Effects of Dicer and Argonaute down-regulation on mRNA levels in human 
HEK293 cells." Nucleic Acids Res 34(17): 4801-15.
Seggerson, K., L. Tang and E. G. Moss (2002). "Two genetic circuits repress the Caenorhabditis elegans 
heterochronic gene lin-28 after translation initiation." Dev Biol 243(2): 215-25.
106
Selbach, M., B. Schwanhausser, N. Thierfelder, Z. Fang, R. Khanin and N. Rajewsky (2008). 
"Widespread changes in protein synthesis induced by microRNAs." Nature 455(7209): 58-63.
Sen, G. L. and H. M. Blau (2005). "Argonaute 2/RISC resides in sites of mammalian mRNA decay 
known as cytoplasmic bodies." Nat Cell Biol 7(6): 633-6.
Sood, P., A. Krek, M. Zavolan, G. Macino and N. Rajewsky (2006). "Cell-type-specific signatures of 
microRNAs on target mRNA expression." Proc Natl Acad Sci U S A 103(8): 2746-51.
Standart, N. and R. J. Jackson (2007). "MicroRNAs repress translation of m7Gppp-capped target mRNAs 
in vitro by inhibiting initiation and promoting deadenylation." Genes Dev 21(16): 1975-82.
Stark, A., J. Brennecke, N. Bushati, R. B. Russell and S. M. Cohen (2005). "Animal MicroRNAs confer 
robustness to gene expression and have a significant impact on 3'UTR evolution." Cell 123(6): 
1133-46.
Stelling, J., U. Sauer, Z. Szallasi, F. J. Doyle and J. Doyle (2004). "Robustness of cellular functions." Cell 
118(6): 675-85.
Sulston, J. E. and H. R. Horvitz (1977). "Post-embryonic cell lineages of the nematode, Caenorhabditis 
elegans." Dev Biol 56(1): 110-56.
Szymański, M. and J. Barciszewski (2008). Noncoding RNAs in Human Diseases. RNA Technologies in 
Cardiovascular Medicine and Research: 235-254.
Takimoto, K., M. Wakiyama and S. Yokoyama (2009). "Mammalian GW182 contains multiple 
Argonaute-binding sites and functions in microRNA-mediated translational repression." RNA 15
(6): 1078-89.
Thermann, R. and M. W. Hentze (2007). "Drosophila miR2 induces pseudo-polysomes and inhibits 
translation initiation." Nature 447(7146): 875-8.
Tops, B. B., R. H. Plasterk and R. F. Ketting (2006). "The Caenorhabditis elegans Argonautes ALG-1 and 
ALG-2: almost identical yet different." Cold Spring Harb Symp Quant Biol 71: 189-94.
van der Krol, A. R., P. E. Lenting, J. Veenstra, I. M. van der Meer, R. E. Koes, A. G. M. Gerats, J. N. M. 
Mol and A. R. Stuitje (1988). "An anti-sense chalcone synthase gene in transgenic plants inhibits 
flower pigmentation." Nature 333(6176): 866-869.
Vasudevan, S., Y. Tong and J. A. Steitz (2007). "Switching from repression to activation: microRNAs can 
up-regulate translation." Science 318(5858): 1931-4.
Vazquez, F. (2006). "Arabidopsis endogenous small RNAs: highways and byways." Trends Plant Sci 11
(9): 460-8.
Viswanathan, S. R., G. Q. Daley and R. I. Gregory (2008). "Selective blockade of microRNA processing 
by Lin28." Science 320(5872): 97-100.
107
Wakiyama, M., K. Takimoto, O. Ohara and S. Yokoyama (2007). "Let-7 microRNA-mediated mRNA 
deadenylation and translational repression in a mammalian cell-free system." Genes Dev 21(15): 
1857-62.
Wang, B., T. M. Love, M. E. Call, J. G. Doench and C. D. Novina (2006). "Recapitulation of short RNA-
directed translational gene silencing in vitro." Mol Cell 22(4): 553-60.
Wang, B., A. Yanez and C. D. Novina (2008). "MicroRNA-repressed mRNAs contain 40S but not 60S 
components." Proc Natl Acad Sci USA 105(14): 5343-8.
Wilusz, J. E., H. Sunwoo and D. L. Spector (2009). "Long noncoding RNAs: functional surprises from 
the RNA world." Genes Dev 23(13): 1494-504.
Wu, L. and J. G. Belasco (2008). "Let me count the ways: mechanisms of gene regulation by miRNAs 
and siRNAs." Mol Cell 29(1): 1-7.
Wu, L., J. Fan and J. G. Belasco (2006). "MicroRNAs direct rapid deadenylation of mRNA." Proc Natl 
Acad Sci USA 103(11): 4034-9.
Xiao, C., D. P. Calado, G. Galler, T. H. Thai, H. C. Patterson, J. Wang, N. Rajewsky, T. P. Bender and K. 
Rajewsky (2007). "MiR-150 controls B cell differentiation by targeting the transcription factor c-
Myb." Cell 131(1): 146-59.
Yekta, S., I. H. Shih and D. P. Bartel (2004). "MicroRNA-directed cleavage of HOXB8 mRNA." Science 
304(5670): 594-6.
Zamore, P. D., T. Tuschl, P. A. Sharp and D. P. Bartel (2000). "RNAi: double-stranded RNA directs the 
ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals." Cell 101(1): 25-33.
Zhang, L., L. Ding, T. H. Cheung, M. Q. Dong, J. Chen, A. K. Sewell, X. Liu, J. R. Yates and M. Han 
(2007). "Systematic identification of C. elegans miRISC proteins, miRNAs, and mRNA targets 
by their interactions with GW182 proteins AIN-1 and AIN-2." Mol Cell 28(4): 598-613.
Zhao, J., B. K. Sun, J. A. Erwin, J. J. Song and J. T. Lee (2008). "Polycomb Proteins Targeted by a Short 
Repeat RNA to the Mouse X Chromosome." Science 322(5902): 750-756.
Zhao, T., G. Li, S. Mi, S. Li, G. J. Hannon, X. J. Wang and Y. Qi (2007). "A complex system of small 
RNAs in the unicellular green alga Chlamydomonas reinhardtii." Genes Dev 21(10): 1190-203.
Zhou, B., S. Wang, C. Mayr, D. P. Bartel and H. F. Lodish (2007). "miR-150, a microRNA expressed in 
mature B and T cells, blocks early B cell development when expressed prematurely." Proc Natl 
Acad Sci U S A 104(17): 7080-5.
Zipprich, J. T., S. Bhattacharyya, H. Mathys and W. Filipowicz (2009). "Importance of the C-terminal 
domain of the human GW182 protein TNRC6C for translational repression." RNA 15(5): 
781-93.
108
6. Curriculum vitae
109

111
 
 
 
 
 
nationality Swiss 
marital status single 
 date of birth 28 09 1981 
 
 
 
 
Contact 
 
professional 
 
 Xavier Ding 
 Friedrich Miescher Institute (FMI)  
 WRO 1066.1.52 
 Maulberstrasse 66 
 4058 Basel, Switzerland 
 
 phone +41 61 697 66 84 
 e-mail xavier.ding@fmi.ch 
 
private 
 
 Xavier Ding 
 Landskronstrasse 46 
 4056 Basel, Switzerland 
 
  
 
 phone +41 79 756 09 82 
 e-mail xavier.ding@gmail.com 
 
Actual position 
 
 Since 1st of December 2005 
 PhD student, Friedrich Miescher Institute (FMI), Basel, Switzerland 
 Supervisor Dr. H. Grosshans (helge.grosshans@fmi.ch) 
 Project Analysis of microRNA mode-of-action in vivo 
 
Publications 
 
Hurschler B. A., Ding X. C. & Großhans H. 
Translational Control of Endogenous MicroRNA Target Genes in C. elegans. Prog Mol 
Subcell Biol 50, 21-40 (2010) 
 
Ding X. C., Lugrin J., Le Roy D., Chanson A.-L., Sweep Fred C. G. J., Calandra T., 
Roger T. 
Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) 
expression by targeting MIF gene transcription through a local chromatin 
deacetylation. Biochim Biophys Acta 1793, 1749-58 (2009). 
 
Ding X. C. & Großhans H. 
Repression of C. elegans microRNA targets at the initiation level of translation 
requires GW182 proteins. EMBO J 28, 213-22 (2009) 
 
Ding, X. C., Weiler J. & Großhans, H. 
Regulating the regulators: mechanisms controlling the maturation of microRNAs. 
Trends Biotechnol 27, 27-36 (2009). 
 
Xavier Ding 
112
Ding, X. C., Slack, F. J. & Großhans, H. 
The let-7 microRNA interfaces extensively with the translation machinery to regulate 
cell differentiation. Cell Cycle 7, 3083-3090 (2008). 
 
Roger, T., Ding, X., Chanson, A. L., Renner, P. & Calandra, T. 
Regulation of constitutive and microbial pathogen-induced human macrophage 
migration inhibitory factor (MIF) gene expression. Eur J Immunol 37, 3509-3521 (2007). 
  
Jovanovic M., Reiter L., Picotti P., Lange V., Bogan E., Hurschler B., Blenkiron C., Ding 
X. C., Weiss M., Schrimpf S. P., Miska E., Grosshans H., Aebersold R., Hengartner M. O. 
A Quantitative Targeted Proteomics Approach to Identify Biologically Significant, 
Predicted microRNA Targets in C. elegans (in preparation) 
 
 
Awards 
 
 2006 PhD student fellowship awarded by the Boehringer Ingelheim Fonds  
 
International conferences 
 
 2007 USGEB, Basel 
   Selected speaker (“let-7 microRNA function in vivo: role of eif-3”) 
 
   16th International C. elegans Meeting, UCLA, Los Angeles. 
   Selected speaker (“let-7 microRNA mode of action in vivo: 
translational effect and role of eif-3”) 
 
   Protein Synthesis and Translationnal control, EMBL, Heidelberg. 
   Selected speaker (“let-7 microRNA mode of action in vivo: 
translational effect and role of eif-3”) 
 
 2008 3rd microsymposium on small RNAs, IMBA, Vienna. 
   Selected speaker (“Translational control of miRNA targets in vivo 
involves AIN-1/2”) 
 
   13th RNA meeting, Berlin. 
   Selected speaker (“Translational control of endogenous let-7 
microRNA target genes in C. elegans”) 
 
Education 
 
 2000 – 05 Diploma of Biology, University of Lausanne, Lausanne, Switzerland. 
Diploma Thesis, Vaud University Hospital Center (CHUV), Lausanne, 
Switzerland 
Supervisor  Prof. Dr. T. Calandra (thierry.calandra@chuv.ch) 
Project Epigenetic regulation of macrophage migration 
inhibitory factor (MIF) expression. 
 
 1997- 2000 Swiss Federal Maturité, Gymnase Auguste Piccard, Lausanne, 
Switzerland. Section Latin, Ancient-Greek. 
 
113
Language skills 
  
 French native language 
 English very good level, read, written and spoken 
 German good level, read, written and spoken 
 
 
 
 
Basel, September 2009 
